%PDF-1.3
%‚„œ”
1 0 obj
<<
/Type/ExtGState
/OPM 1
>>
endobj
2 0 obj
<<
/SM 0.01
/Type/ExtGState
/FL 1
>>
endobj
3 0 obj
<<
/OP true
/Type/ExtGState
>>
endobj
4 0 obj
<<
/OP false
/Type/ExtGState
>>
endobj
5 0 obj
<<
/Length 9334
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
9 0 0 9 14.1732 672.0087 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364)Tj
ET
0 0 0 0 k
14.173 538.7789 473.386 110.354 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
17 0 0 17 39.1434 637.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(CAP)74(A)55(CID)35(AD DIA)54(GN\356STICA DEL GDx VCC P)74(ARA EL)]TJ
4.56563 -1.05882 TD
[(DIA)55(GN\356STICO DEL GLA)50(UCOMA)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
15 0 0 15 56.3835 587.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(DIA)55(GNOSTIC ABILITY OF GDx VCC FOR GLA)49(UCOMA)]TJ
10.18743 -1.06667 TD
0 Tw
[(DIA)55(GNOSIS)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 45.4909 543.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(BORQ)10(UE E)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 100.3443 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(1)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 104.4693 543.5247 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(,)Tj
0.52488 0 Td
0 Tc
0.025 Tw
(FERRERAS A)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 176.8309 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 180.9559 543.5247 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(,)Tj
0.52486 0 Td
0 Tc
0.025 Tw
(POLO V)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 226.4137 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 230.5387 543.5247 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(,)Tj
0.5249 0 Td
0 Tc
0.025 Tw
[(LARR)40(OSA JM)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 304.2887 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 308.4137 543.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.52491 0 Td
0.025 Tw
[(P)92(ABLO LE)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 365.6959 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 369.8209 543.5247 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.52491 0 Td
0.025 Tw
[(HONR)40(UBIA FM)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8.25 0 0 8.25 452.1163 547.1548 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
0 0 0 0 k
14.173 31.181 473.386 118.156 re
f
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 142.086 m
133.228 142.086 l
S
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 131.9149 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Recibido:)-250(3/9/07. Aceptado: 14/5/08.)]TJ
0 -1.12499 TD
(Servicio de Oftalmolog\222a. Hospital Universitario Miguel Servet. Instituto Aragon\216s de Ciencias de la Salud. Zaragoza. Espa\226a.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
6 0 0 6 14.1732 116.555 Tm
0 Tr
0 0 0 1 k
0 Tc
(1)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 21.1732 113.915 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(Licenciado en Medicina. )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
6 0 0 6 14.1732 107.555 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 21.1732 104.915 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(Doctor en Medicina. )Tj
-0.875 -2.25 TD
0 Tw
(Correspondencia:)Tj
0 -1.125 TD
0.025 Tw
(Enrique Borque Rodr\222guez-Maim\227n)Tj
T*
(Consultas Oftalmolog\222a Hospital Universitario Miguel Servet)Tj
T*
(Isabel la Cat\227lica, 1-3)Tj
T*
(50009 Zaragoza)Tj
T*
0 Tw
(Espa\226a)Tj
T*
0.025 Tw
(E-mail: eborque@gmail.com)Tj
ET
0 0 0 0 k
14.173 170.596 226.772 342.9919 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 95.0622 504.7111 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(RESUMEN)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 480.411 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(Objeti)10(v)9(o:)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 62.4247 480.411 Tm
0 Tr
0 0 0 1 k
0 Tc
0.102 Tw
[(Ev)25(aluar la capacidad diagn\227stica de los)]TJ
-4.3865 -1.10454 TD
0.093 Tw
(distintos par\207metros que ofrece el GDx VCC para)Tj
0 -1.10453 TD
0.025 Tw
(discriminar entre ojos sanos y glaucomatosos. )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 443.9612 Tm
0 Tr
0 0 0 1 k
0 Tc
0.197 Tw
(Material y m\216todos:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 118.0965 443.9612 Tm
0 Tr
0 0 0 1 k
0 Tc
0.197 Tw
(Se seleccionaron de forma)Tj
-9.44757 -1.10454 TD
0.083 Tw
[(prospecti)25(v)25(a y consecuti)24(v)25(a 417 ojos de 417 pacien-)]TJ
T*
0.001 Tw
[(tes. Fueron di)25(vididos en 60 controles, 218 hiperten-)]TJ
0 -1.10455 TD
0.201 Tw
(sos oculares, 68 glaucomas preperim\216tricos y 71)Tj
0 -1.10454 TD
0.007 Tw
(glaucomas se)Tj
5.35069 0.00001 TD
(g\234n la presi\227n intraocular)Tj
10.22589 0 TD
-0.0001 Tc
(,)Tj
0.50649 0 Td
0 Tc
(la morfolo)Tj
4.19978 0 TD
(-)Tj
-20.28284 -1.10455 TD
0.134 Tw
(g\222a papilar y los resultados en la perimetr\222a auto-)Tj
0 -1.10454 TD
0.077 Tw
[(matizada con)40(v)15(encional A todos ellos se les realiz\227)]TJ
T*
-0.002 Tw
(una polarimetr\222a l\207ser con el GDx VCC. Se compa-)Tj
0 -1.10455 TD
0.053 Tw
[(raron los par\207metros de la capa de f)20(ibras nerviosas)]TJ
0 -1.10454 TD
-0.037 Tw
(de la retina (CFNR) del GDx-VCC entre los grupos.)Tj
T*
-0.018 Tw
[(Se calcularon las curv)25(as R)40(OC entre el grupo normal)]TJ
-0.0001 Tc
(y)'
1.01572 0 Td
0 Tc
0.266 Tw
(de glaucomas. Se consideraron como mejores)Tj
-1.01572 -1.10454 TD
0.145 Tw
[(par\207metros aquellos con mejor \207rea bajo la curv)25(a)]TJ
0 -1.10455 TD
0.058 Tw
[(R)40(OC y el mejor balance de sensibilidad/especif)19(ici-)]TJ
0 -1.10454 TD
0 Tw
(dad.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 261.7112 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Resultados: )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 75.5987 261.7112 Tm
0 Tr
0 0 0 1 k
0 Tc
0.335 Tw
(La mayor\222a de los par\207metros del)Tj
-5.58414 -1.10454 TD
0.058 Tw
(GDx-VCC mostraron diferencias entre el grupo de)Tj
0 -1.10455 TD
0.081 Tw
(glaucomas y el resto de los grupos. Algunos par\207-)Tj
0 -1.10454 TD
0.234 Tw
(metros fueron tambi\216n diferentes al comparar el)Tj
T*
-0.022 Tw
(grupo normal y el de glaucomas preperim\216tricos. El)Tj
T*
0.088 Tw
(mejor de ellos fue el indicador de f)Tj
14.55858 0.00001 TD
(ibras nerviosas)Tj
-14.55858 -1.10455 TD
0.138 Tw
(\(NFI; \207rea bajo la curv)Tj
9.63325 0.00001 TD
-0.0001 Tc
(a)Tj
0.83201 0 Td
0 Tc
[(R)40(OC: 0,876\). El NFI, el)]TJ
-10.46526 -1.10455 TD
0.03 Tw
(\207rea inferior normalizada y el \207rea superior norma-)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9.6 0 0 12 384.1655 671.8343 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(AR)40(T\352CULO ORIGIN)19(AL)]TJ
ET
0 0 0 0 k
260.787 172.7999 226.772 340.788 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 339.1405 504.7111 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(ABSTRA)55(CT)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 480.411 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(Pur)10(pose:)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 306.745 480.411 Tm
0 Tr
0 0 0 1 k
0 Tc
0.106 Tw
[(T)80(o assess the diagnostic ability of scan-)]TJ
-4.17796 -1.10454 TD
0.08 Tw
[(ning laser polarimetry (GDx VCC) to dif)25(ferentiate)]TJ
0 -1.10453 TD
0.025 Tw
[(between normal and glaucomatous e)15(yes.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 443.9612 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(Methods:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 310.9099 443.9612 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0.298 Tw
(417 e)Tj
2.45158 0.00001 TD
[(yes of 417 consecuti)25(v)15(e subjects)]TJ
-7.00817 -1.10455 TD
0.222 Tw
[(were prospecti)25(v)15(ely selected. The)14(y were classif)20(ied)]TJ
0 -1.10454 TD
0.221 Tw
[(into 60 health)5(y controls, 218 ocular h)5(ypertensi)24(v)15(e)]TJ
0 -1.10455 TD
0.144 Tw
[(e)15(yes, 68 glaucoma suspects, and 71 glaucomatous)]TJ
0 -1.10454 TD
0 Tc
(e)Tj
0.42396 0 TD
-0.005 Tc
0.013 Tw
(yes, depending on intraocular pressure, optic nerv)Tj
19.74781 0 TD
0 Tc
(e)Tj
-20.17176 -1.10455 TD
-0.005 Tc
-0.012 Tw
(head morphology and standard automated perimetry)Tj
0 -1.10454 TD
0.076 Tw
(results. All underwent a scanning laser polarimetry)Tj
T*
0.002 Tc
0.368 Tw
[(with the GDx VCC. Retinal nerv)15(e f)20(iber layer)]TJ
0 -1.10455 TD
-0.005 Tc
0.066 Tw
((RNFL) parameters of the GDx-VCC were compa-)Tj
0 -1.10454 TD
0.035 Tw
(red among the four groups. Recei)Tj
13.37268 0.00001 TD
[(v)15(er operating cha-)]TJ
-13.37268 -1.10455 TD
0.071 Tw
[(racteristic \(R)40(OC\) curv)14(es were plotted between nor-)]TJ
0 -1.10454 TD
0.213 Tw
[(mal and glaucomatous e)15(yes. The best parameters)]TJ
T*
0.101 Tw
[(were def)20(ined according to the area under the R)39(OC)]TJ
0 -1.10455 TD
0.025 Tw
[(curv)15(e and the best sensiti)25(vity/specif)19(icity balance.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 273.8612 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Results:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 302.751 273.8612 Tm
0 Tr
0 0 0 1 k
0 Tc
0.122 Tw
[(Most parameters of GDx-VCC e)15(xhibited)]TJ
-3.81487 -1.10454 TD
0.21 Tw
[(dif)25(ferences between the glaucoma group and the)]TJ
T*
0.061 Tw
(rest of the groups. Some parameters were also dif-)Tj
0 -1.10455 TD
0.077 Tw
[(ferent between health)5(y patients and glaucoma sus-)]TJ
0 -1.10454 TD
0.053 Tw
(pects. The best parameter w)Tj
11.3891 0 TD
[(as the nerv)15(e f)19(iber indi-)]TJ
-11.3891 -1.10455 TD
0.005 Tw
(cator \(NFI; area under the R)Tj
11.28468 0 TD
[(OC curv)15(e: 0.876\). NFI,)]TJ
-11.28468 -1.10455 TD
0.148 Tw
(superior normalized area, and inferior normalized)Tj
T*
0.208 Tw
(area yielded the highest sensiti)Tj
13.07835 0.00001 TD
(vities at 85% and)Tj
-13.07835 -1.10455 TD
0.025 Tw
[(90% f)20(ix)14(ed specif)20(icity)65(.)]TJ
ET
Q

endstream
endobj
6 0 obj
<<
/Length 9612
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
14.173 7.5279 29.435 12.314 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 14.1732 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(358)Tj
ET
0 0 0 0 k
137.36 10.6629 228.784 9.179 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.0444 14.3792 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 14.1732 672.6915 Tm
0 0 0 1 k
(BORQUE E, et al.)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
0 0 0 0 k
14.173 29.7619 473.386 460.997 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 75.4019 481.8819 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(INTR)30(ODUCCI\356N)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 457.5819 Tm
0 Tr
0 0 0 1 k
0 Tc
0.136 Tw
(El glaucoma primario de \207ngulo abierto es una)Tj
-0.97758 -1.10455 TD
0.023 Tw
(neuropat\222a \227ptica multif)Tj
9.64408 0 TD
(actorial en la que se produ)Tj
10.63877 0 TD
(-)Tj
-20.28285 -1.10455 TD
-0.0001 Tc
(ce)Tj
1.12947 0 Td
0 Tc
-0.008 Tw
(una p\216rdida progresi)Tj
8.17682 0 TD
(v)Tj
0.4751 0 TD
-0.0001 Tc
(a)Tj
0.68559 0 Td
0 Tc
(de los axones de las c\216lu-)Tj
-10.46698 -1.10455 TD
0.085 Tw
[(las g)5(anglionares. El da\226o en la capa de f)20(ibras ner)-1(-)]TJ
T*
0.077 Tw
(viosas de la retina (CFNR) se sigue habitualmente)Tj
0 -1.10454 TD
-0.0001 Tc
(de)Tj
1.27214 0 Td
0 Tc
0.078 Tw
(una serie de cambios estructurales en la cabeza)Tj
-1.27214 -1.10454 TD
-0.0001 Tc
(del)Tj
1.49432 0 Td
0 Tc
0.023 Tw
(nervio \227ptico y de defectos caracter\222sticos en el)Tj
-1.49432 -1.10454 TD
0.025 Tw
(campo visual (1,2).)Tj
0.97758 -1.10454 TD
0.043 Tw
(Algunos estudios han sugerido que las alteracio-)Tj
-0.97758 -1.10454 TD
0.217 Tw
(nes en la CFNR pueden detectarse hasta 6 a\226os)Tj
0 -1.10455 TD
0.05 Tw
(antes de la aparici\227n de defectos consistentes en el)Tj
T*
0.006 Tw
[(campo visual (3). Con el f)20(in de superar la subjeti)25(vi)-1(-)]TJ
T*
-0.03 Tw
[(dad en la v)25(aloraci\227n de los m\216todos tradicionales de)]TJ
T*
-0.031 Tw
[(e)25(v)25(aluaci\227n de la CFNR, como las fotograf\222as mono-)]TJ
0 -1.10454 TD
0.014 Tw
(crom\207ticas (4,5), en los \234ltimos a\226os han aparecido)Tj
0 -1.10455 TD
0 Tw
(di)Tj
0.75294 0.00001 TD
0.231 Tw
[(v)15(ersos equipos capaces de obtener im\207genes y)]TJ
-0.75294 -1.10455 TD
0.02 Tw
[(datos cuantitati)25(v)20(os de la CFNR de forma objeti)24(v)25(a y)]TJ
0 -1.10454 TD
0.034 Tw
(reproducible. Una de estas tecnolog\222as es la polari-)Tj
T*
0.024 Tw
[(metr\222a l\207ser (GDx) cuya \234ltima v)15(ersi\227n comerciali-)]TJ
T*
0.006 Tc
0.368 Tw
(zada incluye un compensador corneal v)Tj
17.85669 0.00001 TD
0 Tw
(ariable)Tj
-17.85669 -1.10455 TD
0 Tc
0.026 Tw
((VCC) de la birrefringencia del polo anterior (6-8).)Tj
0 -1.10454 TD
0.0132 Tc
(El)Tj
1.54031 0 Td
0.013 Tc
0.362 Tw
(GDx-VCC estima el espesor de la CFNR)Tj
-1.54031 -1.10455 TD
0 Tc
0.067 Tw
(midiendo el retardo en el haz de un l\207ser polariza)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
-0.037 Tw
[(do, inducido por los microt\234b)20(ulos birrefringentes de)]TJ
T*
0.205 Tw
(los axones de las c\216lulas g)Tj
11.54296 0.00001 TD
(anglionares (9,10). El)Tj
-11.54296 -1.10455 TD
0.006 Tw
(GDx-VCC analiza una franja de la CFNR peripapi)Tj
20.28285 0.00001 TD
(-)Tj
-20.28285 -1.10456 TD
0.01 Tw
[(lar y ofrece al cl\222nico di)25(v)15(ersos mapas y par\207metros,)]TJ
0 -1.10454 TD
0.309 Tw
(tanto globales como relati)Tj
11.26086 0.00001 TD
(v)Tj
0.48023 0.00001 TD
(os, e incluye los de)Tj
-11.7411 -1.1046 TD
-0.01 Tw
(mayor importancia en el informe resumido que pre-)Tj
0 -1.1045 TD
-0.002 Tw
(senta. En este informe tambi\216n se incluye el indica)Tj
20.28284 0.00001 TD
(-)Tj
-20.2828 -1.1045 TD
0.011 Tw
(dor de f)Tj
3.1123 0 TD
(ibras nerviosas (NFI) y los par\207metros rela)Tj
17.1705 0.00001 TD
(-)Tj
-20.2828 -1.1046 TD
0.009 Tw
[(ti)25(v)19(os a la curv)25(a que representa el espesor de la capa)]TJ
0 -1.1045 TD
0.02 Tc
0.425 Tw
(de f)Tj
2.0121 0 TD
(ibras nerviosas, curv)Tj
9.49176 0.00001 TD
0.0199 Tc
(a)Tj
1.15908 0 Td
0.02 Tc
(TSNIT \(promedio)Tj
-12.663 -1.1046 TD
0 Tc
0.3 Tw
[(TSNIT)74(, promedio superior)39(, promedio inferior)40(, y)]TJ
0 -1.1045 TD
0.192 Tw
(desviaci\227n est\207ndar TSNIT\), que se basan en un)Tj
T*
0.006 Tw
(c\207lculo que el aparato establece de forma autom\207ti)Tj
20.28285 0.00001 TD
(-)Tj
2.13662 40.99231 TD
-0.019 Tw
(ca en un c\222rculo alrededor de la papila. El NFI es un)Tj
0 -1.10454 TD
0.009 Tw
(par\207metro global basado en el mapa de espesor que)Tj
T*
0.038 Tw
(se calcula a partir de redes neuronales denominado)Tj
0 -1.10455 TD
0.044 Tw
[(Support V)111(ector Machine (SVM). Los resultados de)]TJ
0 -1.10453 TD
-0.026 Tw
(los par\207metros TSNIT se comparan con una base de)Tj
0 -1.10454 TD
0.038 Tw
(datos normalizada que el aparato incorpora en fun-)Tj
T*
0.047 Tw
[(ci\227n de la edad y grupo \216tnico, para ser estratif)20(ica)-1(-)]TJ
0 -1.10455 TD
0.025 Tw
[(dos por ni)25(v)15(eles de probabilidad.)]TJ
0.97758 -1.10455 TD
0.276 Tw
[(Di)25(v)15(ersos f)9(actores pueden modif)20(icar la v)25(alidez)]TJ
-0.97758 -1.10454 TD
0.115 Tw
[(interna y e)15(xterna de un estudio de precisi\227n diag-)]TJ
0 -1.10455 TD
0.203 Tw
[(n\227stica. Debido a ello, se desarroll\227 la iniciati)25(v)25(a)]TJ
T*
0.315 Tw
[(ST)93(ARD \(Standards for Reporting of Diagnostic)]TJ
0 -1.10454 TD
0.02 Tc
0.362 Tw
[(Accurac)15(y\) \(11\). El prop\227sito de la iniciati)25(v)25(a)]TJ
0 -1.10455 TD
0 Tc
0.194 Tw
[(ST)93(ARD es mejorar la calidad de los estudios de)]TJ
T*
0.157 Tw
(capacidad diagn\227stica. Por ello, el dise\226o de este)Tj
T*
-0.012 Tw
[(estudio se realiz\227 de acuerdo a los 25 puntos def)20(ini-)]TJ
T*
0.025 Tw
[(dos en la iniciati)25(v)25(a ST)92(ARD.)]TJ
0.97758 -1.10455 TD
0.268 Tw
[(El objeti)25(v)20(o del presente estudio es e)24(v)25(aluar la)]TJ
-0.97758 -1.10454 TD
0.175 Tw
(capacidad diagn\227stica de los distintos par\207metros)Tj
T*
-0.01 Tw
(que ofrece el GDx-VCC para discriminar entre ojos)Tj
T*
0.034 Tw
[(sanos, hipertensos oculares \(HT)18(O\), glaucomas pre-)]TJ
T*
0.025 Tw
(perim\216tricos y glaucomatosos.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 265.4756 189.7978 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(SUJET)18(OS, MA)95(TERIAL Y M\203T)17(ODOS)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 271.5408 165.4978 Tm
0 Tr
0 0 0 1 k
0 Tc
0.053 Tw
(El dise\226o del estudio fue aceptado por el comit\216)Tj
-0.97758 -1.10454 TD
0.068 Tw
[(de \216tica del hospital, todos los participantes f)20(irma)-1(-)]TJ
T*
0.094 Tw
(ron el consentimiento informado y la metodolog\222a)Tj
0 -1.10455 TD
0.016 Tw
(del estudio se realiz\227 siguiendo las directrices de la)Tj
T*
0.025 Tw
(Declaraci\227n del Helsinki (1964). )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 81.5978 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Sujetos)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 271.5408 57.2978 Tm
0 Tr
0 0 0 1 k
0 Tc
0.013 Tw
(De enero de 2006 a diciembre del 2006 se prese-)Tj
-0.97758 -1.10455 TD
0.071 Tw
(leccionaron un total de 440 sujetos de forma pros-)Tj
0 -1.10454 TD
-0.012 Tw
[(pecti)25(v)25(a y consecuti)24(v)25(a a partir de las consultas e)15(xter-)]TJ
ET
0 0 0 0 k
14.173 516.176 226.772 132.957 re
f
BT
/F2 1 Tf
11 0 0 11 14.1732 641.6219 Tm
0 0 0 1 k
0.03 Tw
(lizada presentaron las sensibilidades m\207s altas para)Tj
0 -1.10455 TD
0.025 Tw
[(especif)20(icidades f)19(ijadas en el 85% y 90%.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 617.3218 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Conclusiones:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 82.8897 617.3218 Tm
0 Tr
0 0 0 1 k
0 Tc
0.053 Tw
(La mayor\222a de los par\207metros de la)Tj
-6.24695 -1.10455 TD
-0.0001 Tc
(CFNR)Tj
3.03925 0 Td
0 Tc
0.178 Tw
(medidos con el GDx-VCC ofrecieron una)Tj
-3.03925 -1.10455 TD
0.098 Tw
[(b)20(uena capacidad para el diagn\227stico del glaucoma)]TJ
T*
0.2 Tw
(de \207ngulo abierto. El mejor par\207metro del GDx-)Tj
0 -1.10454 TD
0.095 Tw
(VCC para diferenciar entre normales y glaucomas)Tj
0 -1.10453 TD
0.025 Tw
(fue el NFI.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 532.272 Tm
0 Tr
0 0 0 1 k
0 Tc
0.369 Tw
[(P)10(alabras cla)25(v)10(e:)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 96.3348 532.272 Tm
0 Tr
0 0 0 1 k
0 Tc
0.369 Tw
[(Polarimetr\222a l\207ser)40(, GDx VCC,)]TJ
-7.46924 -1.10455 TD
0.025 Tw
(glaucoma, diagn\227stico.)Tj
ET
0 0 0 0 k
260.787 513.8129 226.772 135.32 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Conclusions:)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 327.5766 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.322 Tw
(Most RNFL parameters measured)Tj
-6.07175 -1.10455 TD
0.097 Tw
[(with the GDx-VCC pro)15(vided good diagnostic abi-)]TJ
T*
0.09 Tw
(lity for open-angle glaucoma. The best GDx-VCC)Tj
T*
0.258 Tw
[(parameter in dif)25(ferentiating between normal and)]TJ
T*
0.286 Tw
[(glaucomatous e)15(yes w)9(as the NF)1(I )]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
11 0 0 11 418.9089 593.0219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.286 Tw
[(\(Ar)37(c)15(h Soc Esp)]TJ
-14.37468 -1.10455 TD
0.025 Tw
(Oftalmol 2008; 83: 357-364\).)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 260.7874 556.572 Tm
0 Tr
0 0 0 1 k
0 Tc
0.028 Tw
[(K)25(ey w)10(ords:)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 317.8351 556.572 Tm
0 Tr
0 0 0 1 k
0 Tc
0.028 Tw
[(Laser polarimetry)65(, GDx VCC, glauco-)]TJ
-5.18615 -1.10455 TD
0.025 Tw
(ma, diagnosis.)Tj
ET
0 J 0 j 10 M []0 d 1 w 
0 0 0 1 K
14.173 503.984 m
487.559 503.984 l
S
Q

endstream
endobj
7 0 obj
<<
/Length 10303
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 14.1732 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.093 Tw
(nas del servicio de oftalmolog\222a del Hospital Uni-)Tj
0 -1.10455 TD
0.238 Tw
[(v)15(ersitario Miguel Serv)15(et de Zaragoza. T)79(odos los)]TJ
T*
-0.034 Tw
(pacientes hab\222an sido remitidos desde los centros de)Tj
T*
0.336 Tw
(especialidades dependientes de nuestro Hospital)Tj
T*
0.007 Tw
[(con el objeti)25(v)20(o de realizar un diagn\227stico precoz de)]TJ
T*
0.26 Tw
(la enfermedad en sujetos sospechosos o para el)Tj
0 -1.10454 TD
0.144 Tw
[(se)15(guimiento o tratamiento de sujetos glaucomato-)]TJ
0 -1.10453 TD
0.038 Tw
(sos. En 11 de ellos fue imposible obtener al menos)Tj
0 -1.10455 TD
0.114 Tw
[(una de las pruebas f)20(iables o de calidad suf)19(iciente,)]TJ
T*
0.121 Tw
[(cinco no f)20(irmaron el consentimiento informado, y)]TJ
T*
0.078 Tw
(siete no acudieron a todas las citas para completar)Tj
T*
-0.034 Tw
[(el protocolo e)15(xploratorio. Finalmente, se incluyeron)]TJ
T*
0.04 Tw
(417 sujetos de raza cauc\207sica. Se consider\227 para el)Tj
0 -1.10454 TD
-0.035 Tw
(estudio un ojo de cada sujeto. La elecci\227n se hizo de)Tj
T*
0.047 Tw
[(forma aleatoria, salv)20(o que s\227lo uno de los dos ojos)]TJ
T*
0.025 Tw
(cumpliera los criterios de inclusi\227n.)Tj
0.97758 -1.10454 TD
(T)Tj
0.53101 0 TD
-0.016 Tw
(odos los sujetos, con independencia de su grupo)Tj
-1.50859 -1.10455 TD
-0.018 Tw
(de clasif)Tj
3.32155 0.00001 TD
(icaci\227n, cumplieron unos criterios de inclu)Tj
16.9613 0 TD
(-)Tj
-20.28285 -1.10455 TD
0.069 Tw
(si\227n que fueron: edad entre 18 y 80 a\226os, agudeza)Tj
T*
0.241 Tw
(visual superior a 20/30 en la escala de Snellen,)Tj
0 -1.10454 TD
0.07 Tw
(defecto refracti)Tj
6.123 0.00001 TD
(v)Tj
0.48023 0 TD
-0.0001 Tc
(o)Tj
0.82006 0 Td
0 Tc
(inferior a 5 dioptr\222as de esfera y)Tj
-7.42329 -1.10455 TD
0.089 Tw
(de 3 dioptr\222as de cilindro, medios \227pticos transpa)Tj
20.28285 0.00001 TD
(-)Tj
-20.28285 -1.10455 TD
0.016 Tw
(rentes \(color u opalescencia nuclear)Tj
14.34825 0.00001 TD
-0.0001 Tc
(,)Tj
0.51578 0 Td
0 Tc
(cortical o sub-)Tj
-14.86404 -1.10455 TD
0.142 Tw
[(capsular posterior del cristalino <1 se)15(g\234n la Lens)]TJ
0 -1.10453 TD
0.089 Tw
(Opacities Classif)Tj
6.87225 0 TD
(ication System III\) \(12\) y acepta)Tj
13.41058 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.094 Tw
(ci\227n del consentimiento informado. Se e)Tj
16.61731 0.00001 TD
0 Tw
(xcluyeron)Tj
-16.61731 -1.10455 TD
0.136 Tw
[(aquellos indi)25(viduos con antecedentes de cirug\222a o)]TJ
0 -1.10454 TD
0.103 Tw
[(traumatismos oculares gra)20(v)15(es, enfermedades sist\216)-1(-)]TJ
T*
0.034 Tw
(micas de repercusi\227n oft\207lmica, o imposibilidad de)Tj
T*
0.089 Tw
(realizar o v)Tj
4.65029 0.00001 TD
(alorar cualquiera de las pruebas inclui)Tj
15.63256 0.00001 TD
(-)Tj
-20.28285 -1.10455 TD
0.025 Tw
(das en el protocolo e)Tj
8.35954 0 TD
0 Tw
(xploratorio.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 240.6721 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Pr)Tj
1.03686 0 TD
0.025 Tw
(otocolo exploratorio)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 216.3721 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(A)Tj
0.97096 0 Td
0 Tc
-0.001 Tw
[(todos los sujetos se les realiz\227 una e)15(xploraci\227n)]TJ
-1.94854 -1.10454 TD
0.107 Tw
(oftalmol\227gica completa, que incluy\227 biomicrosco)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.104 Tw
(p\222a con l\207mpara de hendidura, gonioscop\222a, medi)Tj
20.28285 0.00001 TD
(-)Tj
-20.28285 -1.10456 TD
0.25 Tw
[(ci\227n de los ni)25(v)15(eles de presi\227n intraocular (PIO))]TJ
0 -1.10454 TD
0.086 Tw
(basal mediante tonometr\222a de aplanaci\227n de Gold)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10454 TD
0.147 Tw
(mann \(media de tres tomas en d\222as diferentes sin)Tj
0 -1.10455 TD
0.205 Tw
(tratamiento hipotensor\), paquimetr\222a corneal cen-)Tj
0 -1.10454 TD
0.14 Tw
(tral \(DGH T)Tj
5.15157 0.00001 TD
0 Tw
(echnology)Tj
4.10059 0.00001 TD
(,)Tj
0.63978 0 Td
0.14 Tw
(modelo DGH 500, Exton,)Tj
-9.8919 -1.1046 TD
0.161 Tw
[(P)92(A, USA\), e)25(v)25(aluaci\227n del fondo de ojo mediante)]TJ
0 -1.1045 TD
0.058 Tw
(oftalmoscop\222a indirecta y en l\207mpara de hendidura)Tj
T*
0.056 Tw
(\(con lente V)Tj
4.9255 0 TD
(olk de 78 dioptr\222as\), estereofotograf\222as)Tj
-4.9255 -1.1046 TD
0.058 Tw
[(de la papila, perimetr\222a automatizada con)40(v)15(encional)]TJ
0 -1.1045 TD
-0.0003 Tc
(\(P)Tj
0.7969 0 TD
0 Tc
0.025 Tw
(A\) y una polarimetr\222a l\207ser con el GDx-VCC.)Tj
0.1807 -1.1046 TD
0.032 Tw
[(La e)25(v)25(aluaci\227n cl\222nica del nervio \227ptico fue reali-)]TJ
-0.9776 -1.1045 TD
0.043 Tw
(zada con estereofotograf)Tj
9.89278 0.00001 TD
(ias papilares por dos espe-)Tj
-9.8928 -1.1045 TD
0.04 Tw
(cialistas en glaucoma enmascarados con respecto a)Tj
22.41947 55.22724 TD
-0.03 Tw
(la historia cl\222nica del sujeto. Las discrepancias entre)Tj
0 -1.10455 TD
0.352 Tw
[(observ)25(adores fueron resueltas por consenso. Se)]TJ
T*
0.126 Tw
[(def)20(ini\227 la apariencia del nervio \227ptico compatible)]TJ
T*
0.12 Tw
[(con glaucoma como la e)15(xistencia de un adelg)5(aza)-1(-)]TJ
T*
0.238 Tw
(miento del anillo neurorretiniano, focal o difuso)Tj
T*
0.025 Tw
[(con aumento de la e)15(xca)19(v)25(aci\227n o ambas (13).)]TJ
0.97758 -1.10454 TD
0.176 Tw
[(La P)92(A se realiz\227 con el Analizador de Campo)]TJ
-0.97758 -1.10453 TD
0.241 Tw
[(\307Humphre)15(y 750\310 \(Zeiss-Humphre)15(y)65(, Dublin, CA,)]TJ
0 -1.10455 TD
-0.021 Tw
[(EEUU\) \(estrate)15(gia 24-2 SIT)92(A Standard\). Los defec-)]TJ
T*
0.135 Tw
[(tos perim\216tricos fueron def)20(inidos por la presencia)]TJ
T*
0.072 Tw
(de un grupo de al menos tres puntos alterados con)Tj
T*
0.005 Tw
[(un ni)25(v)15(el de probabilidad menor a 5% o un grupo de)]TJ
T*
0.04 Tw
[(al menos dos puntos alterados con un ni)25(v)15(el de pro-)]TJ
0 -1.10454 TD
0.198 Tw
[(babilidad menor a 1% \(se e)15(xcluyeron los puntos)]TJ
T*
0.074 Tw
[(situados en los polos de la mancha cie)15(g)5(a\) \(14\) y/o)]TJ
T*
0.268 Tw
(desviaci\227n est\207ndar de la media (DSM) con un)Tj
T*
0 Tw
(ni)Tj
0.75293 0.00001 TD
(v)Tj
0.48511 0 TD
0.069 Tw
(el de probabilidad menor al 5%; y/o prueba del)Tj
-1.23804 -1.10455 TD
0.108 Tw
(hemicampo glaucomatoso fuera de l\222mites norma)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.051 Tw
[(les. Se realizaron al menos dos P)92(As para disminuir)]TJ
T*
0.076 Tw
(el efecto aprendizaje, y si alguna de ellas no cum-)Tj
0 -1.10454 TD
0.056 Tw
(pli\227 los criterios de v)Tj
8.63946 0.00001 TD
(alidez def)Tj
3.94966 0 TD
(inidos por el propio)Tj
-12.58913 -1.10455 TD
0.093 Tw
(per\222metro \(f)Tj
4.88536 0.00001 TD
(alsos positi)Tj
4.5399 0 TD
(v)Tj
0.48023 0 TD
(os, f)Tj
1.80479 0.00001 TD
[(alsos ne)15(g)5(ati)24(v)20(os y p\216r-)]TJ
-11.71027 -1.10455 TD
0.025 Tw
(dida de f)Tj
3.52852 0.00001 TD
(ijaci\227n\), la prueba fue repetida.)Tj
-2.55094 -1.10455 TD
0.096 Tw
(Las medidas de la CFNR peripapilar se realiza-)Tj
-0.97758 -1.10453 TD
0.363 Tw
(ron con el polar\222metro l\207ser GDx-VCC \(Laser)Tj
0 -1.10455 TD
0.374 Tw
(Diagnostic T)Tj
5.49754 0.00001 TD
(echnologies, Inc., San Die)Tj
11.60467 0 TD
(go, CA,)Tj
-17.10221 -1.10455 TD
-0.035 Tw
[(EEUU\). El e)15(xamen se realiz\227 bajo midriasis por dos)]TJ
0 -1.10454 TD
-0.004 Tw
[(t\216cnicos e)15(xperimentados. En un primer paso el apa-)]TJ
T*
-0.032 Tw
[(rato compens\227 la birrefringencia del se)15(gmento ante-)]TJ
T*
0.192 Tw
(rior con el m\216todo descrito por Zhou y W)Tj
18.11731 0.00001 TD
0 Tw
(einreb)Tj
-18.11731 -1.10455 TD
0.016 Tw
((15), bas\207ndose en el patr\227n de retardo de la re)Tj
18.83778 0 TD
0 Tw
(gi\227n)Tj
-18.83778 -1.10455 TD
0.023 Tw
[(macular (magnitud y eje). T)80(odos los e)15(x\207menes fue)-1(-)]TJ
T*
-0.026 Tw
(ron de alta calidad (mayor de 7) centrados en el ner-)Tj
0 -1.10454 TD
0.092 Tw
(vio \227ptico, con im\207genes perfectamente enfocadas)Tj
-0.0001 Tc
(e)'
0.70914 0 Td
0 Tc
0.015 Tw
(iluminadas de manera uniforme sin artef)Tj
16.2539 0 TD
(actos por)Tj
-16.96304 -1.10455 TD
0.114 Tw
[(mo)15(vimiento. En caso de no cumplir los requisitos)]TJ
0 -1.10454 TD
0.025 Tw
(de calidad la prueba fue repetida.)Tj
0.97758 -1.10455 TD
0.334 Tw
(El softw)Tj
3.68415 0.00001 TD
(are del GDx-VCC \(v)Tj
9.34395 0.00001 TD
(ersi\227n 5.4.1.35\))Tj
-14.00567 -1.10456 TD
0.074 Tw
[(bas\207ndose en los v)25(alores de retardo dentro del c\222r-)]TJ
0 -1.10454 TD
0.188 Tw
(culo de c\207lculo peripapilar ofrece los par\207metros)Tj
0 -1.10453 TD
0 Tw
(TSNIT)Tj
2.7583 0.00001 TD
-0.0001 Tc
(.)Tj
0.81722 0 Td
0 Tc
0.317 Tw
(Otros par\207metros analizados en nuestro)Tj
-3.57552 -1.10456 TD
0.113 Tw
[(estudio fueron: NFI, radio superior)40(, radio inferior)39(,)]TJ
0 -1.10454 TD
0.03 Tw
(superior/nasal, modulaci\227n m\207xima, m\207ximo supe)Tj
20.28283 0.00001 TD
(-)Tj
-20.28283 -1.10456 TD
0.013 Tw
[(rior)40(, m\207ximo inferior)39(, modulaci\227n de la elipse, \207rea)]TJ
0 -1.10455 TD
0.343 Tw
(normalizada superior)Tj
8.77139 0.00001 TD
-0.0001 Tc
(,)Tj
0.84317 0 Td
0 Tc
(\207rea normalizada inferior)Tj
10.75104 0.00001 TD
(,)Tj
-20.3656 -1.10455 TD
0.25 Tw
(temporal/nasal, inferior/nasal, inte)Tj
14.20124 0.00001 TD
(gral total, inte)Tj
6.0816 0.00001 TD
(-)Tj
-20.28283 -1.10456 TD
0.016 Tw
[(gral superior)40(, inferior)39(, promedio temporal y prome-)]TJ
0 -1.10454 TD
0.038 Tw
(dio nasal. El percentil 95 fue usado como punto de)Tj
0 -1.10455 TD
0.032 Tw
[(corte para clasif)20(icar la CFNR como dentro de l\222mi-)]TJ
T*
-0.017 Tw
(tes normales \(v)Tj
6.04996 0.00001 TD
[(alor de 0 a 30\) o en la frontera \(v)25(alo-)]TJ
-6.04996 -1.10455 TD
-0.002 Tw
(res de 31-50\). El 99% de conf)Tj
11.93246 0.00001 TD
(ianza fue usado como)Tj
ET
0 0 0 0 k
461.93 8.5039 25.629 11.338 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 469.559 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
(359)Tj
ET
0 0 0 0 k
137.614 10.57 228.784 9.178 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.2989 14.2856 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 345.0473 672.6915 Tm
0 0 0 1 k
(Diagn\227stico del glaucoma con el GDx-VCC)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
Q

endstream
endobj
8 0 obj
<<
/Length 9727
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 14.1732 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.026 Tw
[(punto de corte para v)25(alores fuera de l\222mites norma-)]TJ
0 -1.10455 TD
0.025 Tw
(les (51-100).)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 593.0219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Clasif)25(icaci\227n en grupos)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 568.7219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.037 Tw
[(Los sujetos incluidos fueron clasif)20(icados en cua-)]TJ
-0.97758 -1.10453 TD
0.218 Tw
[(tro grupos diagn\227sticos: normal o control, HT)18(O,)]TJ
0 -1.10455 TD
0.025 Tw
(glaucomas preperim\216tricos y glaucoma.)Tj
0.97758 -1.10455 TD
0.168 Tw
[<D1>-500(Grupo control (60 ojos): Exploraci\227n oftal-)]TJ
-0.97758 -1.10455 TD
0.021 Tw
(mol\227gica normal, PIO menor de 21 mmHg, morfo-)Tj
T*
0.025 Tw
[(log\222a del nervio \227ptico normal y P)92(A normal.)]TJ
0.97758 -1.10455 TD
-0.01 Tc
0.032 Tw
[<D1>-490(Grupo de HT)18(O (218 ojos): PIO mayor o igual)]TJ
-0.97758 -1.10454 TD
-0.0101 Tc
(a)Tj
0.64938 0 Td
(21)Tj
1.1953 0 Td
-0.01 Tc
-0.024 Tw
[(mmHg, morfolog\222a papilar normal y P)92(A normal. )]TJ
-0.8671 -1.10454 TD
0 Tc
0.001 Tw
[<D1>-500(Grupo de glaucoma preperim\216trico (68 ojos):)]TJ
-0.97758 -1.10454 TD
-0.0001 Tc
(PIO)Tj
1.89322 0 Td
0 Tc
0.033 Tw
(mayor o igual a 21 mmHg, morfolog\222a papilar)Tj
-1.89322 -1.10454 TD
0.025 Tw
(compatible con glaucoma y P)Tj
11.83804 0.00001 TD
-0.0001 Tc
(A)Tj
0.99682 0 Td
0 Tc
0 Tw
(normal. )Tj
-11.85728 -1.10455 TD
<D1>Tj
1.5 0 TD
0.033 Tw
(Grupo de glaucomas (71 ojos): nervio \227ptico)Tj
-2.47758 -1.10455 TD
0.025 Tw
[(compatible con glaucoma y P)92(A alterada.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
11 0 0 11 14.1732 386.472 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(An\207lisis estad\222stico)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 362.172 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.036 Tw
[(P)15(ara realizar los c\207lculos y an\207lisis estad\222sticos se)]TJ
-0.97758 -1.10453 TD
0.011 Tw
(utilizaron los programas estad\222sticos SPSS \(v)Tj
18.17225 0 TD
0 Tw
(ersi\227n)Tj
-18.17225 -1.10455 TD
0.128 Tw
(15.0; SPSS Inc., Chicago, IL, EEUU\) y MedCalc)Tj
0 -1.10454 TD
0.025 Tw
[(\(v)15(ersi\227n 9.3.2.0 MedCalc Softw)9(are, Belgium\).)]TJ
0.97758 -1.10454 TD
-0.018 Tw
[(Se realiz\227 un an\207lisis de la v)25(arianza \(ANO)49(V)135(A\) de)]TJ
-0.97758 -1.10454 TD
0.053 Tw
(los par\207metros del GDx-VCC entre los cuatro gru-)Tj
T*
0.169 Tw
(pos diagn\227sticos con la correcci\227n de Bonferroni)Tj
0 -1.10455 TD
0.025 Tw
(para m\234ltiples comparaciones. )Tj
0.97758 -1.10455 TD
-0.005 Tc
-0.005 Tw
(Entre los grupos de sujetos normales y glaucoma-)Tj
-0.97758 -1.10455 TD
0.041 Tw
[(tosos se calcularon las curv)25(as R)39(OC \(recei)25(v)15(er opera-)]TJ
0 -1.10454 TD
0.043 Tw
(ting characteristic\) para cada uno de los par\207metros)Tj
T*
-0.026 Tw
(de la CFNR. La curv)Tj
8.13301 0 TD
-0.0051 Tc
(a)Tj
0.65739 0 Td
(R)Tj
0.62222 0 TD
(OC)Tj
1.59729 0 Td
-0.005 Tc
(es una representaci\227n de)Tj
-11.00991 -1.10455 TD
0.071 Tw
[(la tasa de f)10(alsos positi)24(v)20(os \(1-especif)20(icidad\) frente a)]TJ
22.41947 38.65907 TD
-0.023 Tw
[(la tasa de v)15(erdaderos positi)25(v)19(os (sensibilidad). Es una)]TJ
0 -1.10455 TD
0.207 Tw
(manera \234til de mostrar la relaci\227n continua entre)Tj
T*
-0.03 Tw
[(sensibilidad y especif)20(icidad de una prueba o medida.)]TJ
T*
0.111 Tw
[(Cuanto m\207s se acerque la curv)25(a R)39(OC a la esquina)]TJ
T*
0.089 Tw
[(superior izquierda de la gr\207f)20(ica, mejor rendimiento)]TJ
T*
0.025 Tw
(diagn\227stico presentar\207 la prueba.)Tj
0.97758 -1.10454 TD
0 Tc
0.177 Tw
[(El \207rea bajo la curv)25(a R)40(O)-1(C)1( )-1(\()1(A)-1(B)1(C)-1(\))1( )-1(es)1( un v)24(alor)]TJ
-0.97758 -1.10453 TD
0.127 Tw
(num\216rico que nos da una medida de la capacidad)Tj
0 -1.10455 TD
0.05 Tw
(diagn\227stica de un test. Una prueba perfecta tendr\222a)Tj
T*
0.189 Tw
(un ABC de 1 \(100% de sensibilidad y 100% de)Tj
T*
-0.032 Tw
[(especif)20(icidad\), mientras que un test sin ning\234n v)24(alor)]TJ
T*
0.032 Tw
[(diagn\227stico tendr\222a un ABC de 0,5. P)15(ara establecer)]TJ
T*
0.01 Tw
(si hubo diferencias en las ABC se utiliz\227 el m\216todo)Tj
0 -1.10454 TD
0.025 Tw
[(descrito por Hanle)15(y McNeil (16).)]TJ
0.97758 -1.10454 TD
-0.014 Tw
[(T)80(ambi\216n se calcularon los v)25(alores de sensibilidad)]TJ
-0.97758 -1.10454 TD
0.034 Tw
[(de los par\207metros del GDx-VCC para especif)20(icida)-1(-)]TJ
T*
0.004 Tw
(des f)Tj
1.89956 0.00001 TD
(ijadas en el 85% y 90%, para discriminar entre)Tj
-1.89956 -1.10455 TD
0.025 Tw
(ojos normales y glaucomatosos.)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 331.2948 396.772 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(RESUL)Tj
3.24195 0 TD
(T)Tj
0.57715 0 TD
(ADOS)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 271.5408 372.472 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.009 Tw
(En la tabla I se incluyen las caracter\222sticas demo)Tj
19.30526 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.108 Tw
[(gr\207f)20(icas de los grupos del estudio. La edad de los)]TJ
0 -1.10454 TD
0.078 Tw
(hipertensos oculares fue menor que la del resto de)Tj
0 -1.10453 TD
0.062 Tw
(los grupos, y la de los glaucomatosos mayor)Tj
18.11049 0 TD
-0.0001 Tc
(,)Tj
0.56159 0 Td
0 Tc
0 Tw
(sien-)Tj
-18.67208 -1.10455 TD
0.064 Tw
(do similares e intermedias la edad de los normales)Tj
0 -1.10454 TD
-0.0001 Tc
(y)Tj
0.88586 0 Td
0 Tc
0.136 Tw
(glaucomas preperim\216tricos. Los glaucomas pre-)Tj
-0.88587 -1.10454 TD
-0.004 Tw
(sentaron una mejor agudeza visual corre)Tj
16.09381 0 TD
(gida menor)Tj
-16.09381 -1.10455 TD
0.3 Tw
(que los otros grupos. La PIO, relaci\227n e)Tj
17.99599 0 TD
0 Tw
(xca)Tj
1.36792 0.00001 TD
(v)Tj
0.4751 0 TD
(a-)Tj
-19.83901 -1.10455 TD
0.084 Tw
[(ci\227n/disco v)15(ertical \(v)25(alorada en estereofotograf\222as\))]TJ
(y)'
1.0052 0 Td
0.255 Tw
[(los v)25(alores de los \222ndices perim\216tricos fueron)]TJ
-1.0052 -1.10455 TD
0.19 Tw
[(diferentes entre los grupos se)15(g\234n los criterios de)]TJ
0 -1.10454 TD
0 Tw
(clasif)Tj
2.14526 0 TD
0.115 Tw
(icaci\227n def)Tj
4.50934 0 TD
(inidos en el apartado de m\216todos.)Tj
-6.6546 -1.10455 TD
0.131 Tw
(Los hipertensos oculares presentaron c\227rneas m\207s)Tj
0 -1.10454 TD
0.025 Tw
(gruesas que el resto de los grupos. )Tj
ET
0 0 0 0 k
14.173 7.5279 29.435 12.314 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 14.1732 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(360)Tj
ET
0 0 0 0 k
137.36 10.6629 228.784 9.179 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.0444 14.3792 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 14.1732 672.6915 Tm
0 0 0 1 k
(BORQUE E, et al.)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
0 0 0 0 k
14.173 31.181 473.386 158.43 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 14.1732 183.4652 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Tabla I.)-488(Caracter\222sticas cl\222nicas de la poblaci\227n del estudio)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
9 0 0 9 91.2424 164.1091 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Normal (n=60))-5710(HTO (n=218))-2991(Glaucoma preperim\216trico (n=68))-1658(Glaucoma (n=71))]TJ
-2.21083 -1.07533 TD
0 Tw
(Media)Tj
3.98121 0.00001 TD
(DE)Tj
4.21952 0.00001 TD
(p)Tj
3.38222 0.00001 TD
(Media)Tj
3.76044 0.00001 TD
(DE)Tj
4.1653 0 TD
(p)Tj
4.71352 0.00001 TD
(Media)Tj
4.90713 0.00001 TD
[(DE)-3121(p)-2697(Media)-1166(DE)-2431(p)]TJ
-35.48177 -2.15071 TD
0.025 Tw
[(Edad)-4575(59,85)-1120(10,78)-2193(H)-3048(53,21)-900(12,01)-974(N, P, G)-3216(59,57)-2046(10,18)-2426(H)-2863(64,83)-1359(9,23)-1737(H)]TJ
0 -1.07534 TD
[(MAVC)-4130(0,89)-1620(0,10)-2193(G)-3548(0,93)-1400(0,10)-2137(G)-4880(0,89)-2546(0,12)-2427(G)-3363(0,83)-1359(0,13)-573(N, H, P)]TJ
T*
[(PIO Basal)-2523(14,39)-1620(2,45)-1028(H, P, G)-1885(23,15)-1400(2,92)-1514(N, G)-3756(22,51)-2547(3,44)-1802(N, G)-2240(24,14)-1359(3,85)-573(N, H, P)]TJ
T*
[(E/D)-5519(0,29)-1621(0,17)-1028(H, P, G)-2384(0,41)-1400(0,13)-974(N, P, G)-3716(0,69)-2546(0,16)-1803(N, H)-2740(0,72)-1359(0,19)-1113(N, H)]TJ
T*
(DM PA)Tj
6.7969 0 TD
0 Tw
(-1,35)Tj
3.7031 0 TD
(2,41)Tj
3.94218 0.00001 TD
0.025 Tw
[(G)-3216(-0,26)-1399(1,06)-2138(G)-4547(-0,43)-2547(1,30)-2426(G)-3030(-6,10)-1359(5,43)-573(N, H, P)]TJ
-14.4422 -1.0754 TD
-0.0001 Tc
(DSM)Tj
2.4417 0 Td
0 Tc
0 Tw
(PA)Tj
4.688 0 TD
(1,51)Tj
3.3704 0 TD
0.025 Tw
[(1,61)-2192(G)-3549(0,96)-1399(0,76)-2138(G)-4880(0,97)-2546(0,72)-2426(G)-3363(5,03)-1360(3,62)-572(N, H, P)]TJ
-10.5 -1.0754 TD
0 Tw
(Paquimetr\222a)Tj
6.1296 0 TD
(551,5)Tj
3.8704 0 TD
0.025 Tw
[(20,24)-2192(H)-2549(572,6)-1399(27,38)-974(N, P, G)-2716(550,9)-2546(22,41)-2427(H)-2363(543,3)-1359(26,54)-1736(H)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 59.8013 Tm
0 Tr
0 0 0 1 k
0 Tc
0.019 Tw
(HTO = hipertensos oculares; DE = desviaci\227n est\207ndar; p= diferencias significativas con; MAVC = mejor agudeza visual corregida; PIO = presi\227n)Tj
0 -1.0754 TD
0.041 Tw
(intraocular; E/D = relaci\227n excavaci\227n /disco vertical valorada en estereofotograf\222as; DM = desviaci\227n media; PA = perimetr\222a automatizada con)Tj
58.8405 0.00001 TD
(-)Tj
-58.8405 -1.0754 TD
0.004 Tw
(vencional; DSM = desviaci\227n est\207ndar de la media. N: Diferencias con el grupo normal; H: Diferencias con el grupo de HTO; P: Diferencias con el)Tj
T*
0.025 Tw
(grupo de glaucomas preperim\216tricos; G: Diferencias con el grupo de glaucomas.)Tj
ET
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 176.5149 m
487.559 176.5149 l
S
14.173 148.256 m
487.559 148.256 l
S
0.417 w 
14.173 71.688 m
487.559 71.688 l
S
1.25 w 
14.173 70.021 m
487.559 70.021 l
S
Q

endstream
endobj
9 0 obj
<<
/Width 472
/ColorSpace/DeviceCMYK
/Filter/DCTDecode
/Subtype/Image
/Height 320
/Type/XObject
/Length 20718
/BitsPerComponent 8
>>
stream
ˇÿˇ‡ JFIF      ˇÓ Adobe eÄ    ˇ€ C 4"@.0&4KBONJBIHS^xeSXqZHIhéiq{ÜáÜQdìùíÇúxÉÜÅˇ€ C=""=ÅVIVÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅˇ¿ @ÿ" " ˇƒ           	
ˇƒ µ   } !1AQa"q2Åë°#B±¡R—$3brÇ	
%&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzÉÑÖÜáàâäíìîïñóòôö¢£§•¶ß®©™≤≥¥µ∂∑∏π∫¬√ƒ≈∆«»… “”‘’÷◊ÿŸ⁄·‚„‰ÂÊÁËÈÍÒÚÛÙıˆ˜¯˘˙ˇƒ        	
ˇƒ µ  w !1AQaq"2ÅBë°±¡	#3Rbr—
$4·%Ò&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyzÇÉÑÖÜáàâäíìîïñóòôö¢£§•¶ß®©™≤≥¥µ∂∑∏π∫¬√ƒ≈∆«»… “”‘’÷◊ÿŸ⁄‚„‰ÂÊÁËÈÍÚÛÙıˆ˜¯˘˙ˇ⁄    ? „®¢ä˘‰:ä(¢ä)ˆÚò&Y#rΩ◊+˘SçØ®QB√#H#Húπ˛ ß?ï	ÆÃ©≥/,™§ï≠€ßú‹jí[ó˚AHNc˚€H]ÿ«æ⁄ñÙﬁ§*÷~h∫2EÁ˘y›ª \g˚øÙ~£õª—ˆÛkˇ m4‰
)ƒú±¥√¶sûkö¢µ.k´ÍB°UwŸ˝ﬂΩUZÍd;J≈üe≥xJpÇî‰˙ÌÏÌ›«MSåÁ&Ø˝€˛®msM¬µÀlçäBJÓPTØ≠#_Jß+o¬$5Vä±ˆŸª˝(˚lø›è˛¯ü≥√;ˇ ¿‡ãŸ·ˇ ùˇ ‡?JîUØÌ	Áïø˝˘_£˚B_˘Âoˇ ~W¸*ΩcÌ≤ˇ v?˚‡QˆŸª˝(ˆxoÁ¯¸ˆxÁ¯¸≠k˚B_˘Âoˇ ~W¸(˛–ó˛y[ˇ ﬂïˇ 
ØEX˚lø›è˛¯}∂_Ó«ˇ |
=û˘ﬂ˛ˇ =û˘ﬂ˛ˇ ´EZ˛–ó˛y[ˇ ﬂïˇ 
?¥%ˇ ûVˇ ˜Â¬´—V>€/˜cˇ æmó˚±ˇ ﬂègÜ˛wˇ Äˇ ¡gá˛wˇ Äˇ ¡*—Vø¥%ˇ ûVˇ ˜Â¬èÌ	Áïø˝˘_™ÙUè∂À˝ÿˇ ÔÅG€e˛Ï˜¿£Ÿ·øùˇ ‡?CŸ·ˇ ùˇ ‡?J¥UØÌ	Áïø˝˘_£˚B_˘Âoˇ ~W¸*ΩcÌ≤ˇ v?˚‡QˆŸª˝(ˆxoÁ¯¸ˆxÁ¯¸≠k˚B_˘Âoˇ ~W¸(˛–ó˛y[ˇ ﬂïˇ 
ØEX˚lø›è˛¯}∂_Ó«ˇ |
=û˘ﬂ˛ˇ =û˘ﬂ˛ˇ ´EZ˛–ó˛y[ˇ ﬂïˇ 
?¥%ˇ ûVˇ ˜Â¬´—V>€/˜cˇ æmó˚±ˇ ﬂègÜ˛wˇ Äˇ ¡gá˛wˇ Äˇ ¡*—Vø¥%ˇ ûVˇ ˜Â¬èÌ	Áïø˝˘_™ÙUè∂À˝ÿˇ ÔÅG€e˛Ï˜¿£Ÿ·øùˇ ‡?CŸ·ˇ ùˇ ‡?J¥UØÌ	Áïø˝˘_£˚B_˘Âoˇ ~W¸*ΩcÌ≤ˇ v?˚‡QˆŸª˝(ˆxoÁ¯¸ˆxÁ¯¸≠k˚B_˘Âoˇ ~W¸(˛–ó˛y[ˇ ﬂïˇ 
ØEX˚lø›è˛¯}∂_Ó«ˇ |
=û˘ﬂ˛ˇ =û˘ﬂ˛ˇ ´EZ˛–ó˛y[ˇ ﬂïˇ 
?¥%ˇ ûVˇ ˜Â¬´—V>€/˜cˇ æI◊w≤çËëg„G›£7ˇ Äˇ ¡gá˛wˇ Äˇ ¡*—Vø¥%ˇ ûVˇ ˜Â¬èÌ	Áïø˝˘_™tVëéÙ∂˛∫G˛4ywø›µˇ øëˇ çiıJÕ/¸˛{,?Ûø¸˛	Vä∑ˆ˘Áï∑˝˘O£ÌÚˇ œ+o˚Úü·Y¥Vóó{˝€_˚˘¯’w∫ö7(ÀT‡ÌU#Û}VóÛKˇ  ˇ ÇThQó√&ˇ Ìﬂ¯%J*ﬂ€Âˇ ûVﬂ˜Â?¬è∑Àˇ <≠øÔ ÖU¢¨}∂_Ó«ˇ |
>€/˜cˇ æ/™“˛i‡J˙≠>Úˇ ¿?‡ï(´_⁄ˇ œ+˚Úø·GˆÑøÛ ﬂ˛¸Ø¯Uz*◊⁄gŸªd[}’iÓf8Tåü@Çü’)˜ó˛ˇ #Ü•-#)‡J¥UØÌ	Áïø˝˘_•ÚìÖÜ‹ü˙‡ø·U®´r»e±ﬁ †â6¸´é’RπÎ—ç'Wt’˚ı©Fìè+∫j˝äîUÈ•ÛÙ≥#G≤Ã´îçWçß“®—EV!EQEPEQEPEQEPEQEPEQEPEQEPEQEPEQEPEQEPEQEPET©sqﬁrO*K”zπ˘—’ƒ.ÔÚ∆œ√r}}j**π‰∫Ö√4d—EX¥˚ìˇ ◊#UÍÕñ6œú„ 9≈V8…€”∂k¶≤˝≈/üÊuV˛/üÊ[”˛Âﬂ˝{üÊµR≠ÈÿŸwûüg?Õj°Î≈QEr°EQEPEQEPEQEPEQEPEQEPEQEPEQEPEQV¢≥Eç%∫ù!çÜUÊvÀ€Ò"™÷Ñ÷ÊsÔ#â#∂Ff|‡Ì˛OR+jQNÔñÂBúπbµ
(•UŒyÕBe±_ï-$`;¥ºü»QÁYˇ œõﬂ”˛}í˙⁄ˇ ﬂ2Ò}í˙⁄ˇ ﬂ2Ò≠“z∏˝—:ñ)Î5˜«¸ƒ¢ùµæø≠&’˛˙˛¥y÷ÛÊﬂ˜Ùˇ Ö:∂öEé;,z;“ù≠¨R≈$˜ñÚBDY2 *>Aœ‚(K¶aàñ÷'*FV2Á∑•mN{§ΩywSzxJ\º’*ˇ °T±¬ıßÑPã)R}È~PÖï„w? ßX9ä“Ãøm˜àˇ íÜ˝jªÕspV)fUÑ∞ÃhË®?‡+≈Wÿã∞§…πNsÉ˛äàIï8>á¸*ï8€ïÀÓqF>¬î¨·+/6ø‡ÿŸˇ æÖ%9[9ëSÎüË)¬4œ˙Ëˇ &ˇ ‚jÕ“⁄«πbÑØµOõ∏≤Ûœ∑j´æ/˘Âˇ èS\ÇÏA»Õ%c*¥a§c¸ˇ ë&r†õm6¸≠˛C\*±U`˜¶“»AëäúÇM%JP:ÇäãıêS|ñıè˛˚_Ò¶QJXär˚ˇ ¿˘ºE=£/óÎ«¨L )œ´®˛¥æKz«ˇ ¸j:)˛Kz«ˇ }Ø¯—‰∑¨˜⁄ˇ ç2ï≥Qí{T™∞n ˙Oˇ "%ZŸCˇ Iˇ ‰I<ñıè˛˛/¯—‰∑¨˜Ò∆£•U,¡TdûÇûËƒ≈êÕ∑R943,jcå‰üºﬁæ√⁄ÜeçLqúì˜õ◊ÿ{TuU´r˚±ﬂÚÈ˜˜$jÚ˚±ﬂÂß›◊ª˚á4D2"êÃGE ÛöVeçJFrOﬁa¸ÖÀîå‰üº√˘
é¨˘˙Îˇ ≤’z∞?‰ÎØ˛ÀUÍq;Sˇ 
˝Eâ⁄ü¯WÊÀkˇ  Üˇ ÆÎˇ †ö©V◊˛Aˇ ]◊ˇ A5Rä(¢πNP¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä*≈ß‹ü˛πØVlâUúØDj±$íOS]u≠Ï)|ˇ 3™µΩÖ/üÊ[”˛Âﬂ˝{üÊµR≠Èƒ™]êpEπ˛kU	……¢ä(ÆCî(¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ßÜ ÍuÃ6“∫˙™~u≠:Rû€Bü6ØHÖQPQV∆ûÎ˛∫{h~≤?í‰”eä“&QÁI)Ê
õS˛≤°ÀÚ˝ÓﬂÜ„Ê•Ü7ıˇ %˛aEUjtqºé±∆åÓxUQík^÷Ú⁄“∆Im-ŸxäZG,sÜ?√∑é*å˙ÖƒÆJ≤†œQT˛$ö”ñï%Ã⁄ø˜nˇ 6ç„N1îc´ı”ßp¢ûå…;NG ÛﬁòI''ìRCi3yw9ño·Ç<Ú}	»~b¶‘.ö=–#≈X’Qî6A<ˇ ıÍíﬂ]¨~Z‹H©çªCv®¢˘UÿuU»>úä⁄5ox€ñ:˜æœœ∑»Èá3Öß)+ˇ ïÙW¸@N …ÙßªÚg SC∏]°ò/¶iÒp≤0Í´ï>ú≠/ü'˜øJkÓ;Yéwäw⁄%ˇ ûçLwg9bI˜Æi‚# ‘[˛æoÚ9˝≠8E˚=˛ª˛Ñt•JÖ'¯ÜE;Œó˛zø˝Ùi¨ÏÁ,≈àı9•Gd˚ßætò∆Ô“ôEaÌ™3˚ŒyJRwì∏îQEQEdHQEQE QEQE*)f
£$ˆ¶ìn»i6ÏÇä)UK0U'†°≥QíiÏÀò„9'Ô7Ø∞ˆ°ôcSg$˝Êıˆ’l⁄¢πcÒu}ºóÍÕõTó,w¸ºóÍ¡T≥Qíz
{2∆•#9'Ô0˛BÜeçJFrOﬁa¸ÖGEQXQV¸Éè˝uˇ ŸjΩXÚ?ı◊ˇ e™ı’â⁄ü¯WÍubvß˛˘≤⁄ˇ »!øÎ∫ˇ Ë&™Uµˇ êC◊uˇ –MT¢ä(ÆSî(¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(´˙=åw≤ ≤,ØÂ«πbà™≥rS¿∆jÃ⁄uçúìß∏hñQ,{C)⁄	œc∑8„≠uC	RT’O≤ Pv∏QJãì–ü•Q◊5B»eg˜GìUà¡#9˙U„nm.omò‰ƒ¨ôı¡™5U„ÀFúZ◊_ÃË≠¸_?Ãµßróc8ˇ G<˛+UZ∑a˜.ˇ Î‹ˇ 5™îQE∆rÖQEQ@QEU´±§˜û¡èp»RYW8Ôå’BŒ¿QENú d0≈úI*)Á˝ú‰QˆHóæÉËäÏÙ~µYŸùÀªf9$úíhD.p∏ı‰‚¥N⁄øØ¸ QEumÏïA3N˘ˇ a˘∑Ù£6±ˇ ´≥V?Ù⁄‡ˇ éÌ™≥pQrß⁄sQ◊Ct‚⁄ÂµøÆ±e¬ü2ªvAEU÷πú©Hí⁄ˇ ¶jäÔÆø≠C+\Œs4∆CÍÚÉ˝j
}ºFi‚âA%ŸTÓiN¥j5O[zÈˇ §öIπ 4·˝=ä)—*¥®¨p§Äi…Ô_π◊˚Î˛5q≠#Ç9•πTwÛR5ùÁ9$û0øù6+6IQèŸ@R	?kèˇ ä™∑n≤]ÃËr≠#>£4˘i¬=„Î˛qGM:†Ω•E√ßúuR,[AﬂåÉçª‘SæO˘‰ø˜Ú£êÉ#r	4˝≤àÂÑgW?:ı Åﬂ‹‘g çŸ6¡∆wu®Ë¨˛≥À¸8Ÿˇ €Øˇ mFO„+?H˛ÍÂæ“πèÁÔØ¯“0çîÇ€IV˛î *Mˇ œˇ }R4Ä¶ƒMãﬂúÊôEdÎMﬂœ…∫”wÛÚCÛ¸Û˚ÏÖ„fƒ]™zÛíiîQEVFAEQEPEQEPEQE®•ò*åì⁄öMª!§€≤
(•U,¡TdûÇÑRÃFIß≥,jcå‰üº√˘jñ51∆rOﬁo_aÌQ÷Õ™+ñ?W€…~¨ŸµIr«À…~¨K0U'†ß≥,jQX˝Ê»PÃ±©HŒI˚Ã?ê®Ë¢ä+ ¢ä(¢ä( ¢ä*¿ˇ êqˇ Æø˚-W´˛A«˛∫ˇ Ïµ^∫±;Sˇ 
˝N¨N‘ˇ ¬ø6[_˘7˝w_˝’J∂øÚo˙Óø˙	™îQE rÖQEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QVÏ.`Ü)‡πéFÜ`π10VRß#≠[ìS¥∏ÃwV≤ò°à$Éw °pƒérVM—UHAAmËºˇ Õî§–™GC“å©Í%ynÊ‚Ú‚E§VrøSúU&*NUvèL’ã%%gU&#¿™ƒ$Ç;VµÂ'Bõ}o˘ù5õˆ˛ôoO?-Ÿ#?ËÁè≈j´NBÖˆkN•ÿQímœÛZ®FQEqÅEQEPEQV≠∆Àßoï]V5˜;î„Ú¨q2∆§(ÍÃz"é§”ÆÁY]R VÜÿ‘ı«©˜?Á•kr.o–ä(®)Ò}…?‹˛¢ûêÑ+êÏ™~^1ﬂ≠0…+çÖ›≥¸9&Æ0ç7Æ˝ø„å[vàQEiï%¥‚tÖHR«©ÌW4»ö)ÃÑºl∞» B˝ﬂ›∂}iPπùFÈá˜K∑?≠hË|0ìKæ´¸œCÍ–äÇ®ÌÆªy_ØÀ‰™π`æµ$H™Ab Jí∏\ˆ˙”£ë’ºŸN;mˇ Î“K4—¡ºpÕîÀª«…m«◊€m1uFVétu9VXÜT˙ä™ÃŒrÃX˚ú“VqîSn˘CM ûú©[C‰T€¥Ü\Úæ‰Jhr;/˝Ú)ôŒYãRsIEQX rñçúí©)+6QEQEIEQEPEQEPEQEPEQE®åÏ$”å[vCI∑dQJäYÇ™íOaB)f
£$”Ÿñ51∆rOﬁaﬂÿ{PÃ±©é3í~ÛAÌQ÷Õ™+ñ?W€…~¨ŸµIr«À…~¨K0U'†ß≥,jQX˝Ê»PÃ±©D9c˜ò!Q—EVEQEPEQEPEUÅˇ  „ˇ ]ˆZØV¸Éè˝uˇ ŸjΩubvß˛˙ùXù©ˇ Ö~l∂øÚo˙Óø˙	™ïm‰ﬂı›ÙU(¢ä+îÂ
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢¨Z}…ˇ Îë™ıbœgŒ@ÚèJÆqì∑•u÷_∏§˝3™≤˝≈'Î˘ñÙˇ πwˇ ^Á˘≠T´zv6]ÁÅˆs¸÷™ºQEW! QE*ñ!TO ÙU»$6⁄yöWê«ø∫Æﬂ·ÙÎ÷Æúûª QEóËêE«ö‹Œ}d¸;˚˝*™#1¬©4ï5≥"owÖ%
øuâØ˚$WTiBvî›ï¥K{+ùQ°¬2©.[ÙµÿQE*ê*÷¶Õë@défuE§ä„∑ ic∫∂∑éSkƒr∫lW2èóê{(Ù®ßú‹$(ë¸®ÅS8@Q◊ÿUzu™¡Y¬-_œÕ˘ƒBîcKF∑”]Zø¬9{	*røÌu˝)C¢+lVRF3ªßÈJ≠∫9N ·xL◊óNÖÊfR0Tπ ‘4Q\ÆTﬁÈ˝ˇ 9TÑ∑M¸ˇ ˚Q∆G ÇÏA˜¶—EQEzr≈Y
U=ﬁX+/ÎÍ¡EQEVfAEQEPEQEPEQEPEQE®Öÿ*åìN1mÚƒqãn»(¢ïªQíhD.¡Tdö{2∆¶8œ˚ÕÎˇ ÷°ŸQLqúÁÔ7Øˇ Z£≠õTó,wÍˇ E˙øí”}[Tó,wÍˇ E˙øªMƒBÏFIß≥*)é3ú˝Êıˇ ÎPÃ®¶8Œs˜õ◊€ÈQ—EV!EQEPEQEPEQEPEUÅˇ  „ˇ ]ˆZØV¸Éè˝uˇ Ÿi¶\ôïOqöÌØNRç6øïyw;+”rå˛U˙ñ◊˛Aˇ ]◊ˇ A5R≠Ø¸Ç˛ªØ˛ÇjÅWnÈ£RUN0›∆ªP—R˘Qœ¬ﬂ'¸(Ú¢ˇ üÑˇ æO¯W?±óu˜«¸Œe//Ωô'îüÛﬁ/…ø¯ö<§ˇ ûÒ~Mˇ ƒ‘TTæT_Ûü˜…ˇ 
<®øÁ·?Ôì˛{w_|Ã=îºæı˛dtTûRœxø&ˇ ‚hÚì˛{≈˘7ˇ QQR˘Qœ¬ﬂ'¸(Ú¢ˇ üÑˇ æO¯QÏe›}Òˇ 0ˆRÚ˚◊˘ë—RyIˇ =‚¸õˇ â£ O˘Ô‰ﬂ¸MEEKÂEˇ ?	ˇ |ü£ ã˛~˛˘?·G±óu˜«¸√ŸKÀÔ_ÊGEIÂ'¸˜ãÚo˛&è)?Áº_ìÒ5/ï¸¸'˝Ú¬è*/˘¯O˚‰ˇ Ö∆]◊ﬂÛe//Ωô'îüÛﬁ/…ø¯ö<§ˇ ûÒ~Mˇ ƒ‘TTæT_Ûü˜…ˇ 
<®øÁ·?Ôì˛{w_|Ã=îºæı˛dtTûRœxø&ˇ ‚hÚì˛{≈˘7ˇ QQR˘Qœ¬ﬂ'¸(Ú¢ˇ üÑˇ æO¯QÏe›}Òˇ 0ˆRÚ˚◊˘ë—RyIˇ =‚¸õˇ â£ O˘Ô‰ﬂ¸MEEKÂEˇ ?	ˇ |ü£ ã˛~˛˘?·G±óu˜«¸√ŸKÀÔ_ÊGEIÂ'¸˜ãÚo˛&è)?Áº_ìÒ5ÈÀrôŒ;”k9E≈∏≤% »ËßKäBÑ©«u¶—E:(ﬁY8ëùÿ·U$˛k˚'Rˇ †uﬂ˝¯o™Ö)Õ^l,¬ä)vüÓößEÉÉE@Ñ¢ä(¢ü2œ éûG=íOéŒÊI(Ì¶gèÔ¢∆IO®ÌUI¸(,P9ÈF•:”ÓOˇ \çW´6d™Œ{àèQUâ…$˜Æö÷ˆæô’Zﬁ¬óœÛ-Èˇ rÔ˛ΩœÛZ©VÙ„µ.œ˝;üÊµPÚsEQ\á(QE<≠4M'ôh§.]±ìRŒ©ûë	¢ë¸“ÿåÁh¶è˘∑˝w_˝‘ÆÈQv‰df∫È∆ZÆö˝Ê‘)∆r˜æ∏QEÎsÂÜï≠“h◊
wÓ⁄§Ù˚§sÚöûWç¢d[@«£9?NI©oÆeVπÅV$â'¬™¬ã”pö•qÃÕZ‘îc{_ßﬂÃubÍFÒåvÛKªÎ∏´«;AÙ£k∏T˜Ê¶fÿíÌT˘\(˘˙’z$eE1¢Æ0πaûMGE≈R£õπ≈Rnn‰≤2¢ò„U ÖÀÛ˛MEEQEQEQ@QEQ@QEQ@QEQ@QER™ñ`™2Oji6ÏÜìn»(¢ïT≥Qíz
K0U'µ=»çLhrOﬁaﬂ€ÈJÃ±)HŒX˝Ê˛Ç¢≠õTó,~.æ^_Á˜∂©.XÔ˘yü‹
•ò*åì–Sÿà‘∆á$˝‚;˚}(fXî¢±·ò!Q—EV!EQEPEQEPEQEPEQEPEUÅˇ  „ˇ ]ˆZeœ˙—˛‚Ë"û?‰ÎØ˛ÀLπˇ Z?‹O˝W~#¯1Ùè˛‹wW˛=#ˇ ∑◊˛Aˇ ]◊ˇ A5œ˙≈ˇ Æiˇ †-LøÚo˙Óø˙	®n÷/˝sO˝j** ˝Éhœ⁄3ﬂi‚_ˇ O?¯Ìr{/4pëQEV•¥Ä‹›√n§)ï÷0OlúTøÒ/ˇ ßü¸vìLñ85KIdm±«23E	™ßN>“1ì—±«p†rh†u©Fó0ªûŸŸ°]ŸÍ¨πP˙‰í].›'ÒÍ1I?ò"ÚƒN9Œ”…‚¨ÿÍ6∆⁄Tπ}≥Fõ!|grS¥˝1ëı5˙¨ó≤eClóA‘àï~P›x\ÙÆÂOEÔÕ¯k◊Ukz>ÂZ!¥Êóo∏°H«=hŒHÕe»Ü92rPï¶”Ó^‚FSï.H?ç2º«æÑ	EQER ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä*KèıÕ¯*é§∏ˇ \ﬂáÚ®ÎZˇ ≈ó´5≠¸Iz≤[ØıÁ˝’ˇ –EER›Ø?ÓØ˛Ç**U%H*Jë–äÈÏ ûx≠/	πWâ,^tjèå„´dÉüîÁöÊaEíTFë"RpY≥µ~∏Æû÷(£í⁄9.,§ëñ#˘í.ÊL˘gÓq¡∆;◊~Y‰‹∂”≠µÈ‹T–Sï~\Á‚ö:˙S∂Ø˜óıÆ]æÒÈ◊µ%+}„ı§Ø,ÃmQZ˙ﬂ≤ﬂmäYdÿòé⁄ÃπÁû∏˚Ω*Ì‰Wç€p”˘—¥ãúºyçv+˝ﬁFMsëªF¡£bå:84ÂñDfdë’õÜ!éO÷Ω
X»¬îi8Ì€’æﬁ’ÀR“¬Ø O“îÉ¸9ÎM¢¥.º∑’5/'oñYˆ‡Ò˜´5î°⁄vˇ ¿Nj{Oπ?˝r5^£%*T›µw¸Ÿ—YØaOæøôsO[∞1˛†ˇ ËKUJøÅÕZ”˛Âﬂ˝{üÊµRä(´V6íÕ,R" V·^ô¸Ör”ÉúπQÕÛIG∏QE:#∂T'≥
Yî≈ßA”ô§oß›_‰ﬂùOÀi¶ÓÛ&∑&o‡ í6˝E>K€Hı8ÂÜ)‰HYB( „i∆Œ¯˝jåüiî#ªÅ”sgËTº%$›∑˘[∑ﬁzrú0¥π!+∑{˛ç*@ËjXÿ,\ªß'Óø≠l?YSû_ˇ ≠Q≥3}Ê'Íhw3I_fÓÁÆ}Í)YZBÀúZyFKv‹1ñ\~F¢ÆZ“ó*R›Í˛ˆyìú¶˘•∏˘•iâf*Xê	®Ë¢ä(¢πâ
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(•U,¡Tdû‘“mŸ&›êQE*©f
£$Ù*ñ`™2OjëôbRëú±˚Ã?ê°ôbRëú±˚Õ˝E[6®ÆX¸_óí˝Y≥jíÂéˇ óê*ñ`™2OAOfXî¢±·ò!CâJ!ÀáÚQE``QEQE QEQE QEQE QEQE QEQE QEXÚ?ı◊ˇ e¶\ˇ ≠Ó'˛Ç)„˛A«˛∫ˇ Ï¥Àüı£˝ƒˇ –Ew‚?ÉHˇ Ì«u‡√“?˚qm‰ﬂı›ÙP‹ˇ ¨_˙Êü˙‘Àˇ  Üˇ ÆÎˇ †öÜÁ˝bˇ ◊4ˇ –¢¢§Gèı˘üÒ£Ãè˛x'Ê∆π}úù~?¸âÀÏ„¸ÀÒˇ "*)·◊ÍìÛ?„FÙˇ û1˛g¸j:û¬πæ∂∑bUeï#$u úS<»ˇ ÁÇ~g¸iˆ•∂°mpÍJE*9◊
A™ß
q©fúoÆˇ ‰Ñ„µ≠˛Òî¥˝Èˇ <c¸œ¯”ZΩ&õo-¥œh.ë‚d]≥¢Ölù∏÷°5˘ï¢ÚWrª2&ûäNzÒ˜z”£s-ÃOss<—G péÂ±œ`MN∑∂S}¶+¥ùbís2∂ÓÔÚê}çtØ™‘}øÚ_—€∑ÀÃ=÷;jëÚÁÒ§⁄…£q»$ìä1ÉP√§_ Ö£∑?+2`≤©‹ΩWÁ>‘è•^§–¬`ÀÃ	@¨ß8Î»<cæzU«÷"íÚ÷·£uÚÆ^fUÁÂ%p©˘j;N+X‡ç„fU2¨ü*üï’G‡üóΩ?eÉø/3ıˇ ¿z[Õ˝¡hÄRh⁄sä3¸Ë_˚*˜ÌGí7ÏﬂùÎ≥oÆÏÌ∆xÎS‹hÚƒ´qJÛ⁄
‡38ˇ «z‘“ÍvrÓ∂uú⁄¥[7$q£)›ª!Wèl”◊Y¥è3¬ƒòb3µQ–ÛÎÛqZFéhÂ˝kÂÈØP¥iŒ(€FGJ3YWvWLã<awå©VVSÙ+≈][}+Ï‰µÁ#+Úu€ü †æ∏∂kx-l÷_*"Õ∫\%∂ˆ *!püŸÜ◊ko3	3€HÆk“ß9F6j⁄_]hÑ*W≠;‰€ﬁöz`Q⁄ØK•€Ahè+‹´<A÷eã0‰Æv‰s˛Œ}j;ç-c≤¥πäBÎ"ØöΩ„$ùøÅ¡¸™{]J ’<»E‹nSk[+∏9…Œ\cÒ®a‘“)Ìèñœ
@∞Õ˛5…'°‚∫%.Œ⁄ˆæû“ΩæE{¢ïsœÂ≈|π£8Èü• ?ïM&ôco{¥“\5Ÿ¶ﬁ1#'9ˇ tV}¸v±Nc¥3Ñ´yªzÁ∂*›Ê•˙Ö≠¬$Å!ëùÅ$¯Á–÷tÓ$ûG\Ìf$gÎXbeGóñö[˛ãıπ2k†Ì™ißn~\˛4§‰Êíñ„˝s~ £©.?◊7·¸™:ÁØ¸Yz≤Î^¨ñÎ˝yˇ uÙQT∑_Îœ˚´ˇ †ää•¥Ñ\\≈	›Û∂ﬂëA?Ä$WOii$v–˘ñÚà–* mëö<t¡ﬁ«bVπXd1Jí*£9⁄ÍO‘ËlÂ∂H≠-$∑âßö5)'Ÿ#d\ÙŒFN;üØ•zk§ØÃµı˚æbÉ@N*@ü/ Á˝ﬂ˛ΩGNc˛ïŒ∑~ΩÈ(oºzuÌEyFch¢ä(¢ä (¢ä±gç≥‰dyF´úd„ÅV->‰ˇ ı»’zÎ¨ˇ qIz˛gUg˚äK◊Û-ÈÿŸwëëˆs”ÍµPı‚≠Èˇ rÔ˛ΩœÛZ©EYb≠¶¬Åî2À! ˙O4∆€"òê±9'#ıßÃ®t¯$TZYÖÈ¬ß¯’—ßmÛ=t”^ÒÚ
T·NkùÎ¶ö˘y9c%7ÂUzrz”ÿ,JäcR≈rrNG?ZcæÂU™™I˘s˛{T6ˇ ÒÒ˚Î¸Èï%ø¸|E˛˙ˇ :é∞©À…^ÔÙ1©…ÕÓ¢ä(¢ä+0¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢äURÃFIÌM&›ê“mŸR™ñ`™2OAB©f
£$ˆ©ñ%)Àº√˘
ñ%)Àº√˘
ä∂mQ\±¯ø/%˙≥f’%Àˇ  U,¡TdûÇûÃ±)D9c√0˛BÜeâJ!ÀáÚQE``QEQE QEQE QEQE QEQE QEQE QEQE QEXÚ?ı◊ˇ e¶\ˇ ≠Ó'˛Ç)„˛A«˛∫ˇ Ï¥Àüı£˝ƒˇ –Ew‚?ÉHˇ Ì«u‡√“?˚qm‰ﬂı›ÙP‹ˇ ¨_˙Êü˙‘Àˇ  Üˇ ÆÎˇ †öÜÁ˝bˇ ◊4ˇ –¢¢ä+í‘˚øª˛	ÕÀKª˚ø‡ëQEU≠*Ó5;Xe]—ºä¨π∆Fj≠Mepm/!∏Tbp€IÎä™nújEøÜ˙Èˇ Lîπ_·ˇ Ö‘Q@‡ÊÆ&êZ›Ìp,çú";∑lOLv<Rkñˆ∂óQ€⁄l!#]Ï•≤ƒåÛüÈÎQ.† ËﬁR¸ñ∆ﬂØb•s˙‘Øzîçs%Â≠´´Â»[?*Åû˙WLΩåÈ∏RäΩ◊‹ºÿ{ØD.ﬂqC`)3œ·J ?ƒÎIe•}™§7PBfê≈>rÃ6˙~¥.ì'ë∏œ
Œc2-æN‚É9=1–åÙ°Æ~ƒˆëFŒ∂≤ôÉ∆N÷'oÀ»›ßkf,õX˛–#1,€éUG›Èú3M,*\≤›zˆW˘ﬁˆ˚=√› π@£oG“É«Õ„ÓÛÎJtmÆË◊∂Í—ƒ%ì!æE;qû:¸›6ÁIh!ï≈‘4H≤lL‰∆qµ∫c∫Ò÷£óQidπsè>àÛ˜vÏÁˇ ˝iEÒñGB©öÌÀpÅv|ﬂ¯Â)<+∫å{€;Ìø{˘Ëm˜«qIûæÙf©ƒûdâeRƒ.XÌQı=´LËrÑEs«.ıﬂµïT¢Ó=W¶;”!∂ä T∫èP±ï°!÷?üÊ+Œ>ÌJ˙ﬁvÌB™?4¨ƒÓBá$—Jï
q˝˛˙}◊]¥Ó	Enªzr9£hÓS˘–[=™8ÙVñ0—]B∆L˘µÅóoßÀÚÛê3å‘qÈM%ã‹Gq2GÊ4Jï_Æ6Á€4˚]]‡≥HÊ DMÊ2Öœ<®8<öˆœ˙Ä⁄Æ„ê[Ãl∆2†>æµv¡∏ﬂØ/ûˆˇ ?ïº√‹æ‚çø.sJÖ€˝ieqä ¢ä+Õ J(¢§∏ˇ \ﬂáÚ®ÍKèıÕ¯*éµØ¸Yz≥Zﬂƒó´%∫ˇ ^›_˝TU-◊˙Û˛Íˇ Ë"¢©m&˚5‘S|ﬂªl¸ç¥˛}´¶≤‘/¶Ç<√tÃcV‹◊€7‰‡`ÍOA\•tP‹€[€Z-≈Ãq ®í|∂Ï˘¬ëN‡>Pkø.´(]sr«˛›_üıπ0`84ÌÃGV¸È¥πˇ ÎW<«,OΩ%ÀúÛ÷äÚ»ä(¢ä(†ä(´d™ŒT‡àè"£Äü4∂rv±œæ”RŸ¨„éb=MEƒå=øÙ^åo…Cµˇ S–W‰°Î˙ñÙ‚U. únyU® 'Õ›‹+˚Ì5>ú2óc˛ùœÛZÇ$#˝Üˇ –M3ñnÂâ¸Mi‹Y≠∂ówr§Û$`äõà˘c‡Ú0z~uè6°'0\ú„h™À4≥eë‰#ÄYâ¨pÒIsKØ˘ØÎÔ'NˆìÔ¯ﬁ>~dg$‰ÚM8"ÑÀß$cm≠NqÉöFfoºI«©•∑ˇ èàøﬂ_ÁQ‘ñˇ ÒÒ˚Î¸Í:∆_√^ØÙ8û‚QEQEêÇä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä)UK0U'µ4õvCI∑dQJ™YÇ®…=
•ò*åì⁄§fXî§g,~Û‰(fXî§g,~Û‰**ŸµEr«‚¸ºóÍÕõTó,w¸ÅT≥Qíz
{2ƒ•Âè√˘
ñ%(Ñ<3‰*:(¢ä¿¿(¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä∞?‰ÎØ˛ÀLπˇ Z?‹O˝S«¸Éè˝uˇ Ÿió?ÎG˚âˇ †äÔƒ>ëˇ €éÍˇ ¡á§ˆ‚⁄ˇ »!øÎ∫ˇ Ë&°πˇ XøıÕ?Ù©ó˛Aˇ ]◊ˇ A5œ˙≈ˇ Æiˇ †-0E!∑˝ÛK‰…ˇ <ﬂ˛˘5 ΩªÍ˚¯h˚uﬂ¸˝Oˇ p˚ß5©ww¸*)¬Y ¿ëø:_6O˘Ëˇ ˜—®¸ô?Áõˇ ﬂ&ß“Q_V≤GUdi„R§d∏S>›wˇ ?Sˇ ﬂ√L∂ñHnböeç’ìåÚEiJQÖH…Ïö%Ú&πFPΩE?Õì˛z?˝Ùiï∑q‰À¡s=ÑíI"$?eà+'Õ…$*Ò∂´Iaß¬ey..<ò§Ú2±Æ‚¸‰ı˚º}k8¨ˆÚ§≠F¡∑.Â«#ö≥°yoÊÃ®çœπº»É&ÓyMv{zsΩÜø7˜ÍØˇ …Ó8Û¡€ˇ §¬˜&êphu4[dñ;yÓdÀ3¡DrªpO∑5:MΩÀ€µºÚò]dﬁY0ÿ;F{‰U5‘nå–»_tëJeBW$±∆sˇ |ä|S_⁄§E"tXK0Ã\|¿úı’L+zS˜˝ü?Pº{
w4ms≈&h…f]*÷iûiVŸ"ﬁT*ô›∑o˘´RÈ∞\F©äêÏÑóÚó%v;Îú/LÛY«RΩI.$àßñ#ÚDW9∆‹cØ46´~e\6Ÿ3P±Å˜A«¶ÒWÿHÈ»Ìˇ Á¯‚.’œ^(«Ù£&ì&£Ω∂∑én-$ë°î≤mëB≤≤„=>¢ØKßŸ§I=‹“™ïÖaâä0}∫~µFÍkÀ˝õ†¬F>DÜ®πÁ¢éÙó7wO√:Ì∞Ö)¥¸´µJ«ûåü&ö[∂Œ˝{äÒÅ‘t£ﬂÙ§'4g5{SÜﬁ«JKh¡içƒàÓc_õaÉ‘v˝k¨]^Õw˛∏©˘ﬁN∂3¸™Ωs‚jB§ÔhŸ%˜
NÏq·1ÔM†íh¢ä(¨QEIq˛πøÂQ‘óÎõ˛Uk_¯≤ıfµøâ/VKu˛ºˇ ∫ø˙®™[ØıÁ˝’ˇ –EEEu6+1∞¥DcS*π⁄® ˚±ÿ*?/zÁ¥˚t∫ø∑∑v*≤:©#Ø>ï±iJ!∂í÷d≤∞Xy1é7cåú‰Ú?ÜªÚÂ(∑.èOÀ…ık˛‰¿)√vﬁ¯¶é¥·”Î˙V}„ŒyÎIA$g4Wñ@⁄(¢¶≥∂kôƒaÇ(ùœDQ‘öø&õim5«⁄ßïaésf4í:ìÏ8¸Í≠ç˚Y«,bﬁ	í]ªÑ™O›˙˛@´˜:ùÖÙÛ˝¶cÖ¶2«‰™‰ˆ!≤{‡r+–°?≤’Æo;€˙˝Kè-ÄRÌPNIÎä@qÿRí§ú˙ˆ™_gkYÔm‹Ç—+!#æUÉÔü˜ˇ A5oÌÍÍˆÂ”ô9\˙ú‚íU#[≠–ÆU∂Bwÿˆ«ÎZÚF^…¡Ëõ˚πé‘ó-ÍÂ´πwˇ ^Á˘≠WÉÔü˜ˇ A5cO?-Ÿ∆—œä‘1d$*Ø»‹˜M+ºPÈP≈Âe¶À≥n« ïP1˙’ª'ômf˚3|®ªGﬂ5U# n.®	¿Œ†˜Æ}9"„≠æKÏÖIBù8>´ˇ ëé˝ˇ ØA¨Q>^JÁ9˜ˇ ÎS)Ô˜"ˇ w˙öe:±®îÆ‚¨1ÕER6≈áb∫±›üîÎQ÷]î`y·EQEV QEQE QEQE QEQJà]Ç®…4„ﬂ,G∂ÏÇä)Q∞U&ÑBÏFIß≥,kÂ∆s˝Êıˇ ÎPÃ®¶8Œs˜õ◊ˇ ≠Q÷Õ™Kñ;ı¢˝_…iæ≠™Kñ;ı¢˝_›¶‚!v
£$”ŸïÀåÁ˚ÕÎÏ=®fTSg9˚ÕÎÌÙ®Ë¢ä+¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä*¿ˇ êqˇ Æø˚-2Á˝hˇ q?ÙOÚ?ı◊ˇ e¶\ˇ ≠Ó'˛Ç+ø¸˙Gˇ n;´ˇ ëˇ €ãkˇ  Üˇ ÆÎˇ †öÜÁ˝bˇ ◊4ˇ –¶_˘7˝w_˝‘7?Î˛πß˛Ä¥—÷?˚Ì∆ó»oXˇ Ô‚ˇ çGEr^üÚøøˇ µ8H®¢äì»oXˇ Ô‚ˇ çX—ø‰3cˇ _ˇ ËB©‘ñ±K5ÃQ[ÁÕf0vÛ€ö∫RåjA¬/Fø≠á¬Å‘Q@Î≈kB/EΩ˘æÛ˛Õ‰úyŸ€ø#f‹˜˛ô´í$”,ë»óvÆ∞∫6˚fPûáÓÉÏO5ŒÀq4¿	¶í@Ω718©ÁÜÚÜ⁄Y
¨ÅJ∆e\Ù»œÀ◊ΩvS≈{≠(∑ø?ª},ˇ 2‘Ö¡⁄sü∆ùÉÉêGÖ0ízöR◊ﬁ™)*ASÇ:Zó7/•X©∏êÔy∑9¡Âz˚Tr^Z)d˛…µer≤»ˆjß2Kÿ•ø(eRzœ‚1\—~∆2Qï””K˜O™]âÿJ2q÷óp˛‚˛¥ï–ﬁ¨”≈yÊ•Â§ãgVmˆÌéÀüªü·ÎR≈≤˜[∂àÌ[ãVâ£=7«µI_™ıŸÆaßô¢XöW1Ø›B«h¸)≤	Å€xËŸÁÛÆØÌÛ_ñ˙´¸Ø˛esÍ8Ái»#˘Pº≤˙änh≠ËÊñ=f“4ï—¨d™± ˛Ê∞díI[tÆŒﬁ¨rhÛ$‹{nQ¥ÚJmq÷ÆÍGóÕøæƒ7qAÁ§¢ä(¢äÁQEQE QE%«˙Ê¸?ïGR\Æo√˘Tu≠‚À’ö÷˛$ΩY-◊˙Û˛Íˇ Ë"¢©nø◊ü˜Wˇ A êr©ÕÌ—wss)ic±rK/˜IÙ®(®å•Öô>¥QEQREQEPEUã0JN' 5+Ç--A‡Ïó˙‘V|$‰œ#V†çeÜ—]äØï31QìÖˇ Jı)[Ÿ“˛æ“=GôPäﬁˇ ˚qoO•ÿ$€üÊµ#∏ﬂ˙	©Ùˇ πwˇ ^Á˘≠WÉ˝aŒq±∫∫jú”,ñˆ—®9â
ú˚±?÷öﬂÒÔ˚Ì¸ñí_+ÓKîˇ l i[˛=£ˇ }øí◊,¥ÊèhØ˝¥Áƒ∑Œ¢ﬁ +òA˝’«Íi¥≠∑?.qÔIQ—E sÖQEQ@QEQ@QER¢`™2M8≈∑hé1mŸR¢`™2MÖÿ*åìOfTSg9˚ÕÎˇ ÷°ôQLqúÁÔ7Ø∑“£≠õTó,wÍˇ E˙øí”}[Tó,wÍˇ E˙øñ€àÖÿ*åìOfTSg9˚ÕÎÌÙ°ôQLqúÁÔ7Ø∑“£¢ä(¨Bä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(´˛A«˛∫ˇ Ï¥Àüı£˝ƒˇ –E<»8ˇ ◊_˝ñôs˛¥∏ü˙Æ¸GcÈ˝∏ÓØ¸zGˇ n-Ø¸Ç˛ªØ˛Çjüıãˇ \”ˇ @Zô‰ﬂı›ÙP‹ˇ ¨_˙Êü˙‘TQErs«˘W„˛g7<ë~?ÊEEQW4VT÷,ŸàUÆI=9™tSÖE	∆j?π2í{FﬂxPΩEVÙwacä€˜Oÿè»πﬁäúıŒ@®uÉq‚GFEhÜp∏∆ûüSXÙWD±≥îT_t˛ÓÅŒ«g∑≈&r√4îWF◊H≥¡jøgÚ$äo3‰Sì∫MºıÏ∏¨˝~Y'π∑ï›ﬁ=Övˇ tgßNs÷≥(¢Æ2Ui:mu]{+XNM´œ )‰˛îQEW!EQEPEQEPEQEPETóÎõ˛UIq˛πøÂQ÷µˇ ã/Vk[¯íıd∑_Îœ˚´ˇ †ää•∫ˇ ^›_˝TTQEëêQEQE QEQE QEfÀg…¿Úè5n‘Øó´∂ﬁ„ˇ @jßi˜'ˇ ÆF¨[ò≠≠RAÈféU‹[Óç•z~5ÈFŒç8˜Oˇ J=J0å£Iø≥Ø˛Mbﬁùçóy‡}úˇ 5™…˜é:m? ¨Èˇ rÔ˛ΩœÛZÜ%^ò‰£˛≥¿$·FI©dFH#WRßspF;-6ﬂ˝r”+ö|±Ö˚§æÂpU¯æQˇ “QQEQ\∆AEQEPEQE®Öÿ*åìN1m⁄#å[vAE®Öÿ*åìB!v
£$”Ÿï«Œ~Ûzˇ ı®fX‘«Œ~Ûz˚}*:ŸµIr«~ØÙ_´˘-7’µIr«~ØÙ_´˝7∞U&ûÃ®¶8Œs˜õ◊€ÈC2¢ò„9œﬁo_o•GEQXÖQEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QV¸Éè˝uˇ Ÿiç$NAhﬂ;Uxqÿc“û?‰ÎØ˛ÀUÎ∂ΩIB0Q˛U—>˝Œ⁄’%¡/Â]Ô‹∂øÚo˙Óø˙	®öHih§‹TÌê¿«˜jUˇ êC◊uˇ –MT©3¸Ûì˛˚¸Má˛y…ˇ }è˛&£¢π˝¥ª/¸?‰s˚iv_¯»óu∑¸Òó˛˛˛&ç÷ﬂÛ∆_˚¯?¯öääì0ˇ œ9?Ô±ˇ ƒ—òÁúü˜ÿˇ ‚j:(ˆ“Ïøˇ ê{iv_¯»óu∑¸Òó˛˛˛&ç÷ﬂÛ∆_˚¯?¯öääì0ˇ œ9?Ô±ˇ ƒ—òÁúü˜ÿˇ ‚j:(ˆ“Ïøˇ ê{iv_¯»óu∑¸Òó˛˛˛&ç÷ﬂÛ∆_˚¯?¯öääì0ˇ œ9?Ô±ˇ ƒ—òÁúü˜ÿˇ ‚j:(ˆ“Ïøˇ ê{iv_¯»óu∑¸Òó˛˛˛&ç÷ﬂÛ∆_˚¯?¯öääì0ˇ œ9?Ô±ˇ ƒ—òÁúü˜ÿˇ ‚j:(ˆ“Ïøˇ ê{iv_¯»óu∑¸Òó˛˛˛&ç÷ﬂÛ∆_˚¯?¯öääì0ˇ œ9?Ô±ˇ ƒ—òÁúü˜ÿˇ ‚j:(ˆ“Ïøˇ ê{iv_¯»óu∑¸Òó˛˛˛&ç÷ﬂÛ∆_˚¯?¯öääì0ˇ œ9?Ô±ˇ ƒ—òÁúü˜ÿˇ ‚j:(ˆ“Ïøˇ ê{iv_¯»óu∑¸Òó˛˛˛&ç÷ﬂÛ∆_˚¯?¯öääì0ˇ œ9?Ô±ˇ ƒ—òÁúü˜ÿˇ ‚j:(ˆ“Ïøˇ ê{iv_¯»óu∑¸Òó˛˛˛&ç÷ﬂÛ∆_˚¯?¯öäätØæB€vÁµ6ä+9I…π=Ÿú§‰‹üQÛ8íB ªAË3öeQERQEQE QE±∆Ú0H—ôè®…•X§feXÿ≤Ú@^V≠Èfº©g)ÖJ˛ˆE„jÁ‘s◊∞ÎZì]]…nf∞Û÷cpëª(!ﬂj(Rÿı95ŸG	”Êm˝ﬂñø◊»®≈0¢Öœn)Ÿ=W=k»ÌYŒƒG≠K!Qal‰Äv»ÅÍj[§è˚SRHBÏ‹·BÙ˚’ü!ê*DÁÂO∫æôÆñù*t€÷1ø˛îzî•ÏË¬RWäOˇ J^Öù8·.œ˝;üÊµ
UXgk∏ıÕOßå≠ÿÛ¿ˇ ËKU;N8Ù9ßD™Ö$gUÎÅŒj*|üÍ‚ˇ tˇ 3LÆÛΩ£nﬂäGó)9;±(¢ä(¢ä¿ê¢ä(¢äTBÌµG4„'À∆.Oñ!E®Ö€jı°ªm^¥ˆuE1≈”¯õ◊ˇ ≠C∫™˘q˝ﬂ‚oÔı™:Ÿ…R\∞ﬂ´˝Í˙˙o´jíÂÜ˝_ËøW◊”qªmQÕ=ùQLq}ﬂ‚nÌˇ ÷°ŸU|∏˛ÔÒ7˜ø˙’QE`bQEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEXÚ?ı◊ˇ e™ı`»8ˇ ◊_˝ñ´◊V'j·_©’â⁄ü¯WÊÀkˇ  Üˇ ÆÎˇ †ö©V◊˛Aˇ ]◊ˇ A5Rä(¢πNP¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä(¢ä( ¢ä*kkªõR∆⁄‚Xw}Ô- ÁÚß}æJÚãπ¸«]¨˛aÀBjΩj¨‚îSvCª J˝“E.„ú‰“QV->Â«˝r5^¨Y„l˘Œ<£“´údÌÈ⁄∫ÊøŸ‡ˇ ∫ˇ Ù£∫K˝û?·˙R-Èˇ rÔ˛ΩœÛZ©VÙÏlªœO≥üÊµPı‚ü'˙∏ø›?Ã”)Ú´ã˝”¸Õ2π™¸_(ˇ È(‡
(¢ä(•D.€TsY∆.Oñ#å\ü,Bä)Q∂’ÎB!v⁄ΩiÓÍ´Â«˜âøΩˇ ÷°›Q|∏˛ÔÒ7˜ø˙’l⁄§π!øW˙/’ıÙﬂV’5À˙ø—~ØØ¶‚!v⁄£ö{≤™˘q˝ﬂ‚oÔı®vU_.?ª¸M˝Ô˛µGEQXÖQEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QEQ@QV¸Éè˝uˇ ŸjΩXÚ?ı◊ˇ e™ı’â⁄ü¯WÍubvß˛˘≤⁄ˇ »!øÎ∫ˇ Ë&™Uµˇ êC◊uˇ –MT¢ä(ÆSî(¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä±i˜'ˇ ÆF´’ã"Ug#®à’rI$û¶ªßo´√¸/ˇ J;Âo´«¸/ˇ JEΩ?Ó]ˇ ◊π˛kU*ﬁúJ•ŸEπ˛kU	……ß…˛Æ/˜OÛ4 |üÍ‚ˇ tˇ 3MD.€Ts\ı"Â5ˆè‰é≈∑À¢äTBÌµz–à]∂®ÊûÓ®æ\w¯õ˚ﬂ˝j’ÀèÓˇ {ˇ ≠Q”mR\êﬂ´˝Í˙˙o´jöÂé˝_ËøW◊”qªmQÕ=ŸU|∏˛ÔÒ7˜ø˙‘;*Øó›˛&˛˜ˇ Z£¢ä(¨Bä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(´˛A«˛∫ˇ Ïµ^¨˘˙Îˇ ≤’zÍƒÌO¸+ı:±;Sˇ 
¸Ÿm‰ﬂı›ÙU*⁄ˇ »!øÎ∫ˇ Ë&™QEW) QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQW¨≠¨˛»noZ`ç'îã‹Á$Á∞»‚¥•I‘|±W
(•∆MCf2≥åÅ˚£÷£ÖGös¥ÌV>£Ö5h€µ•ÕÌ≥òïêü\Øk;í£ç¨	œOî◊£>JpÂ◊_˝(Ôj¯x≈-y_˛îãZp ]å„˝ˇ 5™á≠[∞˚óıÓö’TRÃiôyôWÂ‡vP†Rª™/ó˘âøΩˇ ÷°›Q<∏˛ÔÒ7˜ø˙’qN|óäwow˙/’¸ñõÚ∂©ÆXÔ’˛ãı}}7∂’”›ïWÀèÓˇ {ˇ ≠C≤™˘q˝ﬂ‚oÔı™:(¢äÁ1
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢ä(¢Ä
(¢¨˘˙Îˇ ≤’z∞?‰ÎØ˛ÀUÎ´µ?Ø‘ÍƒÌO¸+Ûeµˇ êC◊uˇ –MT´kˇ  Üˇ ÆÎˇ †ö©EQ\ß(QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEUÎ+´Uµ6◊ê Ò¨ûbò)Œ0TÁ±„Ú™4U”®Èªƒiÿ)TÆ9§¢Ø«3ﬁ]›ÃPî3mÌ…ÈQµ≠«óµ!€ªÔ?˝z©út≠;ù:†ôc∏ëÆmëZd)Ñ¡ ß?¬HØJçe:.2ÉvΩ⁄q[Î÷-Ùgu,Lg(æ™È•ªøÚøÃΩ•£H◊(âΩåÎ “æüyÂÌKV]ﬂyV®Rê=yOÏWÛ»˛bè±\g˝Q¸≈AìÍh…ı5…œÖ˛I‡Kˇ ê2Á¬ˇ $ø%ˇ »Üó{ü¯ˆqGˆ]Ô¸˚=T¢¨}Ü„ÍøZO±\ˇ œ#˘äÉ'‘—ìÍhÁ¬ˇ $ø%ˇ »>˘%ˇ Å/˛@∑˝ó{É˛éÙf^ˇ œ≥’J*¡±∏ˇ ûD˛4%åÂÜËà_®™˘>¶¥¢≤¥û›ñ©ZÂ"ÛHÚÒlÆsúÛÈå÷‘£áúΩ⁄oNú—ˇ ‰Jå∞∑ø≥¯ˇ ‰KgKΩÚÓÊï4ª¬ÿkwUı™t∏º’O±\ˇ œ#˘ä_∞‹c>W·öµ{a0Õˆ{â$ñ’¬L¨õW'å©œLåsYπ>¶ïHaÈ>YAˇ ‡Qˇ ‰EÕÜ[¬_¯ˇ ‰_ŸóøÛÏÙeﬁÌœŸﬂÈUHΩ%Oˆ+ü˘‰1Jlnˇ TO„UÚ}M>¶≤Á¬ˇ $ø%ˇ »ü¸íˇ ¿óˇ  [˛ÃΩˇ üg†Èw†ˇ «ªü•T¢¨è˘Âè∆ìÏW?Û»˛b†…ı5-¥2\Lê∆y=…¿Q‹üaUÜìQç9_¸Kˇ êl3˚ˇ ¿óˇ  []Èˇ ówf^ˇ œ≥’J)Ê∆}´àé{Ú)>≈qˇ <èÊ*¸∫mµ¥˜&‚Ê_≥¬»ä—¶YÀ.z¿‡’ÿ“ÓHÓÿxa∆Gc˘V’iPß¨©æﬂ˘∂eJXkﬂŸø¸	Ú%√•ﬁmR-ﬂ=«• “Ôsˇ Œ*Æ–	…Ëiè±\œ#˘äQcpÂû?ØìÍh…ı5á>˘%ˇ Å/˛@û|/ÚKˇ _¸ÅlÈwπˇ èg£˚.˜üÙw™îTˇ bπˇ ûGÛøa∏¿˝ﬂÎUÚ}M>¶ó>˘%ˇ Å/˛@9ø…/¸	ÚøÏÀﬂ˘ˆz?≤Ôxˇ Gz©EX[ç√1πÁëA≤∏…€«‘Uÿ4»⁄¿O4ó
œu)	h„^@ﬁ{gm6]:Å—n$7qB≤∫˘6ú†Á9 ˙WS√“Pø≥}˛(ˇ Ú%_À¸7ˇ Å/˛D∏ö]·en·s…§˛ÀΩˇ üg™ª~\—Åéº’O∞‹`˛Îı§˚œ¸Ú?ò®2}M>¶πyø…/¸	ÚÛ·í_¯ˇ ‰_Ÿw∏ˇ èw˙Q˝ô{ˇ >œU(´∆‡ıY¸h7˛YcÒ™˘>¶åüSOüÇ_¯ˇ ‰üÇ_¯ˇ ‰gKΩÚÓÊÅ•ﬁü˘wqU(©˛≈sˇ <èÊ)∆∆}äDgvNFG˘ıßiñ¢ÚÌayWil"Âõ;Tw&ÆM¶[€À#œ<Èo#Ú«ö•≥Ñ+úÚì]®Qú9„M€oä>ø TeÜ∑ﬂ˛ø˘ﬂˆeÔ¸˚=)“Ô6ˆw›ìëT‘d“ÌΩg˝äÁ˛yÃRõÄHÚ≥Ó÷Ê“È°Y7¶’dlcrïN>Ü´‰˙ö¬O‡·+ØÔ/˛@ûl2”í_¯ˇ ‰_ŸóøÛÏÙ.Ù}ùœ∏™áÉEX7˛Îç'ÿÆÁë¸≈AìÍh…ı5<¯_‰ó˛ø˘ Á¬ˇ $ø%ˇ »∆ó{œ˙;ä?≥/ÁŸÍ•`ÿ‹q˚Ø◊•*XŒ]CFBÁìëP¬ç,´uM«Ô;mQı5¢⁄l1] ≤\π∂Üï§ç9m¡pwnıΩ(PüΩn◊˛h˙ˇ /ëQñ˜ˆoˇ _¸âlÈwº£Ω*iwÖ‘5ª™ÁìÈTÈvÛ◊ä≠$/ü∂E⁄Lπˇ «j•j∂õk
¥˜2˝êÏÚäF∂‡O ú`Ê®^[õKπmÀÚ€áqÿ‘b·/uÚÚ∆>ÓÈæΩ≠øC<D„7XŸE[{˛àΩ5¥÷⁄IY£1ì:ëü˜MP•¿ı§<Üä(Æú(¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä(¢ä (¢ä+VÍ˛—‚πñõÌ7H©"∞ï'iÔí¢≤®≠i’ï8∏«Ø¸˘64Ï§Æ8ŒM%QEêÇä(¢ä(†ä(¢µ}=,+yÆ#ê(g_%q#èSªÓÁ∂+.ä÷ïWNˆ[ç;/À∑ÇsÙ§¢¥ÔØlﬁìj≥y∑nEp6«ŒJ©Ôœ”•fQE*µ]Wv‹S∑¯sÕ%QE5•¨˜ì,6ÒósŒaÍj#'Àv ¢ä œJÜ≠X_/7mº,´±ñU'åÁ±ZÈ∑WpôaçJÇUrÍ•à!AÍ~î©¶›5ôπX◊À⁄[◊qQ‘ÖÎèzﬁù:–jpã˚∫&é‘°I£i€öøu©ÿﬂK:O¡òŸÀeTÉêO|˙ˆôp.Ø%ùP¢±˘TˆQ¿˝vrﬁ;§>Xÿõÿª™*Æ@Í~¢ãªG¥(·}›<©Uˇ =ßä∫’+Uá<£Óﬂ{zˇ õm´ãï$Á {SOZdÒèƒ–Wo\~†¢ä+êê¢ä(¢äµü< ÃÜàäÃÕ*™Æzì◊É≈T) n–W\(¢î)>üù_µ’aéfïÓ∂±¥kcÀì9∆y„Ø<‚£ñ˛—¢ñdYæ◊4)b†∞=y”ﬁ≤›J;!*Jú|ß"úÒ4n®JUH⁄¿ıÆßã™„ ˇ ßk}ˆ˛ÆW3çΩÚ(%q∆ri(¶QOû∑ûH$]Øaú‡äX`yñC‰Fõ€ûã¿˛µÀ»ÔÀmI
(ËqEGETÄQEoKπé÷w2˘äíDc/ﬁL˜Á°5z]B hç§¶‰¿#ES!e,A+ûü1^æïçEt”≈Nú9ﬂ÷ü÷•)5†™}h ûqÎIEX‘.ÊÈ§â
F™®ä›v™Ö˜¿™ÙQXNNrr{≤^†y4QEQEHQEj}∫÷I§IñUÇ[h°fEïëSúgëï˝k.ä÷ùYS“?÷ÎıcN¡Kï'ú„îVºó÷7µ§¬·-£Ú¸ßERﬂ*êr3ér~ïü}p.Ø%ùSbª|´˝’Ì˙TUUƒN¨m/Î˛‡‰ÿπS◊>‘áìEQEÄÇä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢ä(†ä(¢¥4)⁄JÛLq3|„v‡f≥Ë≠)TtßÆÉNÃ(h¢∂¥‰Y°”•Y¢ç,Â-6˜
Uw»Øßï(1ª«®¨±-∫ZºlÖ◊pm¨ªvıÁ ÷’g,TyvÛÍíKÚÿÆaW±„ä=Û⁄íä€“æ…Á\•íK[ÚÓä¢±ﬁúdÔﬂµIrC©Fe≥≤Ä¥L®∞Œ£'’I,π„8¨
(é1F1˜uèkwøÚøœ‰.aF‹¸º˝iG–°¶—]2∆À=˘¥ñüÀà©ìÀ˘<Æ~·oÎSDˆ‰øê÷∆Áz}§´D™ﬂ"ÁÔpW;≥∂πhÊí8dâ…∑z„ÆE2∂Yäçπc¯˘∑ßﬂ´Î±\„ΩpGjU#ûôÔ“ôEo±Sbﬂb{8Ì{Á+ï';éŒø1˘vÌ«zö+µé¬(RX’ZÓ_óúÓ›¸ÖsTVq« ÒèKoÂoíÚùá≈ ˆœShÆÇ¯ìk/Ÿ•¥[M≤y™€77`uœ›¡T°«îüb{Eî$>wòSò¸§ıÌùŸûïÕQOÎ˙ﬂó∑^◊€∂ˇ üpÁ¯{bó<qèzm◊≈Â5‘ƒÀn÷Úœ7ò∆£$ê†Á,{cÎTC™Èrà‰µ¶ÕUﬂÊewgæsülbπÍ*•òÛF‹Ω˙˜_ó[w1˘‡ÙÁ4áÓˆ∆)¥QEWò@QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEQE QEˇŸ
endstream
endobj
10 0 obj
<<
/Matrix[1 0 0 1 0 0]
/OPI<</2.0<<
/Version 2
/Type/OPI
/CropRect[0.059 0 944.97998 641]
/F(macline1:Users:macline1:Documents:TRABAJOS:SOCIEDADES INTERNET:SEO:06-junio-08 (internet):Imagenes junio:Fig.S07089.01.tif)
/IncludedImageQuality 1
/Size[945 641]
/Inks/full_color
>>
>>
/FormType 1
/Name/Fm1
/BBox[-1.14986 -3.18542 1.0625 1.36597]
/Subtype/Form
/Resources<</ExtGState<</GS1 2 0 R>>/XObject<</Im1 9 0 R>>/ProcSet[/PDF/ImageC]>>
/Type/XObject
/Length 35
>>
stream
/GS1 gs
q
1 0 0 1 0 0 cm
/Im1 Do
Q

endstream
endobj
11 0 obj
<<
/Matrix[1 0 0 1 0 0]
/OPI<</1.3<<
/Version 1.3
/Type/OPI
/CropRect[0 0 945 641]
/CropFixed[0.059 0 944.97998 641]
/F(macline1:Users:macline1:Documents:TRABAJOS:SOCIEDADES INTERNET:SEO:06-junio-08 (internet):Imagenes junio:Fig.S07089.01.tif)
/Resolution[300 300]
/ImageType[4 8]
/Position[260.78699 489.86899 260.78699 643.70203 487.55899 643.70203 487.55899 489.86899]
/Size[945 641]
>>
>>
/FormType 1
/Name/Fm0
/BBox[0 0 501.73196 700.15692]
/Subtype/Form
/Resources<</ExtGState<</GS1 2 0 R>>/XObject<</Fm1 10 0 R>>/ProcSet[/PDF]>>
/Type/XObject
/Length 63
>>
stream
/GS1 gs
q
226.7858 0 0 153.83369 260.773 490.0253 cm
/Fm1 Do
Q

endstream
endobj
12 0 obj
<<
/Length 8992
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 641.6219 Tm
0 Tr
0 0 0 1 k
0 Tc
0.039 Tw
[(T)80(odos los par\207metros estudiados mostraron dife-)]TJ
-0.97758 -1.10455 TD
0.236 Tw
(rencias entre los glaucomas y los dem\207s grupos)Tj
T*
0.25 Tw
[((tabla II), e)15(xcepto el cociente superior/nasal \(no)]TJ
T*
0.133 Tw
(mostr\227 diferencias entre los glaucomas y los nor-)Tj
T*
0.04 Tw
(males\), la modulaci\227n de la elipse \(no se encontra-)Tj
T*
-0.034 Tw
(ron diferencias entre los glaucomas y los glaucomas)Tj
0 -1.10454 TD
0.372 Tw
(preperim\216tricos\), el cociente temporal/nasal \(no)Tj
0 -1.10453 TD
0.053 Tw
(hubo diferencias entre los glaucomas y los glauco-)Tj
0 -1.10455 TD
0.062 Tw
(mas preperim\216tricos\), el promedio temporal \(no se)Tj
T*
0.201 Tw
[(observ)25(aron diferencias entre los glaucomas y los)]TJ
T*
0.155 Tw
(normales y glaucomas preperim\216tricos\), y el pro-)Tj
T*
-0.002 Tw
(medio nasal \(no present\227 diferencias entre los glau-)Tj
T*
0.202 Tw
(comas y los glaucomas preperim\216tricos\). Ning\234n)Tj
0 -1.10454 TD
0.004 Tc
0.371 Tw
(par\207metro mostr\227 diferencias entre controles e)Tj
T*
0 Tc
0.025 Tw
(hipertensos oculares.)Tj
0.97758 -1.10454 TD
0.038 Tw
(La tabla III muestra las ABCs de todos los par\207-)Tj
-0.97758 -1.10454 TD
0.132 Tw
(metros del GDx-VCC para discriminar entre con)Tj
20.28284 0.00001 TD
(-)Tj
-20.28284 -1.10455 TD
0.21 Tw
(troles y glaucomatosos. El par\207metro con mayor)Tj
0 -1.10454 TD
0.054 Tw
(ABC fue el NFI (0,876). Le siguen el \207rea inferior)Tj
0 -1.10455 TD
0.007 Tw
(normalizada (0,847) y el promedio inferior (0,822).)Tj
0 -1.10454 TD
0.229 Tw
(Las curv)Tj
3.67455 0.00001 TD
(as R)Tj
1.9392 0 TD
(OC de los seis mejores par\207metros)Tj
-5.61375 -1.10455 TD
0.015 Tw
(pueden v)Tj
3.63733 0.00001 TD
(erse en la f)Tj
4.38147 0 TD
(igura 1. Al comparar las curv)Tj
11.76404 0 TD
0 Tw
(as)Tj
-19.78284 -1.10455 TD
(R)Tj
0.6272 0 TD
0.093 Tw
(OC de estos seis par\207metros, el NFI present\227 un)Tj
21.79227 1.13061 TD
0.032 Tw
(ABC mayor que la del promedio TSNIT (p=0,012))Tj
0 -1.10455 TD
-0.0001 Tc
(y)Tj
0.77484 0 Td
0 Tc
0.025 Tw
(que la de la inte)Tj
6.41584 0 TD
(gral inferior (p=0,009).)Tj
ET
0 0 0 0 k
461.93 8.5039 25.629 11.338 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 469.559 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
(361)Tj
ET
0 0 0 0 k
137.614 10.57 228.784 9.178 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.2989 14.2856 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 345.0473 672.6915 Tm
0 0 0 1 k
(Diagn\227stico del glaucoma con el GDx-VCC)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
0 0 0 0 k
14.173 31.181 473.386 320.895 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 14.1732 345.9297 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Tabla II.)-488(Media y desviaci\227n est\207ndar de los par\207metros del GDx-VCC estudiados en cada grupo. La columna p expresa)]TJ
4.29167 -1.07535 TD
(los resultados de las comparaciones m\234ltiples (ANOVA) entre los grupos)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
9 0 0 9 104.7627 316.8957 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Normal)-8964(HTO)-6246(Glaucoma preperim\216trico)-4663(Glaucoma)]TJ
-1.42147 -1.07534 TD
0 Tw
[(Media)-1679(DE)-2022(p)-2306(Media)-1593(DE)-2973(p)-2584(Media)-2353(DE)-3121(p)-2697(Media)-1165(DE)-2432(p)]TJ
-8.64403 -2.19755 TD
(NFI)Tj
8.85186 0 TD
(15,68)Tj
3.90741 0 TD
[(9,18)-1134(P,G)-2125(17,64)-1576(7,68)-1809(P,G)-2643(23,35)-2046(11,00)-1455(N,H,G)-1891(40,90)-859(21,93)-848(N,H,P)]TJ
-12.75927 -1.12223 TD
0.025 Tw
[(Promedio TSNIT)-1857(56,63)-1657(6,35)-1134(P,G)-2125(55,02)-1576(4,74)-2211(G)-3047(53,09)-2546(6,33)-1940(N,G)-2378(46,82)-1359(8,46)-847(N,H,P)]TJ
0 -1.12222 TD
[(Promedio superior)-1413(66,91)-1657(8,69)-1537(G)-2528(66,66)-1576(6,96)-1808(P,G)-2644(63,21)-2546(8,12)-1940(H,G)-2378(54,73)-859(11,60)-848(N,H,P)]TJ
T*
(Promedio inferior)Tj
8.85186 0 TD
0 Tw
[(66,48)-1657(8,78)-1135(P,G)-2125(64,24)-1575(7,27)-2212(G)-3046(61,44)-2547(9,45)-1940(N,G)-2377(52,07)-859(11,62)-848(N,H,P)]TJ
-8.85186 -1.12224 TD
0.025 Tw
[(Desv.est. TSNIT)-2079(22,63)-1658(4,92)-1537(G)-2528(22,91)-1576(5,04)-1808(P,G)-2644(20,33)-2546(5,38)-1940(H,G)-2377(16,32)-1360(4,73)-847(N,H,P)]TJ
0 -1.12223 TD
[(Raz\227n superior)-3246(3,21)-1658(1,25)-1537(G)-3028(3,44)-1575(1,25)-2212(G)-3546(3,00)-2546(1,13)-2426(G)-3364(2,26)-1359(0,89)-848(N,H,P)]TJ
0 -1.12222 TD
(Raz\227n inferior)Tj
9.35186 0 TD
0 Tw
(3,34)Tj
3.40741 0 TD
(1,23)Tj
3.28718 0 TD
[(G)-3028(3,45)-1576(1,21)-2211(G)-3546(3,03)-2547(1,17)-2426(G)-3363(2,31)-1359(0,83)-848(N,H,P)]TJ
-16.04644 -1.12223 TD
(Sup/nasal)Tj
9.35186 0 TD
[(2,31)-1657(0,58)-5287(2,54)-1576(0,74)-2212(G)-3546(2,44)-2546(0,75)-2426(G)-3364(2,02)-1359(0,50)-1333(H,P)]TJ
-9.35186 -1.12223 TD
0.025 Tw
[(Max mod)-5466(2,58)-1658(1,16)-1537(G)-3028(2,68)-1576(1,22)-2211(G)-3546(2,26)-2547(1,15)-2426(G)-3363(1,63)-1359(0,79)-848(N,H,P)]TJ
0 -1.12222 TD
[(M\207ximo superior)-1912(78,35)-1158(12,41)-1537(G)-2528(78,29)-1076(10,52)-2211(G)-3046(76,51)-2047(11,72)-2426(G)-2863(64,33)-859(13,90)-848(N,H,P)]TJ
T*
[(M\207ximo inferior)-2191(82,30)-1157(11,61)-1537(G)-2528(78,87)-1076(10,51)-2211(G)-3047(77,79)-2046(13,74)-2426(G)-2863(66,82)-859(14,63)-848(N,H,P)]TJ
T*
(Ell mod)Tj
9.35186 0.00001 TD
0 Tw
[(4,07)-1657(1,77)-1538(G)-3027(4,14)-1576(1,75)-2212(G)-3546(3,54)-2546(1,80)-6512(2,80)-1359(1,30)-1250(N,H)]TJ
-9.35186 -1.12223 TD
0.025 Tw
(\347rea sup norm)Tj
9.35186 0.00001 TD
0 Tw
(0,14)Tj
3.40741 0.00001 TD
(0,03)Tj
2.88423 0.00001 TD
[(P,G)-2625(0,14)-1576(0,02)-1808(P,G)-3144(0,12)-2546(0,03)-1454(N,H,G)-2392(0,10)-1359(0,03)-848(N,H,P)]TJ
-15.6435 -1.12224 TD
0.025 Tw
(\347rea inf norm )Tj
9.35186 0.00001 TD
0 Tw
(0,15)Tj
3.40741 0.00001 TD
(0,03)Tj
2.88423 0.00001 TD
(P,G)Tj
4.1528 0 TD
(0,14)Tj
3.32574 0.00001 TD
[(0,02)-1808(P,G)-3144(0,13)-2546(0,03)-1455(N,H,G)-2391(0,10)-1359(0,03)-848(N,H,P)]TJ
-23.12205 -1.12225 TD
[(Temp/nasal)-4687(0,80)-1658(0,32)-1537(G)-3028(0,79)-1575(0,26)-2212(G)-3546(0,85)-2546(0,21)-6512(0,97)-1359(0,28)-1251(N,H)]TJ
0 -1.12223 TD
[(Inf/nasal)-5854(2,42)-1658(0,59)-1537(G)-3028(2,55)-1575(0,71)-2212(G)-3546(2,45)-2547(0,73)-2426(G)-3363(2,09)-1359(0,46)-848(N,H,P)]TJ
0 -1.12222 TD
0.025 Tw
[(Integral total)-4191(0,53)-1657(0,06)-1134(P,G)-2625(0,52)-1576(0,04)-2212(G)-3546(0,50)-2546(0,06)-1940(N,G)-2878(0,45)-1359(0,08)-848(N,H,P)]TJ
T*
[(Integral superior)-2692(0,20)-1657(0,03)-1135(P,G)-2625(0,20)-1575(0,02)-1809(P,G)-3143(0,19)-2547(0,03)-1454(N,H,G)-2391(0,17)-1359(0,03)-848(N,H,P)]TJ
T*
[(Integral inferior)-2970(0,21)-1658(0,03)-1134(P,G)-2625(0,20)-1576(0,02)-2211(G)-3547(0,19)-2546(0,03)-1940(N,G)-2877(0,17)-1359(0,03)-848(N,H,P)]TJ
T*
[(Promedio temporal)-1135(27,27)-1157(11,24)-4787(25,54)-1576(8,03)-2211(G)-3047(28,83)-2046(11,09)-6011(30,84)-860(11,80)-1736(H)]TJ
T*
[(Promedio nasal)-2634(43,42)-1658(8,30)-1537(G)-2528(40,88)-1576(9,24)-2211(G)-3046(39,43)-2047(10,37)-6011(35,99)-1359(8,03)-1251(N,H)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 68.2335 Tm
0 Tr
0 0 0 1 k
0 Tc
0.037 Tw
(HTO = hipertensos oculares; DE = desviaci\227n est\207ndar; p = diferencias significativas con; NFI = indicador de fibras nerviosas; Desv est TSNIT =)Tj
0 -1.0754 TD
0.056 Tw
(desviaci\227n est\207ndar TSNIT; Sup/nasal = Cociente superior/nasal; Max mod = Modulaci\227n m\207xima; Ell mod = Modulaci\227n de la elipse; \347rea sup)Tj
T*
0.019 Tw
(norm = \347rea superior normalizada; \347rea inf norm = \347rea inferior normalizada; Temp//nasal = Cociente Temporal/nasal; Inf/nasal = Cociente infe-)Tj
T*
0.015 Tw
(rior/nasal. N: Diferencias con el grupo normal; H: Diferencias con el grupo de HTO; P: Diferencias con el grupo de glaucomas preperim\216tricos; G:)Tj
T*
0.025 Tw
(Diferencias con el grupo de glaucomas.)Tj
ET
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 327.9789 m
487.559 327.9789 l
S
14.173 299.054 m
487.559 299.054 l
S
0.417 w 
14.173 78.1529 m
487.559 78.1529 l
S
1.25 w 
14.173 76.4859 m
487.559 76.4859 l
S
0 0 0 0 k
260.787 484.7449 226.772 164.388 re
f
/GS3 gs
q
260.787 484.7449 226.772 164.388 re
W n
/Fm0 Do
Q
/GS2 gs
260.787 395.27 226.772 80.882 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 260.7874 469.3234 Tm
0 Tr
0 0 0 1 k
0 Tc
0.026 Tw
[(Fig. 1:)-500(Curvas ROC de los 6 par\207metros del GDx-VCC)]TJ
0 -1.1 TD
-0.007 Tw
(con mayor capacidad diagn\227stica para diferenciar entre)Tj
T*
0.025 Tw
(normales y glaucomas. )Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
9 0 0 9 260.7874 437.6454 Tm
0 Tr
0 0 0 1 k
-0.01 Tc
-0.03 Tw
(NFI = indicador de fibras nerviosas; Inf Norm Area = \347rea infe)Tj
24.86408 0 TD
0 Tc
(-)Tj
-24.86408 -1.07534 TD
-0.01 Tc
0.125 Tw
(rior normalizada; Promedio Inf = Promedio inferior; Desv St)Tj
T*
-0.009 Tw
(TSNIT = Desviaci\227n est\207ndar TSNIT; Inf Int = Integral inferior.)Tj
ET
Q

endstream
endobj
13 0 obj
<<
/Length 7727
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
14.173 7.5279 29.435 12.314 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 14.1732 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(362)Tj
ET
0 0 0 0 k
137.36 10.6629 228.784 9.179 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.0444 14.3792 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 14.1732 672.6915 Tm
0 0 0 1 k
(BORQUE E, et al.)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
0 0 0 0 k
14.173 345.873 473.386 303.2599 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 14.1732 642.9875 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Tabla III.)-488(\347reas bajo la curva ROC e intervalos de confianza de la curva de los par\207metros del GDx-VCC para)]TJ
4.68056 -1.07533 TD
(diferenciar entre sanos y sujetos con glaucoma)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
9 0 0 9 124.558 613.9535 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(ABC)-5328(DE)-5759(p)-8160(Intervalo de confianza del 95%)]TJ
21.00805 -1.07533 TD
-0.0002 Tc
(L)Tj
0.61084 0.00001 TD
0 Tc
[(\222mite inferior)-5114(L\222mite superior)]TJ
-33.88387 -2.15068 TD
0 Tw
[(NFI)-10558(0,876)-5022(0,03)-4393(<0,001)-6970(0,80)-9442(0,92)]TJ
0 -1.07532 TD
0.025 Tw
[(Promedio TSNIT)-5173(0,822)-5022(0,04)-4393(<0,001)-6970(0,75)-9442(0,89)]TJ
0 -1.07534 TD
[(Promedio superior)-4729(0,799)-5022(0,04)-4393(<0,001)-6970(0,72)-9442(0,87)]TJ
T*
[(Promedio inferior)-5007(0,831)-5022(0,03)-4393(<0,001)-6971(0,75)-9442(0,89)]TJ
0 -1.07533 TD
[(Desv.est. TSNIT)-5395(0,815)-5023(0,04)-4392(<0,001)-6971(0,73)-9442(0,87)]TJ
T*
[(Raz\227n superior)-6062(0,698)-5022(0,05)-4393(<0,001)-6971(0,61)-9442(0,79)]TJ
T*
[(Raz\227n inferior)-6341(0,621)-5022(0,05)-4675(0,002)-7252(0,52)-9442(0,72)]TJ
0 -1.07534 TD
0 Tw
[(Sup/nasal)-8280(0,737)-5022(0,04)-4393(<0,001)-6970(0,65)-9442(0,82)]TJ
T*
0.025 Tw
[(Max mod)-8282(0,762)-5022(0,04)-4393(<0,001)-6971(0,68)-9442(0,84)]TJ
0 -1.07533 TD
[(M\207ximo superior)-5228(0,642)-5023(0,05)-4674(0,001)-7253(0,55)-9442(0,74)]TJ
T*
[(M\207ximo inferior)-5507(0,760)-5022(0,04)-4393(<0,001)-6970(0,68)-9442(0,84)]TJ
0 -1.07534 TD
[(Ell mod)-8949(0,769)-5022(0,04)-4393(<0,001)-6970(0,69)-9442(0,85)]TJ
T*
(\347rea sup norm)Tj
12.16793 0 TD
0 Tw
[(0,792)-5022(0,04)-4393(<0,001)-6971(0,71)-9441(0,87)]TJ
-12.16793 -1.07534 TD
0.025 Tw
(\347rea inf norm )Tj
12.16793 0 TD
0 Tw
(0,721)Tj
7.27202 0 TD
[(0,04)-4393(<0,001)-6971(0,63)-9441(0,81)]TJ
-19.43995 -1.07534 TD
[(Temp/nasal)-7503(0,800)-5022(0,04)-4393(<0,001)-6971(0,72)-9442(0,88)]TJ
T*
[(Inf/nasal)-8670(0,847)-5022(0,03)-4393(<0,001)-6971(0,77)-9442(0,90)]TJ
0 -1.07533 TD
0.025 Tw
(Integral total)Tj
12.16793 0 TD
0 Tw
[(0,664)-5022(0,05)-4393(<0,001)-6971(0,57)-9441(0,76)]TJ
-12.16793 -1.07533 TD
0.025 Tw
[(Integral superior)-5508(0,811)-5022(0,04)-4393(<0,001)-6971(0,74)-9442(0,88)]TJ
T*
(Integral inferior)Tj
12.16793 0 TD
0 Tw
(0,794)Tj
7.27202 0 TD
(0,04)Tj
6.14297 0 TD
(<0,001)Tj
9.78451 0 TD
(0,72)Tj
11.19191 0 TD
(0,87)Tj
-46.55935 -1.07535 TD
0.025 Tw
[(Promedio temporal)-4451(0,815)-5022(0,04)-4393(<0,001)-6970(0,73)-9442(0,87)]TJ
0 -1.07534 TD
[(Promedio nasal)-5950(0,751)-5022(0,04)-4393(<0,001)-6971(0,67)-9442(0,83)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 374.1537 Tm
0 Tr
0 0 0 1 k
0 Tc
0.036 Tw
(ABC = \207rea bajo la curva ROC; DE = desviaci\227n est\207ndar; p = nivel de significaci\227n de la curva ROC; NFI = indicador de fibras nerviosas; Desv)Tj
0 -1.07537 TD
0.022 Tw
(est TSNIT = desviaci\227n est\207ndar TSNIT; Sup/nasal = Cociente superior/nasal; Max mod = Modulaci\227n m\207xima; Ell mod = Modulaci\227n de la elip-)Tj
T*
0.056 Tw
(se; \347rea sup norm = \347rea superior normalizada; \347rea inf norm = \347rea inferior normalizada; Temp//nasal = Cociente Temporal/nasal; Inf/nasal =)Tj
T*
0.025 Tw
(Cociente inferior/nasal.)Tj
ET
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 625.874 m
487.559 625.874 l
S
14.173 596.7479 m
487.559 596.7479 l
S
0.417 w 
14.173 385.4829 m
487.559 385.4829 l
S
1.25 w 
14.173 383.817 m
487.559 383.817 l
S
0 0 0 0 k
14.173 31.181 473.386 295.945 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 14.1732 320.9807 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Tabla IV.)-488(Sensibilidad de los diferentes par\207metros del GDx-VCC para especificidades fijadas en el 85% y 90%, para)]TJ
4.625 -1.07533 TD
(discriminar entre sujetos normales y con glaucoma)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
9 0 0 9 172.2019 291.9466 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Especificidad 85%)-12895(Especificidad 90%)]TJ
-4.1939 -1.07533 TD
[(Punto de corte)-4117(Sensibilidad (%))-3913(Punto de corte)-4211(Sensibilidad (%))]TJ
-13.36484 -2.15067 TD
0 Tw
[(NFI)-13667(23,50)-7861(70,42)-8212(24,50)-8233(69,01)]TJ
0 -1.07532 TD
0.025 Tw
(Promedio TSNIT)Tj
15.27778 0 TD
0 Tw
(49,99)Tj
10.11111 0 TD
(61,97)Tj
10.4615 0 TD
(49,58)Tj
10.48295 0 TD
(57,74)Tj
-46.33333 -1.07535 TD
0.025 Tw
(Promedio superior)Tj
15.27778 0 TD
0 Tw
(60,73)Tj
10.11111 0 TD
(64,78)Tj
10.4615 0 TD
(57,41)Tj
10.48295 0 TD
(53,52)Tj
-46.33333 -1.07535 TD
0.025 Tw
[(Promedio inferior)-8117(57,00)-7861(67,60)-8212(55,02)-8232(61,97)]TJ
0 -1.07533 TD
(Desv.est. TSNIT)Tj
15.27778 0 TD
0 Tw
(17,11)Tj
10.11111 0.00001 TD
(60,56)Tj
10.4615 0 TD
[(16,84)-8233(56,33)]TJ
-35.85038 -1.07535 TD
0.025 Tw
(Raz\227n superior)Tj
15.77778 0 TD
0 Tw
[(1,96)-7861(47,88)-8712(1,70)-8233(33,80)]TJ
-15.77778 -1.07533 TD
0.025 Tw
[(Raz\227n inferior)-9950(2,01)-7862(52,11)-8711(1,85)-8233(33,80)]TJ
0 -1.07534 TD
0 Tw
[(Sup/nasal)-11890(1,72)-7861(32,39)-8711(1,61)-8233(22,53)]TJ
0 -1.07533 TD
0.025 Tw
[(Max mod)-11892(1,51)-7861(54,92)-8712(1,23)-8233(40,84)]TJ
T*
(M\207ximo superior)Tj
15.27778 0 TD
0 Tw
(68,00)Tj
10.11111 0.00001 TD
(54,92)Tj
10.4615 0 TD
[(64,33)-8233(50,70)]TJ
-35.85038 -1.07535 TD
0.025 Tw
(M\207ximo inferior)Tj
15.27778 0.00001 TD
0 Tw
(70,35)Tj
10.11111 0.00001 TD
(60,56)Tj
10.4615 0.00001 TD
[(66,46)-8233(53,52)]TJ
-35.85038 -1.07535 TD
0.025 Tw
(Ell mod)Tj
15.77778 0.00001 TD
0 Tw
(2,75)Tj
9.61111 0.00001 TD
[(59,15)-8711(2,14)-8233(36,61)]TJ
-25.38889 -1.07535 TD
0.025 Tw
(\347rea sup norm)Tj
15.77778 0.00001 TD
0 Tw
(0,12)Tj
9.61111 0 TD
[(70,42)-8711(0,11)-8233(66,19)]TJ
-25.38889 -1.07535 TD
0.025 Tw
[(\347rea inf norm )-9789(0,12)-7861(70,42)-8712(0,12)-8233(64,78)]TJ
0 -1.07534 TD
0 Tw
[(Temp/nasal)-11113(1,03)-7861(32,39)-8712(1,27)-8233(14,08)]TJ
T*
(Inf/nasal)Tj
15.77778 0.00001 TD
[(1,79)-7861(29,57)-8712(1,69)-8233(23,94)]TJ
-15.7778 -1.0753 TD
0.025 Tw
(Integral total)Tj
15.77778 0.00001 TD
0 Tw
[(0,48)-7861(64,78)-8712(0,47)-8233(56,33)]TJ
-15.7778 -1.0753 TD
0.025 Tw
[(Integral superior)-9118(0,19)-7861(67,60)-8712(0,18)-8232(52,11)]TJ
T*
[(Integral inferior)-9396(0,18)-7861(66,19)-8712(0,18)-8233(60,56)]TJ
T*
[(Promedio temporal)-7561(36,69)-7861(25,35)-8211(40,23)-8233(16,90)]TJ
T*
[(Promedio nasal)-9060(34,98)-7861(52,11)-8212(34,06)-8233(50,70)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 14.1732 52.1467 Tm
0 Tr
0 0 0 1 k
0 Tc
0.039 Tw
(NFI = indicador de fibras nerviosas; Desv est TSNIT = desviaci\227n est\207ndar TSNIT; Sup/nasal = Cociente superior/nasal; Max mod = Modulaci\227n)Tj
0 -1.0754 TD
0.013 Tw
(m\207xima; Ell mod = Modulaci\227n de la elipse; \347rea sup norm = \347rea superior normalizada; \347rea inf norm = \347rea inferior normalizada; Temp//nasal)Tj
-0.0001 Tc
(=)'
0.8388 0 Td
0 Tc
0.025 Tw
(Cociente Temporal/nasal; Inf/nasal = Cociente inferior/nasal.)Tj
ET
0 J 0 j 10 M []0 d 0.5 w 
0 0 0 1 K
14.173 304.0299 m
487.559 304.0299 l
S
14.173 274.8929 m
487.559 274.8929 l
S
0.417 w 
14.173 63.337 m
487.559 63.337 l
S
1.25 w 
14.173 61.67 m
487.559 61.67 l
S
Q

endstream
endobj
14 0 obj
<<
/Length 9307
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 29.763 473.386 619.3699 re
f
Q
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 641.6219 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0.031 Tw
[(En la tabla IV se encuentran los v)25(alores de sensi-)]TJ
-0.97758 -1.10455 TD
0.298 Tw
[(bilidad para especif)20(icidades pref)19(ijadas al 85% y)]TJ
-0.0051 Tc
(90%)'
2.13835 0 Td
(de)Tj
1.25445 0 Td
-0.005 Tc
0.076 Tw
(los par\207metros estudiados, para diferenciar)Tj
-3.3928 -1.10455 TD
0.15 Tw
(entre sanos y glaucomas. El NFI, el \207rea superior)Tj
T*
-0.01 Tw
(normalizada y el \207rea inferior normalizada presenta-)Tj
T*
0.051 Tw
(ron las sensibilidades m\207s altas \(70,42% en los tres)Tj
0 -1.10454 TD
0.073 Tw
[(par\207metros\) para una especif)20(icidad del 85%. T)79(odos)]TJ
0 -1.10453 TD
0.089 Tw
(los par\207metros del informe est\207ndar mostraron una)Tj
0 -1.10455 TD
0.003 Tw
[(sensibilidad mayor al 60% para dicho ni)25(v)15(el de espe)-1(-)]TJ
T*
0.183 Tw
[(cif)19(icidad. P)15(ara una especif)20(icidad del 90%, el NFI)]TJ
T*
0.139 Tw
(sigue siendo el par\207metro con mayor sensibilidad,)Tj
T*
-0.001 Tw
[(se)15(guido de nue)24(v)20(o por el \207rea superior normalizada y)]TJ
T*
-0.014 Tw
(el \207rea inferior normalizada, con unas sensibilidades)Tj
0 -1.10454 TD
0.025 Tw
[(del 69,01%, 66,19% y 64,78% respecti)25(v)25(amente.)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 91.4504 445.3719 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(DISCUSI\356N)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
11 0 0 11 24.9266 421.072 Tm
0 Tr
0 0 0 1 k
0 Tc
0.306 Tw
(En el presente estudio hemos demostrado, al)Tj
-0.97758 -1.10454 TD
0 Tw
(igual que di)Tj
4.69542 0 TD
(v)Tj
0.48511 0 TD
(ersos estudios anteriores, que los par\207)Tj
15.10232 0.00001 TD
(-)Tj
-20.28284 -1.10456 TD
0.037 Tw
(metros analizados por el GDx-VCC son \234tiles para)Tj
0 -1.10454 TD
-0.014 Tw
(discriminar entre sujetos normales y glaucomatosos)Tj
T*
0.115 Tw
(con defectos le)Tj
6.20212 0.00001 TD
[(v)15(es o moderados en la P)92(A \(6,7,17-)]TJ
-6.20212 -1.10455 TD
-0.022 Tw
(21\). La mayor\222a de los par\207metros presentaron dife-)Tj
0 -1.10454 TD
0.011 Tc
0.364 Tw
(rencias signif)Tj
5.85854 0.00001 TD
0 Tw
(icati)Tj
1.75203 0 TD
0 Tc
(v)Tj
0.48625 0 TD
0.011 Tc
0.364 Tw
(as entre sujetos normales o)Tj
-8.09681 -1.10454 TD
0.002 Tc
0.373 Tw
(hipertensos y glaucomatosos, no encontr\207ndose)Tj
0 -1.10455 TD
0 Tc
0.012 Tw
(para ning\234n par\207metro diferencias entre controles e)Tj
0 -1.10454 TD
0.025 Tw
(hipertensos oculares.)Tj
0.97758 -1.10454 TD
0.065 Tw
(Entre todos los par\207metros destaca el NFI como)Tj
-0.97758 -1.10455 TD
0.158 Tw
(el de mayor capacidad diagn\227stica. El NFI es un)Tj
T*
0.026 Tw
(indicador global del estado de la CFNR, se basa en)Tj
T*
-0.027 Tw
[(un a)20(v)25(anzado sistema de an\207lisis de redes neuronales)]TJ
T*
0.015 Tw
[(que v)25(alora el perf)19(il completo de la CFNR y obtiene)]TJ
0 -1.10454 TD
0.101 Tw
(un n\234mero que representa la inte)Tj
13.56603 0 TD
(gridad de la mis)Tj
6.71681 0 TD
(-)Tj
-20.28284 -1.10455 TD
0.108 Tw
[(ma. La clasif)20(icaci\227n diagn\227stica del NFI se deter-)]TJ
0 -1.10454 TD
0.022 Tw
(min\227 a partir de la distrib)Tj
10.2238 0 TD
[(uci\227n normal de sus v)25(alo-)]TJ
-10.2238 -1.10455 TD
0.101 Tw
(res en la base de datos incluida en el propio GDx)Tj
T*
0 Tw
(VCC. )Tj
0.97758 -1.10455 TD
0.123 Tw
(Otros estudios (6,7,17) han encontrado tambi\216n)Tj
-0.97758 -1.10454 TD
0.12 Tw
(que el NFI es el par\207metro de mayor rentabilidad)Tj
T*
0.121 Tw
(diagn\227stica para el glaucoma, con ABCs de hasta)Tj
T*
0.125 Tw
[(0,98 (7). L\227gicamente, el grado de la e)15(xtensi\227n y)]TJ
T*
0.045 Tw
(profundidad de los defectos del campo visual tiene)Tj
T*
0.029 Tw
(una gran influencia en la sensibilidad de los instru)Tj
20.28284 0.00001 TD
(-)Tj
-20.2828 -1.1046 TD
0.275 Tw
(mentos de diagn\227stico por imagen. Cuanto m\207s)Tj
0 -1.1045 TD
0.273 Tw
[(a)20(v)25(anzada est\207 la enfermedad mayor sensibilidad)]TJ
T*
0.041 Tw
(presentan estos equipos. Reus y Lemij (7) obtuvie-)Tj
T*
0.124 Tw
[(ron una capacidad diagn\227stica tan ele)25(v)25(ada para el)]TJ
T*
-0.026 Tw
(NFI porque incluyeron una poblaci\227n de glaucomas)Tj
0 -1.1046 TD
-0.025 Tw
[(con m\207s del 50% de glaucomas se)25(v)15(eros. Medeiros y)]TJ
0 -1.1045 TD
-0.0001 Tc
(col.)Tj
1.7354 0 Td
0 Tc
0.014 Tw
((6), encontraron resultados m\207s parecidos a los)Tj
20.68403 55.39542 TD
0.285 Tw
(nuestros utilizando una poblaci\227n de glaucomas)Tj
0 -1.10455 TD
0.238 Tw
(incipientes (ABC de 0,91 para el NFI). En otra)Tj
T*
0.001 Tw
(poblaci\227n en nuestro medio (17), los resultados son)Tj
T*
0.358 Tw
(superponibles, siendo el NFI el par\207metro con)Tj
T*
0.025 Tw
[(mayor ABC de nue)25(v)20(o.)]TJ
0.97758 -1.10455 TD
0.096 Tw
(El resto de par\207metros que ofrece el GDx-VCC)Tj
-0.97758 -1.10454 TD
0.049 Tw
(presentaron ABCs menores que el NFI, la mayor\222a)Tj
0 -1.10453 TD
-0.016 Tw
[(con v)25(alores por debajo de 0,80. Once par\207metros de)]TJ
0 -1.10455 TD
0.014 Tw
(los 21 ofrecidos por el polar\222metro presentan sensi-)Tj
T*
0.071 Tw
[(bilidades superiores al 60% para una especif)20(icidad)]TJ
T*
0.133 Tw
[(f)20(ijada en el 85%, aunque s\227lo 5 la siguen mante-)]TJ
T*
-0.003 Tw
[(niendo para una especif)20(icidad del 90%. Estos resul-)]TJ
T*
0.054 Tw
(tados son similares a los de otros estudios como el)Tj
0 -1.10454 TD
0.161 Tw
(de DeLeon (21), que presenta 13 par\207metros con)Tj
T*
0.135 Tw
[(sensibilidad mayor al 62% para una especif)20(icidad)]TJ
T*
-0.018 Tw
(del 80%, a pesar de que en este estudio la poblaci\227n)Tj
T*
0.359 Tw
(era de predominio afroamericano, que presenta)Tj
T*
0.012 Tw
(diferencias en la presentaci\227n y e)Tj
13.33488 0.00001 TD
(v)Tj
0.48023 0 TD
(oluci\227n del glau-)Tj
-13.81511 -1.10455 TD
0.025 Tw
(coma frente a la raza cauc\207sica.)Tj
0.97758 -1.10455 TD
0.021 Tw
[(En nuestro estudio tratamos de v)25(alorar la capaci-)]TJ
-0.97758 -1.10454 TD
0.077 Tw
(dad diagn\227stica de los par\207metros ofrecidos por el)Tj
T*
0.066 Tw
(GDx-VCC de manera independiente. Encontramos)Tj
T*
0.26 Tw
(que cuatro de los cinco par\207metros del informe)Tj
T*
0.113 Tw
(est\207ndar son los que mayor capacidad diagn\227stica)Tj
0 -1.10453 TD
0.107 Tw
(presentaron de entre todos los que el softw)Tj
17.81636 0 TD
(are del)Tj
-17.81636 -1.10455 TD
0.035 Tw
(aparato nos ofrece. Es f)Tj
9.5413 0.00001 TD
(actible que combinando los)Tj
-9.5413 -1.10455 TD
0.309 Tw
(par\207metros en f\227rmulas discriminantes podamos)Tj
0 -1.10454 TD
0.094 Tw
[(conse)15(guir una mayor capacidad diagn\227stica, como)]TJ
T*
0.169 Tw
[(se ha demostrado al e)25(v)25(aluar di)24(v)15(ersos sistemas de)]TJ
(e)'
0.41895 0 TD
(v)Tj
0.4751 0 TD
0.115 Tw
(aluaci\227n objeti)Tj
6.00462 0 TD
[(v)25(a de la CFNR (20,23-29). En la)]TJ
-6.89866 -1.10455 TD
0.106 Tw
(generaci\227n anterior del polar\222metro l\207ser)Tj
16.65439 0 TD
-0.0001 Tc
(,)Tj
0.60629 0 Td
0 Tc
(el GDx-)Tj
-17.26068 -1.10455 TD
0.062 Tw
[(NF)74(A, mediante la f\227rmula discriminante propuesta)]TJ
T*
0.037 Tw
[(por W)80(einreb (26), se observ\227 una mayor capacidad)]TJ
0 -1.10454 TD
0.002 Tw
(diagn\227stica que con el \307n\234mero\310 que aporta el ana)Tj
20.28283 0 TD
(-)Tj
-20.28283 -1.10455 TD
0 Tw
(lizador)Tj
2.72119 0 TD
-0.0001 Tc
(.)Tj
0.52497 0 Td
0 Tc
0.025 Tw
(Este \307n\234mero\310 es el equi)Tj
10.12779 0 TD
[(v)25(alente al NFI del)]TJ
-13.37394 -1.10455 TD
(polar\222metro l\207ser GDx-VCC.)Tj
0.97758 -1.10454 TD
0.044 Tw
(Hemos de ser cautos a la hora de generalizar los)Tj
-0.97758 -1.10455 TD
-0.035 Tw
(resultados del presente estudio para no sobreestimar)Tj
T*
0.083 Tw
[(los resultados del mismo. Los pacientes pro)15(vienen)]TJ
0 -1.10454 TD
0.149 Tw
(de una consulta especializada en glaucoma de un)Tj
0 -1.10453 TD
0.158 Tw
(hospital terciario (poblaci\227n seleccionada), por lo)Tj
0 -1.10455 TD
0.191 Tw
[(que los resultados del estudio en un conte)15(xto de)]TJ
0 -1.10454 TD
0.258 Tw
(consulta oftalmol\227gica primaria ser\222an, con toda)Tj
0 -1.10455 TD
-0.012 Tw
[(se)15(guridad, menores. A pesar de todo esto, encontra-)]TJ
T*
0.009 Tw
(mos en nuestro estudio una b)Tj
11.65962 0.00001 TD
(uena capacidad discri)Tj
8.62322 0.00001 TD
(-)Tj
-20.28283 -1.10455 TD
0.069 Tw
(minatoria entre controles sanos y sujetos con da\226o)Tj
T*
0.131 Tw
(glaucomatoso inicial o moderado mediante el uso)Tj
0 -1.10454 TD
0.065 Tw
(del polar\222metro l\207ser GDx-VCC. El uso de combi)Tj
20.28285 0.00001 TD
(-)Tj
-20.28285 -1.10456 TD
0.022 Tw
(naciones de par\207metros u otros m\216todos de an\207lisis)Tj
0 -1.10455 TD
0.189 Tw
(de la CFNR pueden apo)Tj
10.35645 0.00001 TD
(yarnos en el diagn\227stico)Tj
-10.35645 -1.10455 TD
0.025 Tw
(precoz de glaucoma y deben ser estudiados.)Tj
ET
0 0 0 0 k
461.93 8.5039 25.629 11.338 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 469.559 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
(363)Tj
ET
0 0 0 0 k
137.614 10.57 228.784 9.178 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.2989 14.2856 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 345.0473 672.6915 Tm
0 0 0 1 k
(Diagn\227stico del glaucoma con el GDx-VCC)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
Q

endstream
endobj
15 0 obj
<<
/Length 9998
>>
stream
/GS0 gs
q
0 0.157 501 700 re
W n
1 g
0 700.157 0 0 re
f
Q
/GS1 gs
q
/GS2 gs
0 0 0 0 k
14.173 70.711 473.386 578.4219 re
f
Q
/GS2 gs
q
BT
/F1 1 Tf
13 0 0 13 78.809 640.2562 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(BIBLIOGRAF\352A)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
9 0 0 9 18.6732 613.2562 Tm
0 Tr
0 0 0 1 k
0 Tc
0.102 Tw
[(1.)-640(American Academy of Ophthalmology. Glaucoma Panel.)]TJ
1.38977 -1.11111 TD
0.13 Tw
(Preferred Practice Pattern. Primary open-angle glauco-)Tj
T*
0.214 Tw
(ma. San Francisco: American Academy of Ophthalmo-)Tj
T*
0.025 Tw
(logy; 2005. Disponible en: www.aao.org/ppp)Tj
-1.38977 -1.11111 TD
-0.003 Tw
[(2.)-640(Quigley HA. Neuronal death in glaucoma. Prog Retin Eye)]TJ
1.38977 -1.11112 TD
0.025 Tw
(Res 1999; 18: 39-57.)Tj
-1.38977 -1.11111 TD
0.201 Tw
[(3.)-640(Sommer A, Katz J, Quigley HA, Miller NR, Robin AL,)]TJ
1.38977 -1.11111 TD
0.067 Tw
(Richter RC, et al. Clinical detectable nerve fiber atrophy)Tj
T*
0.022 Tw
(precedes the onset of glaucomatous field loss. Arch Opht-)Tj
0 -1.11112 TD
0.025 Tw
(halmol 1991; 109: 77-83.)Tj
-1.38977 -1.11111 TD
-0.003 Tw
[(4.)-640(Weinreb RN, Zangwill L. Retinal nerve fiber layer evalua-)]TJ
1.38977 -1.11111 TD
0.025 Tw
(tion in glaucoma. J Glaucoma 2001; 10: S56-S58.)Tj
-1.38977 -1.11111 TD
0.201 Tw
[(5.)-640(Sommer A, Quigley HA, Robin AL, Miller NR, Katz J,)]TJ
1.38977 -1.11112 TD
0.018 Tw
(Arkell S. Evaluation of nerve fiber layer assessment. Arch)Tj
0 -1.11111 TD
0.025 Tw
(Ophthalmol 1984; 102: 1766-1771.)Tj
-1.38977 -1.11111 TD
0.067 Tw
[(6.)-640(Medeiros FA, Zangwill LM, Bowd C, Weinreb RN. Com-)]TJ
1.38977 -1.11111 TD
-0.006 Tw
(parison of the GDx VCC scanning laser polarimeter, HRT)Tj
T*
0.186 Tw
(II confocal scanning ophthalmoscope, and stratus OCT)Tj
T*
0.057 Tw
(optical coherence tomograph for the detection of glauco-)Tj
0 -1.11112 TD
0.025 Tw
(ma. Arch Ophthalmol 2004; 122: 827-837.)Tj
-1.38977 -1.11111 TD
-0.011 Tw
[(7.)-640(Reus NJ, Lemij HG. Diagnostic accuracy of the GDx VCC)]TJ
1.38977 -1.11111 TD
0.025 Tw
(for glaucoma. Ophthalmology 2004; 111: 1860-1865.)Tj
-1.38977 -1.11111 TD
0.139 Tw
[(8.)-640(Leung CK, Chan WM, Chong KK, Yung WH, Tang KT,)]TJ
1.38977 -1.11111 TD
0.211 Tw
(Woo J, et al. Comparative study of retinal nerve fiber)Tj
T*
0.314 Tw
(layer measurement by StratusOCT and GDx VCC, I:)Tj
T*
0.103 Tw
(correlation analysis in glaucoma. Invest Ophthalmol Vis)Tj
T*
0.025 Tw
(Sci 2005; 46: 3214-3220.)Tj
-1.38977 -1.11111 TD
-0.008 Tw
[(9.)-640(Weinreb RN, Dreher AW, Coleman A, Quigley H, Shaw B,)]TJ
1.38977 -1.11111 TD
0.196 Tw
(Reiter K. Histopathologic validation of Fourier-ellipso)Tj
22.97433 0 TD
(-)Tj
-22.97433 -1.11112 TD
0.005 Tw
(metry measurements of retinal nerve fiber layer thickness.)Tj
0 -1.11111 TD
0.025 Tw
(Arch Ophthalmol 1990; 108: 557-560.)Tj
-1.88977 -1.11111 TD
-0.003 Tw
[(10.)-640(Zhou Q, Knighton RW. Light scattering and form birefrin-)]TJ
1.88977 -1.11111 TD
-0.015 Tw
(gence of parallel cylindrical arrays that represent cellular)Tj
T*
0.004 Tw
(organelles of the retinal nerve fiber layer. Appl Opt 1997;)Tj
T*
0.025 Tw
(36: 2273-2285.)Tj
-1.88977 -1.11111 TD
0.088 Tw
[(11.)-640(Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glas-)]TJ
1.88977 -1.11111 TD
0.006 Tw
(ziou PP, Irwig LM, et al. The STARD statement for repor-)Tj
T*
0.072 Tw
(ting studies of diagnostic accuracy: explanation and ela)Tj
22.97431 0 TD
(-)Tj
-22.97431 -1.11112 TD
0.025 Tw
(boration. Clin Chem 2003; 49: 7-18.)Tj
-1.88977 -1.11111 TD
0.121 Tw
[(12.)-640(Chylack LT Jr, Wolfe JK, Singer DM, Leske MC; Bulli-)]TJ
1.88977 -1.11111 TD
0.035 Tw
(more MA, Bailey IL, et al. The Lens Opacities Classifica)Tj
22.97435 0 TD
(-)Tj
-22.97435 -1.11112 TD
(tion System III. The Longitudinal Study of Cataract Study)Tj
0 -1.11111 TD
0.025 Tw
(Group. Arch Ophthalmol 1993; 111: 831-836.)Tj
-1.88977 -1.11112 TD
0 Tw
(13.)Tj
1.88977 -0.00001 TD
0.246 Tw
(Tuulonen A, Airaksinen PJ. Initial glaucomatous optic)Tj
0 -1.1111 TD
0.053 Tw
(disk and retinal nerve fiber layer abnormalities and their)Tj
0 -1.11111 TD
0.025 Tw
(progression. Am J Ophthalmol 1991; 111: 485-490.)Tj
-1.88977 -1.11111 TD
-0.009 Tw
[(14.)-640(Caprioli J. Automated perimetry in glaucoma. Am J Opht-)]TJ
1.88977 -1.11111 TD
0.025 Tw
(halmol 1991; 111: 235-239.)Tj
-1.88977 -1.11111 TD
0.302 Tw
[(15.)-640(Zhou Q, Weinreb RN. Individualized compensation of)]TJ
1.88977 -1.11111 TD
0.368 Tw
(anterior segment birefringence during scanning laser)Tj
T*
0.132 Tw
(polarimetry. Invest Ophthalmol Vis Sci 2002; 43: 2221-)Tj
T*
0 Tw
(2228.)Tj
-1.8898 -1.1111 TD
(16.)Tj
1.8898 0 TD
0.057 Tw
(Hanley JA, McNeil BJ. A method of comparing the areas)Tj
0 -1.1111 TD
0.28 Tw
(under receiver operating characteristic curves derived)Tj
T*
0.025 Tw
(from the same cases. Radiology 1983; 148: 839-843.)Tj
25.51181 63.30349 TD
0.09 Tw
[(17.)-640(Ferreras A, Polo V, Larrosa JM, Pablo LE, Pajarin AB,)]TJ
1.88977 -1.11111 TD
0.152 Tw
(Pueyo V, et al. Can frequency-doubling technology and)Tj
T*
0.007 Tc
0.368 Tw
(short-wavelength automated perimetries detect visual)Tj
T*
0 Tc
0.375 Tw
(field defects before standard automated perimetry in)Tj
T*
0.006 Tw
(patients with preperimetric glaucoma? J Glaucoma 2007;)Tj
T*
0.025 Tw
(16: 372-383.)Tj
-1.88977 -1.11111 TD
(1)Tj
0.5 0.00001 TD
0.026 Tw
[(8.)-640(Da Pozzo S, Fuser M, Vattovani O, Di Stefano G, Ravali-)]TJ
1.38977 -1.11112 TD
0.186 Tw
(co G. GDx-VCC performance in discriminating normal)Tj
T*
0.049 Tw
(from glaucomatous eyes with early visual field loss. Gra-)Tj
0 -1.11111 TD
0.025 Tw
(efes Arch Clin Exp Ophthalmol 2006; 244: 689-695.)Tj
-1.88977 -1.11112 TD
0.16 Tw
[(19.)-640(Reus NJ, Lemij HG. The relationship between standard)]TJ
1.88977 -1.11111 TD
0.002 Tw
(automated perimetry and GDx VCC measurements. Invest)Tj
T*
0.025 Tw
(Ophthalmol Vis Sci 2004; 45: 840-845.)Tj
-1.88977 -1.11112 TD
0.011 Tw
[(20.)-640(Lauande-Pimentel R, Carvalho RA, Oliveira HC, Gon\215al-)]TJ
1.88977 -1.11111 TD
-0.013 Tw
(ves DC, Silva LM, Costa VP. Discrimination between nor-)Tj
T*
-0.003 Tw
(mal and glaucomatous eyes with visual field and scanning)Tj
T*
0.094 Tw
(laser polarimetry measurements. Br J Ophthalmol 2001;)Tj
T*
0.025 Tw
(85: 586-591.)Tj
-1.88977 -1.11112 TD
0.096 Tw
[(21.)-640(Kanamori A, Nagai-Kusuhara A, Esca\226o MF, Maeda H,)]TJ
1.88977 -1.11111 TD
0.104 Tw
(Nakamura M, Negi A. Comparison of confocal scanning)Tj
T*
0.284 Tw
(laser ophthalmoscopy, scanning laser polarimetry and)Tj
T*
0.002 Tc
0.373 Tw
(optical coherence tomography to discriminate ocular)Tj
T*
0 Tc
0.227 Tw
(hypertension and glaucoma at an early stage. Graefes)Tj
0 -1.11112 TD
0.025 Tw
(Arch Clin Exp Ophthalmol 2006; 244: 58-68.)Tj
-1.88977 -1.11111 TD
0.001 Tw
[(22.)-640(Dele\227n-Ortega JE, Arthur SN, McGwin G Jr, Xie A, Mon-)]TJ
1.88977 -1.11111 TD
0.182 Tw
(heit BE, Girkin CA. Discrimination between glaucoma-)Tj
T*
0.172 Tw
(tous and nonglaucomatous eyes using quantitative ima-)Tj
T*
0.069 Tw
(ging devices and subjective optic nerve head assessment.)Tj
T*
0.025 Tw
(Invest Ophthalmol Vis Sci 2006; 47: 3374-3380.)Tj
-1.88977 -1.11111 TD
0 Tw
(23.)Tj
1.88977 0 TD
0.053 Tw
(Bowd C, Chan K, Zangwill LM, Goldbaum MH, Lee TW,)Tj
0 -1.11111 TD
0.025 Tw
(Sejnowski TJ, et al. Comparing neural networks and line-)Tj
T*
0.209 Tw
(ar discriminant functions for glaucoma detection using)Tj
T*
0.002 Tc
0.373 Tw
(confocal scanning ophthalmoscopy of the optic disc.)Tj
T*
0 Tc
0.025 Tw
(Invest Ophthalmol Vis Sci 2002; 43: 3444-3454.)Tj
-1.88977 -1.11111 TD
0.004 Tw
[(24.)-640(Ford BA, Artes PH, McCormick TA, Nicoela MT, Leblanc)]TJ
1.88977 -1.11111 TD
0.094 Tw
(RP, Chauhan BC. Comparison of data analysis tools for)Tj
T*
0.072 Tw
(detection of glaucoma with the Heidelberg Retina Tomo-)Tj
T*
0.025 Tw
(graph. Ophthalmology 2003; 110: 1145-1150.)Tj
-1.88977 -1.11111 TD
0 Tw
(25.)Tj
1.88977 0 TD
0.073 Tw
(Weinreb RN, Zangwill LM, Berry CC, Bathija R, Sample)Tj
0 -1.11112 TD
0.195 Tw
(PA. Detection of glaucoma with scanning laser polari-)Tj
0 -1.11111 TD
0.025 Tw
(metry. Arch Ophthalmol 1998; 116: 1583-1590.)Tj
-1.88977 -1.11111 TD
0 Tw
(26.)Tj
1.88977 0 TD
-0.031 Tw
(Medeiros FA, Susanna R Jr. Comparison of algorithms for)Tj
0 -1.11112 TD
-0.002 Tw
(detection of localised nerve fiber layer defects using scan-)Tj
0 -1.11111 TD
0.105 Tw
(ning laser polarimetry. Br J Ophthalmol 2003; 87: 413-)Tj
T*
0 Tw
(419.)Tj
-1.88977 -1.11111 TD
(27.)Tj
1.88977 0.00001 TD
0.14 Tw
(Essock EA, Zheng Y, Gunvant P. Analysis of GDx-VCC)Tj
0 -1.11111 TD
0.004 Tc
0.371 Tw
(polarimetry data by Wavelet-Fourier analysis across)Tj
0 -1.11111 TD
0 Tc
0.219 Tw
(glaucoma stages. Invest Ophthalmol Vis Sci 2005; 46:)Tj
T*
0 Tw
(2838-2847.)Tj
-1.88977 -1.11111 TD
-0.009 Tw
[(28.)-640(Essock EA, Sinai MJ, Bowd C, Zangwill LM, Weinreb RN.)]TJ
1.88977 -1.11111 TD
0.237 Tw
(Fourier analysis of optical coherence tomography and)Tj
0 -1.11111 TD
0.057 Tw
(scanning laser polarimetry retinal nerve fiber layer mea)Tj
22.97431 0 TD
(-)Tj
-22.97431 -1.11112 TD
-0.003 Tw
(surements in the diagnosis of glaucoma. Arch Ophthalmol)Tj
T*
0.025 Tw
(2003; 121: 1238-1245.)Tj
-1.88977 -1.11111 TD
0 Tw
(29.)Tj
1.88977 0.00001 TD
0.06 Tw
(Medeiros FA, Zangwill LM, Bowd C, Bernd AS, Weinreb)Tj
0 -1.11112 TD
0.076 Tw
(RN. Fourier analysis of scanning laser polarimetry mea)Tj
22.97432 0.00001 TD
(-)Tj
-22.97432 -1.11112 TD
0.043 Tw
(surements with variable corneal compensation in glauco)Tj
22.97432 -0.00001 TD
(-)Tj
-22.97432 -1.1111 TD
0.025 Tw
(ma. Invest Ophthalmol Vis Sci 2003; 44: 2606-2612.)Tj
ET
0 0 0 0 k
14.173 7.5279 29.435 12.314 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
12 0 0 12 14.1732 11.6477 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(364)Tj
ET
0 0 0 0 k
137.36 10.6629 228.784 9.179 re
f
Q
/GS3 gs
/GS2 gs
q
BT
/F2 1 Tf
8 0 0 8 170.0444 14.3792 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
(ARCH SOC ESP OFTALMOL 2008; 83: 357-364 )Tj
ET
0 0 0 0 k
14.173 668.976 473.386 9.178 re
f
BT
/F2 1 Tf
8 0 0 8 14.1732 672.6915 Tm
0 0 0 1 k
(BORQUE E, et al.)Tj
ET
0 J 0 j 10 M []0 d 0.3 w 
0 0 0 1 K
14.173 668.976 m
487.559 668.976 l
S
Q

endstream
endobj
16 0 obj
<<
/Nums[0<</S/D/St 357>>]
>>
endobj
17 0 obj
<<
/Differences[32/space 40/parenleft/parenright 44/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon 61/equal 63/question 65/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T 86/V/W/X/Y/Z 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z 135/aacute 141/ccedilla 150/ntilde/oacute 231/Aacute]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
18 0 obj
<<
/Subtype/Type1C
/Length 9043
/Length1 9043
>>
stream
  UYBKMX+Times-Italic   @¯ ¯¯¯¯˚=˚m˙Ü˙
 ãã
 ãã  7  3  “ª  ## ∑√»003.001Copyright (c) 1985, 1987, 1989, 1990, 1993, 1997, 1998, 1999 Adobe Systems Incorporated.  All Rights Reserved.Times is a trademark of Linotype-Hell AG and/or its subsidiaries.Times ItalicTimes  L  " 3 $ )  4 0 & 1 ' 5 - .            	 S D I P T Q G U B M N 
  J H  V W E F » ( % Y 7 O Z ÿ / *  C ´ [ X  2   , + 8 ; L # K : R   Œ ◊ 9 N   xYËÎpøN∆GôÓ}‘ßÒ^ßÚ(C±Ù	9	†	Ï
Å
»E⁄Y—Y©^ú≈*·3∫'¬≈5ûJ†"ö xæ·XËF‰ï )¿®Ísë s‹c  ±¸$dãõ˜fØ¯*wX˜˚¯˚˚<˜<Ë¯˘0˚∂¸àÙ9˚ ÇàeÇ{˜Oõ]è~ê•°ëòô¶ƒ˜˜pü˚ç}ã}ãäcqÖWá{˜äõQêÖñ—-¯ ˚o¸*˜)˜óå∑˚ódãõˇ6Ä ˇ "Ä ˜ö©{õ¯wÙÿ¯ÀõUç{Æ~Æ.˜â˜#¶¡—⁄˜$˚@ãg˚å{∫Ö£âdÇhàÄ˚¸NyLâXÇ{˜àõUí}ç±ìãèó∏√˜eÃÜ˜˚ÿ˜(Ë˚ó¯Áùíèï∏ƒ…t5@f=˚$pÉåèsúy∏¯ÔØÕ˜˘ ¯e∞˜[vÅÜÖntN£C˚y˚E˚q˚U˚\˜&E˜˜&‰Ù∑∞zô[\ED˚ã˚Tﬁ˜˜'Ò˜Ü˜\˜#î˚oç”ãõ˜ µ˜°õÉ˘õ˘ì˘!˚ã{∂Ü¶àhyÜsÖw]˚8˚±¡˜WùÕªêÆéõ˚•{Ωá¶ÜiyÜsÖw˚¸NzM|àZÇ{˜äõ_ëpé≠ëåìçîÕ˜à˜±J˚ÄyKfá]Ö{˜•õ]èkéØëåìçî˜¯uú õçºî¸$˚*yÆÄv˘¨æù…„˜‚º¯h¯h≥˜[tyÇÉtwëíxëysë^.<H*JêÄ˜˚'¨h∞lKYh9-1S⁄‰ìåêåìwç|i˚sùºòèíüß≠æg–˜—ÛÈÕv≤/Á4‡£∫Œæ¨¬˜é"Rå”y¨¯˛¨«Ù¯AÙ˘O¯;˜<˚÷˚˚G˚x˚n˚q˚R˜T‡˜t˜X˜Ñ˜]¸™˚Ü˜Ô˜÷˜ZÍØE0˚+˚„˚_˚ã˜#¢dã¨˜ª¨˜ó¨{õ¯‹ûË˘˘!¸Öÿ{æá•ÜhÄÉcàÅ˚¸NzM|àZÇ{¯è…˜6{ìD(`e˚Uãq`é™óèùÀ˜{˜7ÜããZ{à{á|üÜœ˜|yèÅuÇxÇ}ulÖÇ˚5âËÕ˜}ëüçë”ã˜2¶|Mä~ä{†âdãõ˜µ∞˜≠©{õ¯äÚÿ˜&˘µÜ®àf}ÅcÑt˚
¸=yK~âXÉ{˜âõWí{ç≠úããó∑¿˜U°Üôà—ã˜\ƒ˜’Ë˜+˚;å_˚å˜DQóèëõ©˜©aA˚9˚ãB~çéwdãõ˜…Ø˜ó¨{õ¯Áùÿ˘˘!¸Ü{øá§âfyÑmá}˚¸NyK~âXÉ{˜êõiçaç≥ñéóë°…˜sûä≥âºãú¨à_vÜtà}úÜ◊˜~yê]1âã˚<àËÕ˜}í¢ñé ã˜(Ø~L}â}ä}†â-ãõ¯ÓÆ¯”ô˘˘!¸®a˚.ùá≈˜Ωã˜ã˚$¸§yI`á^á{˜∂õ@ê|å¥ôèöìß˜¯Ü¬À≥{DÄä~â|úâ-ãØ¯ÌõÉ¯À¯'˘!˚•{Ωá¶ÜiyÜsÖw˚¸NzM|àZÇ{¯ë≈˜GwëI˚&:à˚ãWYãÆéãèåèî±˜¯OùÕªêÆé˜Kãõ˘õy˜˚˙–˘˝˘!˚;˚·¸}àT¯}˚I{¬äûzvÇÄlÄc‡!¸j˚wÑ^Ñ{˜Zõkçdê≥íè£êû˜¯;è«¸¨ú¯¯Ωé˚¸b}WtzKÖ{˜•õRêwç∞üêûë†˜¯Oú óç¿î˚*ã◊¯£‘¯·¯$˜gz{pI˚Rê˜T˜T˜˜§∏ãŒ÷SÁ!r˚á˚0U†Ñô§±–ÂãÿπOMjáQ˚ ˚)˚f˚tz˜˜Ω˜˚*Ñß˘ß´⁄˜«⁄˜˜0Ï”¯˜)·ã%m˚C5˚‘˚kTû˜¯˜¢Ìp˜,˚˚˚:˚b˚¢#ƒ$Û˜<˜˜˜Z˚*Ñ°˘¢©œ≥Ÿ˜-÷xœÙ©˜1m†˚˜G¯˜€‰·Ÿc»@÷Ù¬ù˜ØÏ˜˚ ¨I-4Z$W•\»JÙsÑ˚?X˚%œà˜˜¬•ì¯Ï'§qJ+=aUÙ5V«⁄˜
¯Œ±∑À‹•F[8PoTq,·ã™•˚—†v˜ﬁ˜ãwÒÀ{˜∞Ø˚ƒß‘ Œ∂r®iÉaÜa_∏äãifTfw~»˜F¯N†Æõ±´r§lmrsjd≠|†˚*Ñ±¯Ôµ˜Ÿ€p‚–˜F¯ÀüöÆ∫ ±ºsH˚ ˚_'}å{íåìãíã‡„÷a˚˚-iiSj«ã]fÅyv^¬}∆˜MÊ˜"˜˜F©qóé–Ù≤ΩÆ◊ﬁCµAR@_Or˚—ïvã˜˜z˜ãwΩ˜Ä˜òıÄ†≠õ±X´q§nlrqlòe≠{°§Ó˜È†Æõ±´r§lmrsjd≠|†˚*Ñµ¯ƒ“˜Ú–˜Ç¯Á˜z¢“˚î#˚n|˜rÚu˚-4B˚)Ur¬ã^xvno©o”˜Wˆ˜.˜˜1”˚•˚*òv¯Ì‘Åï÷¯b∞¯≠˘$Öï–¸:˚ôÇ≠≥¶´”ã˜rçà¸¸Í—˚—†v˜T º˜}˜Æ˜ì˚o}L˜p˚*Ñ•¯úzØ˜sõ©◊˜û‰‹¯ú˘B˚≈x˚M˚è˚b˚8ÓV‹˜>‹˜=º˜"&µG{|âá|‹|à}Ü}Ñáç£Ω˜˜=˜D¢˚ü˚ó◊µ[91U˚@˚)ã˜•õï˜Ç˜˚*†v˜F ¯Gwå¯r˜©˜Ö˚hè˜ƒ˜“è€˚÷,˜¯Gb¸5¸CwH˜öZ˚F⁄π˜DÔ˚—†v˘"wÆwµ–∞˜3˚C[˜ã„Œ ú˜≥˜–ª˜æ¡ªΩ∞~ö˚J˚/=˚0ã˚9Kã˚&Ó˚8˚ô†v˜ËJÃdó∏¯»˜¥˜ô∏±”®öì«˜™»£|gã∂ñØãø≠rötL?˚	IjÉwâçº˜[àçò^ÑP~XÑzçññéñ™ê{}ÇÖiÅf:˚∏˚bÄØ¯4v©·˜r‚˜Úıcg\bONm∏ÿÎ–˜E˜ùüÜ|z|Öãqtö}§§°ùß™rΩ7˚(˚˚-˚!˚ﬁrÃÙ≈÷´§˚*Ç∫zv¯æˇ «Ä ˇ Ä °w˜¥⁄éŸ¥¯e˜	[eslwÉÉíój†‹˜îãÆÃ]íu1%˚.Ylâç˜
¯KÜêrWVÇWÖ{•å¨äì~ã|{RÄa˚¸â÷¨˜ö¬∏œüßﬂ˜ΩãõãòÅãz¥~9˚≥ãqpòx´Õ∂…øØ˚*ïv¯Xv¶ﬂ˜•ﬂ˜’¯M˚&˚(˚5˚'8∏Nı˜-˜˜I˜Õl›˚Ñvª°_W <˚c˚YmØƒ˜
Ê˜[˜˚ôïvû˜˜1˜Ö¢˜‘π◊•õúØ˜&w˚3õ\ñëèïôú®≥xã©√Ë§˜‡˚‰ã º´î°ûÃ£QRêÆõúü˜}¨ÉÜÖÅzúmwúã^!};l>˜+ãIj{[S:{Á∑Ñ˚*˚aö˜Gû¯∂ãw@˜!∞ô˜öÂÓ¯˜Õ˚1˚N˚rrñ•≤≥˜§Àœ•≈π∫ÃåQp˚◊Â¢åé†ùzv%¸p˚kÉÖpV{˜aöqeã´üß˜î≠¢üÜ§˜˜4˜:˜/”m∆29RBhsâç¶Ëåéåéãçèàåâﬁ˚/u¸˚Nv¯Ô´˜x°˚'◊¯4⁄Æ¯ Â3¸8Écq˚KãÑììñîããú£sò}âgâãeà]ë¥~™˜	√˜5˜ß”˜‘˜ë´˚ æî©˜E›òïáÉÄÅããuÄëp´¢ùüüü{∏C˚Y˚96q/¸Äº˜˙´∞‹:˜ó–˜º¯@;ßÚãçåçãçêâèááÉàÑÜá‡oh[^jzzÇoÑÖÇâàäàãáãâåâãâ’C˚ßá{xNã|mßÅüø≤∑ÿæ~írkh\wãÄÜìîéãçåé„˜·ﬂ˚*Äº[æ¯!wå°úﬂ˜X‘Üúl¯d˜_^wr|ÉÖëí™Á˜ÈéóÑéöNÑààÅ_âßàj•`˚˚-˚O˚'né2Ôú«¿©˜ﬁçâ{NÜuãtzãqµ∂≠Ø’«¸îÂÂ˜p˜	ö®ßx[))˚l!úpjù¿¸Ä∂¯Ùõ°w¥ÿ–˜x˜LZvor|ãôëñì¶çî∞˜+¯◊Üê–WWÇWÖ{ô§®àuv˚%¸ûãvoèi∑…≤ªÿæ”Ç∫zv¯ø\õ˜ˆÿﬂ◊ç⁄¨˘E˜	\eqkxàéújô‹˜†ã≠≥t¶gI:3˚Eâçô≥¢ﬁãôµv¢e7$˚/Zmâç√˜\àçZVÄVÅUÅ{ºöâuu9˚Æ{I÷∞˜üÕ≥«j≥¶◊∏îòãpxF˚äq*÷®˜ú ª◊™º”„¥ãóãîÉã|¨w=˚´ãp}ãhµ√Ω√æØêí˚—†v˘1w˜p–®˚H˜(˜˜˜:˜Q˜p˜C˜	xÜ•T¢(ã 3{˚b˚^˚QN_]¸$ïvã˜¶˜†›Ä†Æú∞`™q•mmrrk†e≠{†¸Ä∫¯ õ§w˜ıº÷∂Ïº˜r˜QbnwÇÑìíóó≥èô„˜÷àç‹dÑ8{eâ{¬ìÜvo<˚åã\yã_∫√∑¬∆≤®¯Ñ°z¨jstxhh¢z§¨õ™ü˚*˚b°˜¯v˜k≤ô°ì¬¨Ÿ˜+«j⁄˛¯l¯)NÑÇîîzﬁîyrîb9˚Q˚F∂sØ{it`nlxöóÇ7TjuRT¿S˜˜Ÿ»‡˜˚i{ã¿ò°¶ôòôáãò˝„Í›’üàüÖûΩﬁ˚'¸[YZ^1|˚ èË¢ã¶¥Æéé≠¶ëìÏfÇùûÇØz^›¶¯L8Y+I^z¨∏Œ∑Òÿµönd˚*ãö¯ˆò±wº˜¸º˜´ö}`nêßõò∞êü˜#¯õéïéñãìèäéàÉ˚mÉ\|ƒçîã®ããkÉá}àÄ˚¸Ä~^càPÖ˚*Ä¿X∫˜˛ôùw®wµÿ˜>ŸV¯a˜	_hohxÄäñêöò∑ëü⁄˜øAd uLZAéWiL-`zÜòóéãéåéÊ˜ˇàç¶YYÇYÖ}¥ûãnp?˚êã__û|ØÂ’˜˜œéNt9w7y|çf∏Ω••Ê ˚bév¯:ó§w˜“˜<æÿ†¯'åïìãìºéu=ôïQò˚6Czã~îöùü“Õ∏¨Æ˜)˜FÁ∞s•jw{}|UµñãdY;˚RPlkÑ˜Ö›m˜ûÜäåÉâÜZ}ÄB˚*~¿Xª¯¢˜^úùwö‚˜M◊Ñöu˜7∞NãƒúÊÍ˜l˜∫ã_t˚)˚R,Æ˜¿’[awtwÅÉíöõ˜¯>∂˜BÜêuXÄXÑXÜz¬äíÜt}ÑrÉo`˚3ââá°Ñ¨Sã˚˚>˚K˚+W†IﬁvΩ√ú˜”çâÉhátãtvìr≤¨Ã∫Œ∂˚bÄ∏¯¢™‚˜xÕ˜,˜ê‰∞œÿ¡§ïxvÉÜ˚˚ba˜s(bYaiUaW¢œüêüê†ßè˜6¢È‹ã⁄∑l£X˚!˚2˚<˚#L´=ÙÔÊÁõñ˚*Äº[æ¯!wå°˜swúﬂ˜X‘Üún¯d˜_^wr|ÉÖëí™Á˜ÈéóÑéùNÑààÅ_âßàj•`˚˚-˚O˚'né2Ôû«¿©˜ﬁçâ{NÜuãtzãqµ∂≠Ø’«¸îÂÂ˜p˜	ù®ßx[))˚l!ûpjù¿ù¯¯ñíëíöù|úvÄÉáÖÖ˚6˚4Æ”y∞˜∞õ˜Õ≠ø˜˘X˘*|èÅ}}wdãqM≠ã6˚j˚S˚Y˚y`®˚k˜ú‘È°≥Àº˜OúÀ¶è¿èõ˚û{¡Ü£àn{g˚BnttnrÄX˚>k˜Ÿ˜8Ì˜ã˜]“Ôj˚îùà”ã©¯Â©{õ˜cı˜®˜∏˜˘æá•ÜiwÉlàÄ˚¸NzM|àZÇ{˜ë˜∫˜5˜M˜^ÿÙM˜5˚z˚™˜KPôèèöƒ˜E≠˚&Nj˚»˚œ\së¨õò∑î¨˚bÄ¬T≈Qÿ˜¬‘S√f∞p¯nä¯&˜mpwfvwÑ§õáÖ§i˜ùãœ˜®í°ízã££ïûùä£uóxW\N9WÄ¬y„|ãuãkIsÇpFè|´ìôéîã¶è}lîåÜ≠˚Ç˚1qiz*yyûãuuy{äsõx¨™óñûú≠∞µ¡ªÕ©˚Vòö}®¢®ã˜“dév˘#õ¯…˜˘D˘!˚N{ûâ∑áno`AÇ{˚^˚ÒÜJ¯Häëãêãê¥©è∫êõ˚Ö{√ÑéÜü˚‡¸úû¯	¯˚ëïû©™ã˚*Ç∫zv¯æ\õ˜≥÷ä‹®¯`˜	\frkwâ}çöd©€˜ãã∂µt£]8/˚A\âçÀ˜eàçXUÄUÅUÅ{¡ïÄ|vH˚~l˚÷¥˜ò∂π–d√Ø ·ªûë}y®cA˚àãsnçmπ¡ÆπŒΩ˚b˚b¬Tﬁ¯£ò£w¯≥®ö¯$éóíåöƒò`0¶úUµ˚CepaZrnci~Ç{Xy~ßãmvzzvòa∂àì˜˜¨¯f˜Øw•fqÄv}]¡ñãbV<˚`Ew˜~÷P˜F~ãy={É[˚*ïv¯Xv˜àw¶ﬂ˜•ﬂ˜’¯M˚&˚(˚5˚'8∏Nı˜-˜˜I˜Õl›˚Ñvª°_W <˚c˚YmØƒ˜
Ê˜[˜˜0˜Hñíëíöù|úvÄÉáÖÖ˚6˚4Æúëvöõ˘õw˜¯~˜x˘k˘!˚[{¬áöÅdzÑxá}&¸à˚b¯É˚5{ªà†{úf˚¸5f˚ÄÅTÉ{˜Zõnçbé≥ìçùí•˜¯4è®˜x¸¥ù˜$¯ã≠˜êôÃô˚—ãõ˘õÉ¯É˜àõ`êré´£êüëü˜¯Oú õçºîõ˚ã{∂Ü¶àhyÜsÖw˚¸NzM|àZÇ§†v˜Õ˜Õ·¯å¯‚¯¸åI¯å˚¸åI¯å˚*Ä¢¯º˜^úùw¢·˜´‡Ï¯˜«7,˚g˚\ã•íÙÎ˜Ü˜ ïUl˚™˜‰≈äíÜt}ÇrÑo˚¸âáuÿl¿˜-˜;˜A˜2‘ZªE1L.Wjâå‹≠˜π˜N°›ÜêÏWÅXÑYÖdãõ˜fØ¯*wX˜˚¯˚˚<˜<Ë¯˘0˚∂¸àÙ9˚ ÇàeÇ{˜Oõ]è~ê•°ëòô¶ƒ˜˜pü˚ç}ã}ãäcqÖWá{˜äõQêÖñ—-¯ ˚o¸*˜)˜óå∑˚ó˜0¯∫ñíëíöù|úvÄÉáÖÖ˚6˚4Æ˚ôOvÌv¯«˜∫–‹˜…√°†é±˜&˚ ¸îÇòñöíúã—”5ã÷æ∂∞±´rêÇt}zuôÄãÄ~{àÅxã¨qWŒzûIô˜∂˜Ïñ˚∞l˚úév¯:ò¢w†w˜–¯.ªÃõ¯'üåñ¨êÄGñîTî5éHè3}ãjòöí†˜@Ï∏⁄£µù´ç®˚–å{ã}ñãñòûª≥úπ¡˜/˜W‚®{¶fnÇyzj∂ÜãgW>*3˚¨k˜˚äçãêÑãÖàáÜà˚S˚¬âúùÅ˜y¡ÅàçÖÇN{ÉR¸év˘@wJ¯W˜Õ˘.¸˝@‘¯˘@”˚JœsÕ√¨n®¯¸¨«Ù¯AÙÆ˜´{˜t˜X˜Ç˜]˜<˚÷˚˚G˚x˚n˚q^˚5ÎL€|*6ÇÖDXï|†Æ∏ï∞ÆæÛ_ã‚∫˜•ˆ“|ñcbih&ãmañïanñabïpáräO˜í˜Ô˜÷˜ZÍØE0˚+˚·˚_˚ã˜!¢˚*èv˜äπùv¯•–„˜ò÷º¢z˜¡Ø˜<˜}˜^˜(;’$˚	˚˚˚‹˚ÕH‡∑∑û•≥èâÄ`˚˚Y˚Jl˜¯/Ëª˜%˜Óã˚ dp{%rd`oSzl'áÙ´¸$˚˜z“Àê˚ƒß‘ Œ∂r®iÉaÜa_∏äãifTfw~úãõˇBÄ ØˇÄ õí˘_˘f˘!˚r{¬Üëàzr?KG[˚$&Öåæ˜PùÕΩê¨éõ˚•{Ωá¶ÜiyÜsÖw˚¸NzLâVÇ{˜åõVëxç±ôêóî´«˜oìä˜˚Zóv•[ãruvâUÖ{˜ßõPëÅåoº˚B˜√˜¿˜víêÆ•¨ê˚by™˘õÖË¯˘!˚í{∏á´àhwÉoá|˚¸eÖwÇiiãrÅô§ïåîãë§u°qnztlN«p¿˜≤Ûı®Ú¯ùÀòçæì˜Kév˘#õˇæÄ ˇ ZÄ ˜ç˜˙˘!˚M{∑á†âfwzgáÉ˚L˚ˇàc¯!äëãêãè∫¶í¥èõ˚Ç{«äîë^îF˚>˚Îàá©d¯äêãêãê∏¶èπêõ˚Ä{ Éããõ˚…¸ôû˜r¯ZêΩ¸Zü˜√¯€¶øóîØñ-ãØ¯ŸØÖ¯¯¯Ú˘!¸z]˚&ûÜ≠–°π˜-ã˜?¸s¸Ô}¯ç¡˜<xéZ$fk˚8ã˚5¯w¯Ô˚bÄøwv¯0õ˜hõ°wô¯S˚˜¥¯2˜YnÅyuqxπ˜?Cj˜˜±©ºçõ˚K{¶ßãxl˚+T`âç˜¯YÜêtWWÇWÖ{ô§®àuâuuAÇg˚¸w÷ª˜Hµ´¥ïm±3ót©Pùt™ã∑ã®∞±”dã©˜¡™˜ô©{õ˜cı˜
˜ W“É˜Æ‘˜˜…˜ÌE©V¢ç⁄ÈûŸ∂Â˜+≠#˚ñ{∫à©àfzÜuÖt˚¸NzM|àZÇ˜G∆ûø˜AöÀ‹œäπä§{©x£hãXã(R<˚!ã⁄njí±Í˜"¯úöèéò¬÷∞gG˚˚y.ÄÄåãÅ¸˚c¢ˇHÄ ˇ Ä §w˜ı˚‹˜rÏº∆à>xr#XÇÄåïóòãã††wöwfáháZ∏|¨‰≈÷˜4¥Û¯/àç‹dÑ1{bâ{≠å≠àêÑãzåâãàà~ÜtÄb˜%˜ °z¨jstxhh¢z§¨õ™ü-ãõ˘õŸ¯ø˚˜‡Ê˘øÉìäõRÿ˚°N˚hxIdá\á{˜µõEêxå∞®† õ¡®–˜o˜¢´≥ñì¶òõ˚Q{æÜùâpa˚#˚2^SsÁ`˜¶´•çπèõ˚É˚*˚eù˜H¿¯°§·˜°ô¯˚S|qjé•éåèåè˜8¯’B}_â•Ç~¨S˚˚5˚R˚G•Rÿ‰≈‹ÿ¿çâ5˚±}^ráTá{˜Ö˚¨˜Ÿ˜˜˜OË™®v^)˚ ˚i"hv™∂˚*Ú¯ª°˜ıUÀ˜*’Ë˜l˜Bí®ú”¬∑∂Æ›¨™—’T¿+ÿDIdDnöy£ï©ê©°|íã£∫Ããê‘íPr˚'˚Kb{˚VË≤˚ú{¨fmttnn¢u™Øõ¨ü˚b˚mÆ‡≠¿Æ¯4v©·”’◊‚˜Úıcg\bONm∏ÿÎ–˜E˜ùüÜ|z|Öãqtö}§§°ùß™rΩ7˚(˚˚-˚!˚
Ãj«ÖU5îÉïèñéñã£°zsãkTrtìíyzn´~≠É£ãº‘ûœ∂g£_ÖäâÇ±√Îë¿—£©˚*Ç∫zv¯æ\õ˜«{∆˜≥÷ä‹¶¯`˜	\frkwâ}çöe©€˜ãã∂µt£]8/˚A\âçÀ˜eàçVUÄUÅUÅ{¡ïÄ|vH˚~l˚÷¥˜ò∂π–e√Ø ·ªûë}y™cA˚àãsnçmπ¡ÆπŒΩq¯úvÑÉtefeV∂ãUAzGeÅ®ßíúûßû®ÄÄ®jÄßßÄú∏≥∞Œñdãõ˜¶v¯õn˘@˘#˘!˚d{≤á°ÜpzÅÅ˚%˚;P˜'ÑõÉ•ãñ´§íπêõ˚ú{∆áõ}ú`ı˚õ˚2˚LRKw|ou~ÖpÖ{˜jõngå≠õîõóô˜+˜@Œ˚9í{èyã}ivâTá{˜•õLì|çqÀ%˜ñ˜=˜VÀ‘´ó®ïyù˘!ú˚Üò˜í˜†é¸tè}ô˘*ô˚vï˜sã˜öì¸|å	´
◊˜é˘
endstream
endobj
19 0 obj
<<
/Descent -205
/Flags 98
/FontName/UYBKMX+Times-Italic
/CapHeight 653
/FontBBox[-169 -217 1010 883]
/StemH 0
/ItalicAngle -15.5
/FontFile3 18 0 R
/StemV 76
/XHeight 683
/Type/FontDescriptor
/Ascent 676
>>
endobj
20 0 obj
<<
/BaseFont/UYBKMX+Times-Italic
/Type/Font
/Widths[250 0 0 0 0 0 0 0 333 333 0 0 250 333 250 278 500 500 500 500 500 500 500 500 500 500 333 333 0 675 0 500 0 611 611 667 722 611 611 722 722 333 444 667 556 833 667 722 611 722 611 500 556 0 611 833 611 556 556 0 0 0 0 0 0 500 500 444 500 444 278 500 500 278 278 444 278 722 500 500 500 500 389 389 278 500 444 667 444 444 389 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 444 0 0 0 0 0 0 0 0 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 611]
/LastChar 231
/Encoding 17 0 R
/FirstChar 32
/Name/F0
/Subtype/Type1
/FontDescriptor 19 0 R
>>
endobj
21 0 obj
<<
/Differences[32/space 37/percent 40/parenleft/parenright 44/comma/hyphen/period 48/zero 53/five 56/eight/nine/colon 65/A/B/C/D/E/F/G 73/I/J/K/L/M/N/O/P 82/R/S/T/U/V 89/Y 97/a/b/c/d/e/f/g/h/i/j 108/l/m/n/o/p 114/r/s/t/u/v/w/x/y/z 131/Eacute 135/aacute 142/eacute 146/iacute 151/oacute 156/uacute 231/Aacute 234/Iacute 238/Oacute]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
22 0 obj
<<
/Subtype/Type1C
/Length 7206
/Length1 7206
>>
stream
  LYGIRE+Times-Bold   @¯ ¯¯¯¯˚<˚n˙|˙;
 ãã
 ãã  3  /  ∏ƒ  Ì ∑¡∆003.001Copyright (c) 1985, 1987, 1989, 1990, 1993, 1997, 1998, 1999 Adobe Systems Incorporated.  All Rights Reserved.Times is a trademark of Linotype-Hell AG and/or its subsidiaries.Times BoldTimes  A  $ " 1 * %  ( / ª 4 5 & - Y 7 3 0 6 . # : ' C K F U J W P  B S M Z N œ E T V ∂ Q I +  ≤ O D , X G ÿ H » ”   ﬁ 	 
 ´ [      C   h ÕAz⁄›[∑'¨ˇq∫L†n’AÀ7ú¯	]	∞	Ú
C
ú
Ê¢¸)™I∑$öÒE¥eò&í⁄X÷*ê]˝HgÅÙ)^ﬁ(≥ﬂT´¸$”xª˘	¨àwº˜E¯6§ÿ˘%˜,.8@m=l<ö”afÀÖÎ«˜=≤˜-˜&˜ﬂ˚	4Æ§∏˜~pÿrÅÇvpq>º1˚f˚$˚0˚_˚O˜˚8˜}˜Ÿ ﬁ‘”ã§˜@≤¯Zwî˜˚˘<Ë˘E§á^{ÆÛ_˚s¯¢o˚r¸∏m@}iUÉr˜_§iç[é±õõ¥ß”˜uôk´ApjyäMÜr˜ÿ¸à˜ÄÈ˜á˚ádã§˜™Æ˜√Ær§Ô˜6˜:˜@Ïõ˜‚§Fîxç‹˜N˜åæåÀØ€∏ñ“ãÆã˜=˚Jö;ã˚÷‹r¿Ü™à7¸NS}~ÇÑÜâäZÉÏ˜ä¯Ÿ°åòò≠›Øe˚˚al˚Ä˚ôã§˘§˜˜6¯§TècéÀ¯xœªå∫ç§˚Úrπà∫âI¸xMdáUÜr˜Ú”ã§rÆ¯Û≠r§Ï˜6˜ï˜B¨ô˜–˜êì˜ ˜0˜L˜.0˜B˚¨˚≈úr≤á∑âN¸ÅfwnLl˜â¯Œìüëû√˜@¢˚i0˚É3K˚[Çù≥¸$˜x¨˜å§¯¨àw∞˜E˜ø˜0f§Ï˘á˜≥˚Îr–á´âK"`{m3˚QÖ˜ç“˜@≥˜,˜%Í˜ﬂ˚	4Æ§⁄˜~pÍrÅÇvpq>º1˚l˚˚6˚Y˚B˜˚E˜éÏ‚˜ß≠ª˜›£é…í”évù§˘§Û∑¯C∑xõ˜w§Aìvû”¯$ç∏¯Q¸≤ß¯·ªë¢”î§˚kr‹ÖójO˚√â˚Ô¯?˚gròõàF√x¸nIoÑOÑ˜x¨˘¨Æ˜E˜ˆ˜E¯˘&˜ ∞˚D˚&4Ö˚˚?˚?Ö˜‚˜&∞˜D˜ ¨˚U˚5˚˚n˚f˜)˚%˜a˜a˜)˜%˜f˜n˚5˜˚U˜
˜£öõïßØlìyÅxâqt˚˚1√-x¨˘™Æ®w˜˜Ö˜P©‰¯x¯o˜mmxÜÜ|tn\¨;ÿ˚Rl˚N]ã5˜?9ŒkÃl∫sãH~Ü(˚Ë˚Q˜wn˚ã®õèêù†™∏iÍ˜LÀ˜„˜?≈iú˚'‘‘7µx°¡Ã¬©ø˜
«˚Eùúã§¯ˇ´ˇ  Ä ˇ Ä ˜U˜6˜Tß¯ï§Aêsç‡¯£–áÚÜü˚4®â˜]¸Ïà˚]®ü˜4Úê—è¸£7sâBÖr˜˘úã§r™˜æ≠˜´≠r§Û˜6˜6•˜§Øõ˘πàµâI¸xMlàRÖwr¯›≥˜do˚+L%q)Jxó∑˜ÜÓæm˚ó•˜Êq˚|Zp.Ü˜|∂ùè¬˜“r˚"¢§˜]¸’úã§r™˘ §Ù˜6p˘˜wn˚]S8˚+Huìª¯l„™å—é§˚Òr∏à¥âI∞¸xNmàSÑpr¯÷˚*ã£˜°v˜9£ó¯l¸j˜=˜˜<¯x£~èÉéÇò˚(˜xÏ˜ù¢£óßè£˚<s≤àóäv}ããA,|ûSŸúõ¢è££˚és¶áìÇúq˜˚Y˚˚?àä_Üs˜=£zåjã§ü»Ÿû¢™Zúvî|óxë{ãÖã{táuäs˜Ö”év˘1§¯“˜˘Q˘8˚irƒà®ádwÄqÇt˚˚›˚˜–Å§wµãû±¢ã è§˚‰r∂Ñöà•O˜î¸Î¶˜x¯ﬂ°√òû¬í”ã§˜¥´˜Ω≠r§˜˜6˜K˜?Ï˜®¯Ï™êçñ¬€¥`&˚Wu˚ä¯K˚‘|åù}˚]˜±¡úÚ™ã˜˜<˚hìE˚÷‹rƒá™â5¸N:wàGÉr˜Ê§Iîué€˜X¶˜c˚Õ˜a˜x¨˘¨Æ˜E˜ˆ˜E¯˘&˜ ∞˚D˚&4Ö˚˚?˚?Ö˜‚˜&∞˜D˜ ¨˚U˚5˚˚n˚f˜)˚%˜a˜a˜)˜%˜f˜n˚5˜˚U”xº˘§Ì˜3˜÷∑˘Q˘8˚pr·áóiN˚≈Kâ˚-˚D˚$ã˜ƒ˜‚„™åÕé§˚Êr√Ö•â7˚‚˚ •h∂eRÃÈÖ∑«‚û¡Ωµ∏ô‰∆˜”Õ¢ñ¬ì˜∫ã§˘§Ùµ¯ß˜/˙-§Iîué€¯N·´ç√è§˚ê˚\¸l˚\¯l˚ër“Üù}W¸oQ~|=Ñr˜~§8êy£—¯eç˜é¸·¶˜é¯ç¸åInàOÖr˜‡úã§r´˜À©˜•©r§Û˜4˜0˜9˚˜@n˜ú˜Î©uÃà„|˚#N~2˚ayõ∏¯å¢åå•æv‹°PE%ua˚˚å¸	˜÷m˜gè—Ìﬂ˜"Ω7ôçÆµò˜•˜˜0˚`èS˚…rπàµâI¸xNkáSÖ”ã§˘§˜™˜6˜˜˘O˘8˚pr∫à∞âdpkTÑÄ˚˚M˚˜|Éõ{§ãößóë–§˚„ræà£`êÇ˜K˚‡˚'8sâFÑr˜Ô§Eíuçﬁ˜L˜S˜Àü´®èûédã§˜ƒ≠˜´≠r§Û˜6˜-§˜£ﬁõ˘∫à¥âI¸xMlàRÖr˜¸§EécçÕ˜}˜õB9ñ§˜Êr<}|E˚ÜÓ˜|∂ùè¡˜@¶L#°£˜]¸À-}´¯%¡˜G£”˜˜7˜'ú˘ ØÑûá\¸Ûó⁄√π^ª™ã˜9œ˜˜˜B˚Fgeyz˜ó˚V˜V˚–°îö∞π‚ë˚P˚1hXOT~æß˚—˚_™¯ı£÷˜/R˜∑˜/˚"˜Ù˜ò¯a˚^sÆàßäT¸naÉicànåõö¢ûã§†y¨bawloAŸo¬˜Kå˜(ƒ¯˚,¯˜`™iπ∂Æ¨∑∂hÆ`^kga˚b}”˜O∞˜4™§˜˜8˜Æ˜≠°∞ÆòruëìmãWålÛ˚1txh_P,uÒ‡à˜ê¡à~˜B˚B˚0-˚(˚?ÒA€ƒ´Ë»˚—“˜˙∑”˜˜≈¯a-˜=rG*^_V^pø˚ÿvåè7˜ ÂØ–∂†rñÄvzlnãeä∞ù˜√È¸ã£¯1£÷˜/«˜/˚&˜Ë˜ì£dèÉ°™¯˚Ts±ÑöÑ^˚∫[zàgÇs˜É˚W¯˘`´iπ∂≠¨∑∂iÆ`^jga˚*ív¯W£˜‚˜+¯y¯a˚+s§ä©ãk~á|ÑzC˚J<˜_Ç¢ãéãè¢üå¨é£˚és§áêãótë©M°U˜˚º•˜4¯ üΩôç£é˚*}™¯=™§˜'˜1˜'˜@˜y˜êÓ’»úP˚.˚É6F;ãÛ˜ ˚'˚‚˚˜˜‰˜˜˜-Ù˚˚4˚˚˚—~˜=˜'˜=›˜=›“\Øfª∫±Øªπe≤\[gc^˜—\Øeª∫±∞ªπe±\[gd^˚*}ÀK“¯´§˜&˚˜˜˜¨¯mÀÅÅàààäáãuãûë˜ôÈ2∂˚˚LNLG¡ãóøö±ù≤mìã†õ¢üØ’ôfXBt˚"`˚c#?…lª£—êÃÃoëìa—∏∞£¨ß˚Wƒ{}tpig|Ø™‚Ó®¢ê˚bã£˜ƒ˜%5’s£ﬁ˜ò˜ª£Néö»®˜Q‘∑°ö»´äPã≈Ωô¥•£|¡GJ^Olvâò⁄˚Qs©á£ÜY˚∫YuákÖs˜û¸ã£˘£Œ˜˜ì£dÅ™®¯‰˚Rsºç\Ä¸ísÄgcs˜É˚*˚aƒ¯›£õ˜˜S˜+¯t¯a˚+s§ä©ãk|Ü~ÖzG˚TC˜MÇ°Ä•ãï£¶å•ç£˚és§áêãótë©M°U˜˚ªyVÑurOiãÜóêèéêãîùÄ¨^OÖX}k¶]ÃÈ†ƒ˜Ω˜)¯!ûΩúç°é˜Kã£¯Œg£“˜˜˜˜˜º˘¬£Yåã™§˜è‹˜<™TQ^oP^´|r¬07_Os}âº”˚Ss®á•àW˚∫ZuÜjÖs˜Ñ£dèÑ°™‹˜üì≥Ω∂¬ãXk˚Ütãl[às˜~£eéÇ°´˜üìµΩµ¡ãWl˚ÜsãlZâs˜Ç˚b}”˜O∞˜4™§˜˜8˜Æ˜≠°∞ÆòruëìmãWålÛ˚1txh_P,uÒ‡à˜ê¡à~˜B˚B˚0-˚(˚?ÒA€ƒ´Ë»;¯ç£öõïßØlìyÅxâqt˚˚1√-}√u¢¯
√˜G£§˜(˜7˜|¯™∂Rçâ®¶¯”˚ks¬á†äV˚K•siØO-(8˚Bº˚&Á7ﬁ÷ßß±ØJ|…úîå˜öº˚ZÁÄfP];ã˜≈ÏôÂ“√°Nä˚ô}≠˜∆˜Ä¨§§tÔ˜Î`°≤˜Ë˜⁄˜%u“Éàáy¨xb°ã\/HP3˚.˜Çëã/mvgY¥˚sÙ¶Öo˚9§üïëìñîœnΩËÀ∆Í¨˜8˚~tãÒ™ß•Ø≤ƒπ`D†-}Ã¯£Ã˜˜˜¯≠∂^åÄù≤˜¸˚]s≠àßäT˚ØxxrreTä∂ß˜Á˚Ps¥Ñìc˚êD≠FÒŒπ¥§®Jƒûôå˜ò˚ôã§˘§˜˜6¯§TècéÀ¯xœªå∫ç§˚Úrπà∫âI¸xMdáUÜr˜ÚQ˘Œ£öõïßØlìyÅxâqt˚˚1√-˚Lv˜T¬¯
ƒg£÷˜˜6˜(Ï˜j˜Óô≤√∏‘ê˚7Sà˚9Tu»ãŸ˚≥\çlî⁄˜!j≠ßp√ÒÂÂ˜9˜6(–7;m^jzâ‹Õ˚SsπÖì|e¸âbÅÅ]Ñs˜•-ã£¯Œ˜G£–˜˜˜¯™£Zã∂ú˜å˜<™TW`uS[˜≠˚Ts≤Éôà\¸íZzágÑs˜Ö£]êà®¢˜üî∂º≥¡åTo˚Üf}zjàs˜˚*+¨˘^§é˜#›˜6¯s˘8˚Ùrƒâ∑äG¸¿lãSJo{ôúß¶âã≤¬YüunauTzû˚˜*Ú˜±˜I¯H‚´åƒè¸$Ö˜5˜/œƒ˚H¿©˜Ã˜øn…B]gmWLπ{ßóêçãêòíÅS:Roxúã§r™˜æ≠˜´≠r§Û˜6˜6•˜§Øõ˘πàµâI¸xMlàRÖwr¯›≥˜do˚+L%q)Jxó∑˜ÜÓæm˚ó•˜Êq˚|Zp.Ü˜|∂ùè¬˜“r˚"¢§˜]¸’¯N˜*£öõïßØlìyÅxâqt˚˚1√-ã£¯Œg£’˜˜˜∏¯Ø£Zçã™£˜èÿ˜<™T6`Os}â∏”˚Ss≥ÖòÉ^˚∫ZzágÑs˜Ö£]êà®¢ÿ˜üî∂º≥¡åTo˚Üf}zjàs˜˚b}Œ¯™§˜!˜˜¯0˜psqnR=N‹˜ ∏í˜Ÿö•ÇmUãZ√ì«ãÀ”7∞D-˚"N˚Y˚·!˜⁄Õ≥Ãπ˜ã§˘§˜	˜6˘ï§wå}ç|ù˚≈¯˜<˜@ªºÙë§˚µr”áòÖtxÇÇpp˚m˚n˜j·≠ç¬è§˚Êrπà¥âI¸xNkáTÖr˜Â§Víhè«˜X¶§˜J˚wõxìã~{yàNâr˜‰”ív¯W£¯–˜˘W¯a˚sßàüâkuX˚p?âyŸa˜††°ç•ç£˚~s£àñãîvêëwïiG˚?Y˜i◊†•£çôç£˚rs•ÜêÑ•J˜(¸
£˜˜√êÔ˚√¢˜/¯%ú∑ôçûè˚—ã£¯∑˜[™“˜ƒ˜ô˜™£Jçzì–˜Œ‚∑4˜¶åΩªóùà{|u{ãpwúiµ≥¢¶Æ–@™N˚Iä˚*R_ƒ˚·Vtàiá˚*}™¯=™§˜'˜1˜'˜@˜y˜êÓ’»úP˚.˚É6F;ãÛ˜ ˚'˚‚˚˜˜‰˜˜˜-Ù˚˚4˚˚˜Î¯£öõïßØlìyÅxâqt˚˚1√˚*˚b´˜ˇ wÄ ˇ VÄ ß˜l¿Ç™ß„<˜˚˜˜,˜f⁄ÚÄ¯v¯"¿˚ÍÄõciëg˚G<;CªU’pâÈ@`AdLW¨|∏{âÏ@SÜgmcS’h˜˜˜¶˜˜˚ïZåÒÄJåAåqåã≠©∞üûÏããî®”¢¨ø»«m®ÅïÏ@>¸Vøß|gD˚ãcz"çÀ°îò•†ÍÄ¢˜ˇ êœ»Õã5^RàCLPÑ«–˚*}ÀK“¯´§˜&˚˜˜˜¨¯mÀÅÅàààäáãuãûë˜ôÈ2∂˚˚LNLG¡ãóøö±ù≤mìã†õ¢üØ’ôfXBt˚"`˚c#?…lª£—êÃÃoëìa—∏∞£¨ß˚Wƒ{}tpig|Ø™‚Ó®¢êœ¯£öõïßØlìyÅxâqt˚˚1√¸ã£¯1£–˜˜ì£dèÉ°™¯˚Ts±ÑöÑ^˚∫[zàgÇs˜ÉÖ¯¸£öõïßØlìyÅxâqt˚˚1√¸$~˜=¥˜=¥“\Øfª∫±Øªπe≤\[gc^˚—†v˜?˜∑˜á˜≥˜≥˚á˚˜á-}Ã¯£Ã˜˜˜¯≠∂^åÄù≤˜¸˚]s≠àßäT˚ØxxrreTä∂ß˜Á˚Ps¥Ñìc˚êD≠FÒŒπ¥§®Jƒûôå˜ò˚(¯Ë£öõïßØlìyÅxâqt˚˚1√˚—˚'v˘Úwπ˜˜∆˘JTr˚a˚˚∏9ß˚j˜|˚ß*∆Y“˜§˜≈À∑ﬁ√˚—˚'v˘Úw˜B˜¶˚<¬§˜a˜˜∏›o˜j˚|˜oÏPΩD˚§˚≈K_8S”ã§˜@≤¯Zwî˜˚˘<Ë˘E§á^{ÆÛ_˚s¯¢o˚r¸∏m@}iUÉr˜_§iç[é±õõ¥ß”˜uôk´ApjyäMÜr˜ÿ¸à˜ÄÈ˜á˚á„¯‚£öõïßØlìyÅxâqt˚˚1√˚bã´¯!´ˇ )Ä ˇ Ä ¯8˜4oÑloITvqÉlâlãn˜{¯'•¸Ñ˚"••˜∫ã˜
å˚~¸(r¯˚*~´˘®ß˜˚˜˜9˜˚˜‘˜<¯÷¥¨≥º’öDXOystlÅê˚≈ËÌ˜˚4H6.8ÀN÷aËHv8d˚˚Q˜ ˜#ÁŸ˜ËK—5æ‰¬ù‹Ø‡‘ƒc„˚,Ë˚	¸ß‘†™©∏œ^Ã`9qã02JmÕ”˚*É»˜™˜ãw˜¯	Ÿ∏˜)¯π˜™∂˜˚÷ÿ*˚Ì”Ü◊ÜŒm¿t¡YN9IuiLR‚ãF`xkoRÕlÿ˜JÛ˜˜ÌP ^§H±Më0ê˜Ú}πxv˜¬πxæ˜i±ì∫ôw˜˜˜V≠–˜	˜T¨ï‡˘ Á±«˜SŸΩèQz@F˚EVã≥üï‡˚	¶DΩM›˜&À˜Hﬂ—iø3)˚˚˚´‡˜U¯—eÑÖÉÑÜÑÜO\5Tuôôx•‡òwzô\I˚+<˚C=«WŒ˜%—˜>˜m‡ëäêãëàùñâõ≠ºñô©çâ˚Ó¸¸¬•‡+¯%∆’˜G∆îï~ÜòòÜõÅmAK˚.;ky†´˚*ìv˜ü∏Üvã•˜˛¶•˜,˜˜1Æ™~˜¿©˜"˜T˜J˜Ñ˚ƒ1˚He˚>UŒ˚@˜e–ùöåéöÆöçôêöìX˚Q˚	X'wû˜'¯é⁄ã »…öM˚YtÖXà{ÉäpÜ{F{◊˜$˚*~ß˘ß£˜2˜˜2˜“˜rIÇKÜvwÜÄgfWzÀ˜#˜yﬁã˜Œª†Q˚+˚∫˚˚]Ì˚$˜˜ ·˜9˜H˜Ñ˚˜"&˚#˚êxû˘8ö˚zó˜†í¸ué}ô˘*ô˚vï˜sã˜öì¸|å	∑
˜å
7í	˜é˘
endstream
endobj
23 0 obj
<<
/Descent -203
/Flags 262178
/FontName/LYGIRE+Times-Bold
/CapHeight 676
/FontBBox[-168 -218 1000 935]
/StemH 0
/ItalicAngle 0
/FontFile3 22 0 R
/StemV 139
/XHeight 691
/Type/FontDescriptor
/Ascent 676
>>
endobj
24 0 obj
<<
/BaseFont/LYGIRE+Times-Bold
/Type/Font
/Widths[250 0 0 0 0 1000 0 0 333 333 0 0 250 333 250 0 500 0 0 0 0 500 0 0 500 500 333 0 0 0 0 0 0 722 667 722 722 667 611 778 0 389 500 778 667 944 722 778 611 0 722 556 667 722 722 0 0 722 0 0 0 0 0 0 0 500 556 444 556 444 333 500 556 278 333 0 278 833 556 500 556 0 444 389 333 556 500 722 500 500 444 0 0 0 0 0 0 0 0 667 0 0 0 500 0 0 0 0 0 0 444 0 0 0 278 0 0 0 0 500 0 0 0 0 556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 0 389 0 0 0 778]
/LastChar 238
/Encoding 21 0 R
/FirstChar 32
/Name/F1
/Subtype/Type1
/FontDescriptor 23 0 R
>>
endobj
25 0 obj
<<
/Differences[32/space 37/percent 40/parenleft/parenright 44/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon/less/equal 64/at/A/B/C/D/E/F/G/H/I/J 76/L/M/N/O/P/Q/R/S/T/U/V/W 90/Z 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z 135/aacute 142/eacute 146/iacute 150/ntilde/oacute 156/uacute 199/guillemotleft/guillemotright 209/emdash 231/Aacute]
/Type/Encoding
/BaseEncoding/MacRomanEncoding
>>
endobj
26 0 obj
<<
/Subtype/Type1C
/Length 8943
/Length1 8943
>>
stream
  BWGAKU+Times-Roman   @¯ ¯¯¯¯˚<˚n˙|˙
 ãã
 ãã  5  1  ⁄ª  "ø ∑¬«003.001Copyright (c) 1985, 1987, 1989, 1990, 1993, 1997, 1998, 1999 Adobe Systems Incorporated.  All Rights Reserved.Times is a trademark of Linotype-Hell AG and/or its subsidiaries.Times RomanTimes  Q  # 0 3 2 6 &    ' " 4  1 - 7 + . ) / * F D J C E P        Q U B    S W G M N H ” T O V œ $ ; [ ◊ % R  ÿ ! » ( Y K Z  I ﬁ 	 
  5 X  L  j x 8 â  ´ S   ï Â`Ÿ9¥∑Ô,ùv»8{œÑÓOÖÿ/çÓ	{	√

s
é
Û?pöfÛ,ï|Ÿ'cÿ4ª-òe¶Ï£zêıøjÁxﬂ^ø5æ¯2é‹p6¿‰eÁuä≠ ;¸$úãûx∞˜µ≥˜ó∞xû˜Ò˜ÜÒ:˜Æú˘›áôA¸PDz7âx˜‚≠˜rü˜±Ù;ª4ùçÆ∏ñ„°˜˜/˚Cô4˚¨˜Z˚‰Î´ÜÅ≠uø{ºj9˚˚ÇIQyè∞¯ôöçôüïôåã†∂“Ûx˚˚˚âo,ä”}Ø¯˛Ø≠˜¯>˜˜˝}˜I˜&˜˜i˜z˚7˜˚8˚8˚7˚˚z˚i˜&˚˜IØ˚%‰˜p˜x˜‹ÒÒ˜:˚x˚p%2˚úãû˜¥Ø˜Æ∞xûÒÒ˜~˜Ï˘'ûbçsùu¶˚b˜ëæï˜£˜˜.˚9†2˚®‹x—ÑöÇA¸E@áv:Üx˜©û;èÅûŒ˜Y√ç˜Ç˚»˜5Ï¸[¯·®îí¿¥˜à˚˚#˚*â7ä”˚Fû˜,®¯˛Ø≠˜¯>˜˘Q˚3/çR©\∞zôVøÇú˜ ò˜.Ûã˜pã˜z˚7˜˚8ã˚8ã˚7˚	ã˚yã˚i˜.Ër∫T2Ÿ˜j˜òüãåô˚Ë˘≈Ò˜:˚y˚o%2˚˚%‰˜o˜y˜‹Ò”}∑¯˘ûÛÒ˜˝∑˘U˘*˚|x—á£z ˚¢:Åj~u\nRk=˚Bã˜À˜‘“óò⁄ëû˚Øx◊ÜôÄA˚ÃOã˚W˜å˜óã˜P€˜ôÙúöÿìdã±˜µ¥˜î±xûÓÒ˜ú¢¨ˇ Ä Ó¯È˜=o&_Ym˚˚)ãå¥˜å˜.âﬁäö}ó;¢˜|tDÄÅs2˚.˜r≠óã†˜˜•{2ö§à˜#¸ßﬁx Ü£Ö<¸P>tÇKáx¯∞¸$˚*ãö˘)w˜i·˜
˜®ö@wñª¯ÏÉç˚H0}°√ããó≠ãqv¸YAfâQâ¸$Ö˜ 8v˜0≤†ﬁ˚!©ï›Õ“ﬁQòtrj|`cØÅ•íêååéåèéåç`ííÜÇx{^Ia-ãû˜»¥˜î±xûÓÒ˜ì¢µˇ Ä Ó¯s˜{˜|t@Åyw9˚%˜r©íè§˜˜•{2ö§à˜#¸ßﬁx Ü£Ö<¸E9|@áx˜¨ûDéwó÷˜n˜%÷â£Åñ7”ãû˜Y¥¯5wö˜˚˘GË˘Vû_é}ñk‘˚ç¯Ãw˚d¸x_lBtryxzâ{äx˜Zûv\ãµñéôêòπ˜	˜ö¥+ë}òjã{fjäfx˜ì¸~˜ï˜˜ß˜˚ß-}Ø¯˘¥“·˜}¯S˘8vÄâÜtorU≠O10S˚(À_ÁV˜'5õiRUcR;˚X˜∫xt©˚h°õïú†©ºiã◊˜#œÎ‡˜a˚‚üã˜*…æ™ΩÙÀ19ú§˚*ã◊¯¢’˜Ê·¯o˜~êdLxàfã˚É˜<˜D∑∫ﬂÊãı˜1œ03-[˚+m†Ü°¡©◊Êã˜
§/X@`14.˚F˚Q¯-ãû˜°≥˜Ω∞xûÔÒ˜{˜‹õ˘‘ÑñD¸ECãt7Öx˜¨û>çzö‘˜Jâ£ûä£ÙÀù¥∂úõ∑¥ŸÏ˜˚¿˚˚ú˜ND¨ñå©∑˜&â˚#˚,˚ãfvwåçxdã≤¯ûÓÒ˜∫˘*˚Æx Ü£Ö<¸P>tÇKáx¯Æª˜Br˚RKá˚*8yå≥¯m⁄§íœè”ïv˘"û¯…˜˘M˘*˚ax±âÆàbvzaâÖ˚'¸˚+˜Êtæy¥ãö´ûç√éû˚ûx∫âù¥0˜ä¸πö˜r¯≈©◊ôôªé˚ô}±¯ˇû˜DÒ˜™¯Ω’ôñŸêû˚≥x‹Üó}D¸cW|}se§ﬂãGnzmx}ë{õyñ§~µ¶˜!é˜V˜Éãû˘û˜∑¯ùÒ˘Û˘*˚[˚q¸ç˚{¯ç˚Zx’á†É=¸*˚ v|?Üx˜ûBév°Ú¯#ç˜ç¸∂ô˜í¯Õç¸U9~|=áx˜¨ûKètîÿ¯P⁄£ë ê”ãû˜º∑˜∞ûˆÒ˜√Òû˜™û=êÅûÕ˜b˜√˚W@áu7áx˜™û=êÅûÕ¯P“óò◊ëû˚™x’ÖôÅA˚V˚√˜V“óò◊ëû˚™x’ÖôÅA¸E@áu7á”ïvñû˘û˜∑¯3∑x˘W˘*˚xœÜßÉ˚˚‚â¸¯u˚?x≥õÜY¥¸M˚ v|?Üx˜ûBév°Ú¯ç∏¯L¸∏ú¯¢˜	´è í˚—ãû˘û˜Òù˜ΩûAçsïŸ¯P€§í‘éû˚ΩxﬁáôA¸PDz6â˚bÅ–˜n´˜Ø§–˜eÒ¯,˜8ft`G2I:¥˜E˜À˜ÄDø-;˚N˚M˚"◊9˜˜$≈˜™ï˚€˜,„õ≤¶¬⁄ïH[í˚bÅ”¯®§ÿ¯"˜0Xif`C7F◊˜˜'Á™∞¿êymìëuëvõr£ãé©çõû¢ù~™m†õr^ög˚ ˚8˚8˚2ˆJ€‹Ã∂˜¡¸ãö¯ñøw¢w˜!ÒŸÒ6ﬂ⁄õ˜ÅöFèÜúÕÍ˜˜áéWxXxWz|çòòçôõûäP˚|=zÖMà‹…¯˝xôkØ©°°®ßu¢mh|kx˚*Å´¯ ˜8ö∑w–ﬂ˜w„˜-˜÷ƒèÀù´ÊØ$.I{˚˚rDòÆ7{fÙpΩ˜M∆˜2ÂˆR˜˚?VQtÖâ˜¬Üç[zZ}[~{åëïãë∑ãvm˚*Åøovºö¯ß˜8ö∑w¶·˜wﬂü˜ËÒgÉdsaIC√˜)˜œº√∫ºkGí?˜+˚¶äÑÖãÜZãü∞¯ÀÜç[zZ}Y~{åìïãë∑ãvm˚0®jmô`˚,˚˚ü˚`˜#w≤’∞∞¶ùçNèà¿ûπõªú˚*Åß¯2ß®Â˜ôÂ˜â¯`˚9˚˚˚Â$˜˜,—˜Ó˜%-‚˚ú¸N˚t˜L’Û¬ø Áæ˚˚˚#HeX¸ïvã˜˜å˜ãw‹˜®˜˜†Æú∞™q•mmrrke≠{†˚˚†Æú∞X™q•mmrrk®e≠{†˚*}Ø¯Ê«˜“⁄e”–˜-˜ﬁ§æ¢Ö{™ÀjóAr@b<.Pe√ã]{tÑoW‚Ü£˜1˜„˜"˜6Æaù‡Õ∂¶∂¡¥pÈ˚H2l˚cöáößµŸÊã’ØVX/@[0n¸ív˘FwÇ˜º˜≥˘8H˚y˝Fœ˚*ûv˜É∂¯ß©Á˜ÑÏ∆u˜íõ˜&˜R˜h˜;+˜˚˚;˚ ˚9π˚˜Ω¿ù∞∑çâÖrT˚w˚Üc˜∆˜˘yà~Åzvayj!u˜	◊›¢Ëﬂ˜ã˚WP˚*}•˘•£Î˜òÎ˜é˘˜ç˚èG<â˚Ñ˚˚â˜Ç‹œç˜è˜•˚La˚w˚
˚µ˚t˜L˜Lµ˜t˜˜
a˜w˚L˚*òv¯Ë’ü¯A¯U˘*¸{_`$úÉ¨øù®Ãã˜m˚Z¸ËÃ˜h˘"¸$ïvã˜—˜†˜Ä†Æú∞`™q•mmrrk†e≠{†˚*˚mù˜Q´¯öÇ«÷ﬂ˜u·‹÷˚`ávIÜz˜ÜùC{ñÀ˜1k¨ßÄ≥˜“˜ ˜˜?›2>]Zovâç‘ÖçÏ[x[z[|{åîïãîÆézc‹ﬂà±ë√ßØ˜ê˚6t˚B1xjT\∂¢¸Åø¯´—ﬂ˜ì¯V&˜ìãêÑfV|ueduuuÖããàçàçä¿˚¡'¥pæπ∫¨∂£~ñÄ~yukãXã∆™˜≤˚bÅƒ˜Üv˜<£∞„Fﬁ˜(‹Ù˜≥˜màl|ÜÇl~ufn™∫ç≠ñ√˜+Ω˜/˚^ÇÄ~Åvnã®®˜W«ãÔ˚)Ï˚\Dc{óo™•û°†îÜöãö™±ù¨©∫ÄCNÙ˚7K4i'Høf¡¬¿≥¨∞Cêµäùõ™åºµ˚*†v˜;À¯Qwó≥˜ÑŸ¯l˜{%¯Q_˚Œ¸QK˜≠˚;ÿ˜;Ò˚HÀ˚Ñ˜Ç˜Ëç˚*}∞¯ƒ⁄˜¯—˜I¯€˜Xñîãîé±‰ÇíÄ|ÇÄqã˚e˚˚ÅäâãâãäÜéàè˜ á˜E\˚4˚ASJUp…ãKcãnÅg∫s⁄˜2˜ı˜‰Ä®`øP”-ú;ô˚*}ß˘ß√◊E’˜o–T◊‰˜h˜Ã˜9µmAE\aL:]ÃÿËÊª≤´•˚0˚:=Õ9˜‰˜:¨˜øŒv≈˚Îÿ¡®€µÁ◊MÕ˚5&U&:≥iﬂAË2Gbl4ÿ€¯%ª´¿÷ÿÆUT3Sferg¢2ƒŸ˚—ãö˜ÔÌIóÇ ◊ﬂ»◊ﬂS{àTÅ|˜ÑöXçiè–ò˜u´∑Ω£»£ïhãÆ£ôû§¨w†ieiwD\â‰Üç®ZwYyZ{{çîñçôõûäP˚*ív¯Uö¯Á¯q¯V˚|§ä°ÇtgD˚0i+%˜îàìÖöãó§°é£çö˚X|üäüÖömØDÎ˚|£Mõ`çáîãíãî¢ñ¶˜˜’£∆íõ≠é˚—ãö¯'´˜aßÚﬂ˜…¯V˚˜∞êø¬∫ê@ãµü¢ò®≠_¶S˚Hã˚ES9k›˚Œ>zÇIà|˜òö/çä•»˜Œ˜¸ãö¯ˆô∑wÌﬂ†˜ÄöQézì≈¯ÈáçVzV}V~{åóîåò≤ë{^¸qTy~Pá˜ãö¯òÑø·ﬂ˜Lﬂ˜Lﬂº·‡Hmâcä|˜röhåjçº˜Æêπ¡–øúdI˚mJtà^à|˜töbålé◊˜ê≠°≠¶¬”åPX˚gK{âYÖ|˜oöqçaíä¶ã°˜e’}Û#<NOsvµÄlµJUbk^P÷Ñç‹]z\|\~zçìïçôõûäL˚*˚nƒ˜Hv£v˜(§˜j≤êßß—nﬁ<«˜Xÿ¶ß÷ Ì1©ù†™∞∫Å°ãÈà’âºâã^ãVG_˚	ã˚ãg≥ã™µ`¡¯DŒ≤¢Ø·õ˚ouÜAG=q‰⁄π ˜“π≤>{yçìvµ öcuìh?+[˚Q≠]∆q¥†2<ã~zo•¶~∂ Xg\b^V÷_ÒÂ˜:√˜ß}’ ê∏‡˚ëmå[éã¢ü≥¥üçëØÜãó√Ú≤˜ ΩÇûÅ¢¸ãö¯ñøw¢wÍﬂÿõ˜ÅöFèÜúÕË˜˜áé˚/T|çòòçôõûäP˚|=zÖMàÂ¯Ä˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˚ôÅ°êv¯[wë¢æ…Nò˜i—[ò•˜œ˜Œá˜ÄôáàÜÑÇzlü_*`ISA¬f…hñ≈j´yüsãkR\{i)x‚¿{U˚0òñîëèéóçßµyã∑À‹µ‚«hßZ©ô˚ Àf°Ö®ãü•†≤¬∑∏v%°˚*ãö¯òÅ¬€ﬂ˜Dﬂ∏€ÂP|~\à|˜höWé}õ¨˜≠∞±™ü©∆ùgN˚e?qÜfà|˜döZèö∫˜y˜D¶]Peh]Z⁄Ñçÿ]z\|^~zçèñçôõûäL˚*Å≈iv∂ô¯ú“ﬂ˜Fﬂ<¯sΩÑVâ°Æ˜Î˚2z—âèvcú˚jÑÅÇÉupm}mIÇ…ô˜⁄˚&}©â´âO˚ê!Ÿs¥ùªè≤≤|∂∂8çâ∫ú±ô¡ô˚bÅ–˜n´˜Ø§–˜eÒ¯,˜8ft`G2I:¥˜E˜À˜ÄDø-;˚N˚M˚"◊9˜˜$≈˜™ï˚€˜,„õ≤¶¬⁄ïH[íA˜Z˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(ú}∑¯Ú≥ß˜˘ ¯WÇ˜uvjÉjãÜuJ¨2˚@˚<˚˚t˚ç˜A+˜5˜L·˜çåyùlmCD˚ã˚˚‚˜h˜$∑À≤±¥µ≈üΩ˜”;"§dã±¯ﬁ±î¯‡¯“˜DBuxJ˚˚ï¯D¯ıö¸¢w˚?•ŒòóÕ˜#˜q¸I¸ı|¯»£˜D˚bã©¯©ˇ 6Ä ˇ Ä ¯6˜yè{=Öl!ã˚˜°¯)ö˚Ôà˚
ù¡íè≠‘˜˚û¸)|¯˚*ãö¯òÅ¬”√Å¬€ﬂ˜Dﬂ∂€ÂP|~\à|˜höWé}õ¨˜≠∞±™ü©∆ùgN˚e?qÜfà|˜döZèö∫˜y˜D¶]Peh]Z⁄Ñç÷]z\|^~zçèñçôõûäL˜∆˜¿cz}Åp|vîëÆsótóuëvãHmR_É®úëñ®±óòÜÖó∂¢Ä®}†Å™ãŸù”≠î”ã∞¯‡∞xûÛÒ¯˜ÿõ˜∞˜∆⁄˜X˜˜t˚3˜˚Ñ˚¢∏xÿÖñÅA¸PE{?áÿ˜R¯Àüãû∫˜√p`ª–M£:7˚∑˚äãK[í≠˚*˚mú˜R»¯ßáw£·˜{ﬂÏ˜¸¯=°dtòX˚)˚˚˚+÷D‰»—µ©úê˚NY}t@àz˜Äô^ïyèª‹¯ÈáèÑàB˚ﬁäkã{WxyÑzâ|ã2ãdÍãÁÏ˜¡‘‹ÍåDo˚—†v˜V ≤˜ä≤˜ïL˜ä ˚*Åß¯2ß®Â˜ôÂ˜â¯`˚9˚˚˚Â$˜˜,—˜Ó˜%-‚˚ú¸N˚t˜L’Û¬ø Áæ˚˚˚#HeX^¯}˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˜£}≤˜
¨k∂˜©∑˜™˜ﬂ˜“˜"Œ˜<≥æÄ¯–¯#˚!~MDaho£«˜‰”ªﬁÄ©òta˜˚⁄qRWu2˚B˚˜˜#˜r˜˜
˜-˜KÙ˚+˚5Z˚
:ﬂÄkÖ£üìåìåèÃ˜íFÅe~£ß]ã˚M˚>EæÄ˚ |©éﬂÄ≈ëππñùçä}£SÃ˜Œ˜Ò˜=˚$˜˚L˚Z˚;˚%˚l˚˜˚W˜ôŸœß® ˚bÅƒ˜Üv˜<£∞„Fﬁ˜(‹Ù˜≥˜màl|ÜÇl~ufn™∫ç≠ñ√˜+Ω˜/˚^ÇÄ~Åvnã®®˜W«ãÔ˚)Ï˚\Dc{óo™•û°†îÜöãö™±ù¨©∫ÄCNÙ˚7K4i'Høf¡¬¿≥¨∞Cêµäùõ™åºµ˚ë¯g˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(”}≥˜ ù˜Æ≥´˜¯ Ïd•¯˘Y˜ˆ˚ìyœÜüä8˚6gFtG˚/#˜˜I˜ë˜' ÍÙ˜ ø(C¶¢É˜guoÖjÜÉk]¨&˚h˚˚;˚<˚©P¿Q>“˜mÓ¯˜˜≈ô˜]“•ç∑è˚*ãö˜©v˜8öú˜%˚%¯b˚`˜2Ë˜¬‘èÜó|vÇálä|˜]özåpåe≈˚˜XÙﬁ˜ìò©©∂åö˚2|úä¢ävÄÖÇN3x®b»ù†§çùö˚c|ï•ôÖUØÈ˚$˚˚9k]}âpà|˜%özvãùâñô†ëî⁄˜¸˚n≠¯÷óæw¢w˜!ÒÁÒ6ﬂ⁄˜^9ãRYgÅ«ã`xv|tfπx∫˜¥˜	Í¯]ÜéWwWyW{{çöòçôõûäP‹z˜æxôkØ©°°®ßu¢mh|kx˚*˚nﬂ7Ò¯ªöô¯a˚˜®¯o¯V˚|è®öÅyÇ~kÅp=˚r˚˜ëàíÑõãò¶Æå¢åö˚b}òâ•Üór˜˚äôlª/|{c˚Wp~lùãp]âeÖ®q¢kΩ÷∑Õ˜æ˜.¯,ö¥üçòç˚*}ß¯π˜Ñõ≠Ë˜èÂ¯R˘@˚ÜÉ˚>˚J˚_˚fÒ,˜
˜FØ˜3‘˜=◊!SvjTû˜Ó˜˜Fß˚b˚≤ı©'$˚]WL@H’˜<«ï£ïï£§Øì≠˚*ãö¯¡˜8ö∑w‘ﬂ˜Nﬂ¯{öYîÅê‘˜[≥ä˜˚OZkYhâ˜¬Üé[zZ}^~{åéïãë∑ãvm¸kBÅÑUÑ|˜löZêxêÿ˜Öª¥≤ö®¬°dH˚Z>xÜZÜ|˜h˚*Å≈iv∂ô¯ú“ﬂ˜Fﬂ<¯sΩÑVâ°Æ˜Î˚2z—âèvcú˚jÑÅÇÉupm}mIÇ…ô˜⁄˚&}©â´âO˚ê!Ÿs¥ùªè≤≤|∂∂8çâ∫ú±ô¡ô˚ö¯k˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˚—†v˘8wª·˜ª˘8˚///˚*˚@˚¨CºC±SÕE≈lóõ˚>˜ã˜oÒ˜íÎŸ’∆˚—†v˘8w˜[·±˚E˜/ÁÁ˜*˜@˜j”Z”e√I—Q™{˜>˚ã˚o%˚í+=AP¸Ö˜ 8v˜Ú˜ãw‹˜≤îˆ˚!¨ó⁄Ã—ﬂPóvÄ[àTf©~´íêååéåèéåçTííÜÇx{^Iah±¯j†Æú∞™q•mmrrke≠{†dãû¯Ìµ¥v˜~Ò˜~v8¯Xû7éûœ¯ì¡˜ßy˚†£Ö˜>¸»Ö˚>£˜°¶û˜¡¸àAàt0áx˜∏”ív˜¿v˜>ö†˜¯4˜¯œ¯V|£ÜüásÖpÄr1˚r;˜j|≤Öñãù®§é¨êö˚_|¥ÜñÑ∞˚0˚[]˜P˜Æß¢è¢çö˚H|§âì~ü[˜˚ÍiôêÅíëêñßô˜˜ÑÊ˚ÄôgçÑìãìèï≤õ˜˜Óö∞êï†íö˜Kìvò©˜ó≠õ´˜h§£©ôw»◊˜r§Ã◊˜q•U‡˘+¯˚#˚!F©GË˜⁄˜*˜ÚBígU‡òk≥©gZ6E˚4Kã√üµ¡˜SÏ[‡a˜Âdmkbe7Wyôò{u‡ô{}ò]˚
*˚'&”h∏˜ÿ˜/Ûù‡†àïáôÖöóá≤¡ßöò¢çâ˚Ò˝ªu‡Y˜‰dtû¬ﬁŸ˜,Õû~{{ ëxéÄz˚;˚
;˚*ãö¯8ö˜Cô∑w›ﬂí˜~öwåjçuìã¥˜Iç˜˚LózîÇãÑ~~àÉx|˜nöpçdíXÀ˚-˜V®¶˜˜ßã¿ãö˚`}µìÉÄÇÉÄ|}ciPTglâç¯4áçVzV}Z~{åìîåò≤ë{^¸vUÉâHÄ5òvß¯ê¯¨«¸=˜U¯=˜Uœ¸ê˚zM¯ê˚z˚*¡v¯wµ¯2µ˜wâ’KïÇSÀ¬Lìëêèíòo≥y£u©d∑u©°®ı˜ãôãíâèÉãáãããKLHPjo˜5pâ’KïÇSÀ¬Lìëêèíòo≥y£u©d∑u©°®ı˜ãôãíâèÉãáãããKLHPjo˚*¡v¯w∑¯2¯^˜rçAÀÅî√KT ÉÖÜáÑ~ßcùs°m≤_°mun!˚ã}ãÑçáìãèãããóóÀ Œ∆¨ß˚5¶çAÀÅî√KT ÉÖÜáÑ~ßcùs°m≤_°mun!˚ã}ãÑçáìãèãããóóÀ Œ∆¨ß˜∫ïv˘"û˘∑˜˙8˘*˚Zx≠àÆádvÉmÉv˚˚Á˚˜È|≤°ãúØπç™û˚üx¿äöÖ¨8¨9 ˚Æ˚$¯ÜòÖúãô•üë∏çû˚âxƒÜôn´8±'Û˚∞æ˚-ö˜.¯;∂˚›˚fÆ#ö∆˜U€˜j–˜Nô≤õôºì˜Ú†v˜]ºã˙|˜éZ˙|º5†v˜Õ˜Õ©¯å¯™¯¸åI¯å˚¸åI¯å”ãû˜Y¥¯5wö˜˚˘GË˘Vû_é}ñk‘˚ç¯Ãw˚d¸x_lBtryxzâ{äx˜Zûv\ãµñéôêòπ˜	˜ö¥+ë}òjã{fjäfx˜ì¸~˜ï˜˜ß˜˚ß˚¯b˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(}ô˘*ô˚vï˜sã˜öì¸|å}ô˘*ô˚vï˜sã˜öì¸|å	ß
ﬂ˜é˘
endstream
endobj
27 0 obj
<<
/Descent -217
/Flags 34
/FontName/BWGAKU+Times-Roman
/CapHeight 662
/FontBBox[-168 -218 1000 898]
/StemH 0
/ItalicAngle 0
/FontFile3 26 0 R
/StemV 84
/XHeight 676
/Type/FontDescriptor
/Ascent 683
>>
endobj
28 0 obj
<<
/BaseFont/BWGAKU+Times-Roman
/Type/Font
/Widths[250 0 0 0 0 833 0 0 333 333 0 0 250 333 250 278 500 500 500 500 500 500 500 500 500 500 278 278 564 564 0 0 921 722 667 667 722 611 556 722 722 333 389 0 611 889 722 722 556 722 667 556 611 722 722 944 0 0 611 0 0 0 0 0 0 444 500 444 500 444 333 500 500 278 278 500 278 778 500 500 500 500 333 389 278 500 500 722 500 500 444 0 0 0 0 0 0 0 0 0 0 0 0 444 0 0 0 0 0 0 444 0 0 0 278 0 0 0 500 500 0 0 0 0 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 500 0 0 0 0 0 0 0 0 1000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722]
/LastChar 231
/Encoding 25 0 R
/FirstChar 32
/Name/F2
/Subtype/Type1
/FontDescriptor 27 0 R
>>
endobj
29 0 obj
<<
/Kids[30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R]
/Type/Pages
/Count 6
/Parent 36 0 R
>>
endobj
30 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R/F0 20 0 R>>>>
/Parent 29 0 R
/Contents 5 0 R
>>
endobj
31 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F0 20 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 6 0 R
>>
endobj
32 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 7 0 R
>>
endobj
33 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 8 0 R
>>
endobj
34 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/XObject<</Fm0 11 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F0 20 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 12 0 R
>>
endobj
35 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R>>>>
/Parent 29 0 R
/Contents 13 0 R
>>
endobj
37 0 obj
<<
/Kids[38 0 R 39 0 R]
/Type/Pages
/Count 2
/Parent 36 0 R
>>
endobj
38 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R>>>>
/Parent 37 0 R
/Contents 14 0 R
>>
endobj
39 0 obj
<<
/MediaBox[0 0 501.73199 700.15698]
/Type/Page
/Resources<</ExtGState<</GS0 1 0 R/GS2 3 0 R/GS3 4 0 R/GS1 2 0 R>>/ProcSet[/PDF/Text]/Font<</F1 24 0 R/F2 28 0 R/F0 20 0 R>>>>
/Parent 37 0 R
/Contents 15 0 R
>>
endobj
36 0 obj
<<
/Type/Pages
/Kids[29 0 R 37 0 R]
/Count 8
>>
endobj
40 0 obj
<<
/Type/Catalog
/Pages 36 0 R
/PageLabels 16 0 R
>>
endobj
41 0 obj
<<
/XPressPrivate(%%DocumentProcessColors: Cyan Magenta Yellow Black\n%%EndComments)
/Producer(QuarkXPress(tm) 6.5)
/CreationDate(20080603125837)
/Creator(QuarkXPress(tm) 6.5)
>>
endobj
xref
0 42
0000000000 65535 f 
0000000015 00000 n 
0000000059 00000 n 
0000000111 00000 n 
0000000157 00000 n 
0000000204 00000 n 
0000009590 00000 n 
0000019254 00000 n 
0000029610 00000 n 
0000039389 00000 n 
0000060273 00000 n 
0000060808 00000 n 
0000061469 00000 n 
0000070514 00000 n 
0000078294 00000 n 
0000087654 00000 n 
0000097705 00000 n 
0000097751 00000 n 
0000098146 00000 n 
0000107272 00000 n 
0000107495 00000 n 
0000108213 00000 n 
0000108610 00000 n 
0000115899 00000 n 
0000116121 00000 n 
0000116830 00000 n 
0000117292 00000 n 
0000126318 00000 n 
0000126536 00000 n 
0000127264 00000 n 
0000127371 00000 n 
0000127597 00000 n 
0000127823 00000 n 
0000128039 00000 n 
0000128255 00000 n 
0000128505 00000 n 
0000129245 00000 n 
0000128722 00000 n 
0000128801 00000 n 
0000129018 00000 n 
0000129309 00000 n 
0000129378 00000 n 
trailer
<<
/Size 42
/Root 40 0 R
/Info 41 0 R
/ID[<FE17D168C8B27239B012BDA99E3598E6><FE17D168C8B27239B012BDA99E3598E6>]
>>
startxref
129573
%%EOF
